U.S. patent application number 14/295184 was filed with the patent office on 2015-01-29 for membrane bioreactor for increased production of isoprene gas.
The applicant listed for this patent is Danisco US Inc., The Goodyear Tire & Rubber Company. Invention is credited to Anthony R. CALABRIA, Gopal K. CHOTANI, Robin FONG, Alex T. NIELSEN, Karl J. SANFORD.
Application Number | 20150031105 14/295184 |
Document ID | / |
Family ID | 43827141 |
Filed Date | 2015-01-29 |
United States Patent
Application |
20150031105 |
Kind Code |
A1 |
CALABRIA; Anthony R. ; et
al. |
January 29, 2015 |
MEMBRANE BIOREACTOR FOR INCREASED PRODUCTION OF ISOPRENE GAS
Abstract
The invention provides improved methods for the production of
isoprene from biological materials.
Inventors: |
CALABRIA; Anthony R.;
(Wilmington, DE) ; CHOTANI; Gopal K.; (Cupertino,
CA) ; FONG; Robin; (Mountain View, CA) ;
NIELSEN; Alex T.; (Kokkedal, DK) ; SANFORD; Karl
J.; (Cupertino, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Danisco US Inc.
The Goodyear Tire & Rubber Company |
Palo Alto
Akron |
CA
OH |
US
US |
|
|
Family ID: |
43827141 |
Appl. No.: |
14/295184 |
Filed: |
June 3, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12976572 |
Dec 22, 2010 |
8778647 |
|
|
14295184 |
|
|
|
|
61289352 |
Dec 22, 2009 |
|
|
|
Current U.S.
Class: |
435/167 |
Current CPC
Class: |
Y02E 50/343 20130101;
C12P 5/007 20130101; Y02E 50/30 20130101 |
Class at
Publication: |
435/167 |
International
Class: |
C12P 5/00 20060101
C12P005/00 |
Claims
1-124. (canceled)
125. A method of producing isoprene, the method comprising: (a)
culturing cells comprising a heterologous nucleic acid encoding an
isoprene synthase polypeptide under suitable culture conditions for
the production of isoprene; (b) removing a portion of the culture;
(c) filtering the removed portion of the culture to produce a
permeate and a retentate; (d) returning the retentate to the
culture; and (e) producing isoprene; wherein the cultured cells
undergoing steps (b), (c), and (d) either produce isoprene at a
higher titer, or have greater average volumetric productivity of
isoprene than the same cells cultured without undergoing steps (b),
(c), and (d).
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No. 12/976,572, filed on Dec. 22, 2010, which
claims priority to U.S. Provisional Patent Application No.
61/289,352, filed on Dec. 22, 2009, the disclosures of which are
herein incorporated by reference in their entirety.
FIELD OF THE INVENTION
[0002] This disclosure relates to improved methods for the
production of isoprene.
BACKGROUND OF THE INVENTION
[0003] Isoprene (2-methyl-1,3-butadiene) is an important organic
compound used in a wide array of applications. For instance,
isoprene is employed as an intermediate or a starting material in
the synthesis of numerous chemical compositions and polymers.
Isoprene is also an important biological material that is
synthesized naturally by many plants and animals, including
humans.
[0004] The isoprene used in industrial applications is typically
produced as a by-product of the thermal cracking of petroleum or
naphtha or is otherwise extracted from petrochemical streams. This
is a relatively expensive, energy-intensive process. With the
worldwide demand for petrochemical based products constantly
increasing, the cost of isoprene is expected to rise to much higher
levels in the long-term and its availability is limited in any
case. There is concern that future supplies of isoprene from
petrochemical-based sources will be inadequate to meet projected
needs and that prices will rise to unprecedented levels.
Accordingly, there is a need to procure a source of isoprene from a
low cost, renewable source which is environmentally friendly.
[0005] Several recent advancements have been made in the production
of isoprene from renewable sources (see, for example, International
Patent Application Publication No. WO 2009/076676 A2). Such methods
produce isoprene at rates, titers, and purity that may be
sufficient to meet the demands of a robust commercial process,
however process improvements to reduce the operational costs
associated with the production of isoprene derived from biological
sources, and to increase yields of isoprene are needed.
[0006] All patents, patent applications, publications, documents,
nucleotide and protein sequence database accession numbers, the
sequences to which they refer, and articles cited herein are all
incorporated herein by reference in their entireties.
BRIEF SUMMARY OF THE INVENTION
[0007] Disclosed herein are improved methods for the production of
isoprene from biological materials, comprising the operation of a
membrane bioreactor in conjunction with a bioreactor culturing
isoprene-producing cells.
[0008] In one aspect, provided herein are improved methods of
producing isoprene, the methods comprising: (a) culturing cells
comprising a heterologous nucleic acid encoding an isoprene
synthase polypeptide under suitable culture conditions for the
production of isoprene, wherein the cells either (i) produce
isoprene at a titer greater than 40 g/L or (ii) have an average
volumetric productivity of isoprene greater than about 500
mg/L.sub.broth/hr of isoprene; (b) removing a portion of the
culture; (c) filtering the removed portion of the culture to
produce a permeate and a retentate; (d) returning the retentate to
the culture; and (e) producing isoprene; wherein the cultured cells
undergoing steps (b), (c), and (d) either (i) produce isoprene at a
higher titer, or (ii) have greater average volumetric productivity
of isoprene than the same cells cultured without undergoing steps
(b), (c), and (d).
[0009] In another aspect, provided herein are improved methods of
producing isoprene, the methods comprising: (a) culturing cells
comprising a heterologous nucleic acid encoding an isoprene
synthase polypeptide under suitable culture conditions for the
production of isoprene, wherein the cells either (i) produce
isoprene at a titer greater than 40 g/L or (ii) have an average
volumetric productivity of isoprene greater than about 500
mg/L.sub.broth/hr of isoprene; (b) removing a portion of the
culture; (c) filtering the removed portion of the culture to
produce a permeate and a retentate; (d) returning the retentate to
the culture; (e) producing isoprene; and (1) recovering the
isoprene; wherein the cultured cells undergoing steps (b), (c), and
(d) either (i) produce isoprene at a higher titer, or (ii) have
greater average volumetric productivity of isoprene than the same
cells cultured without undergoing steps (b), (c), and (d). In some
aspects, the filtering is by tangential flow filtration.
[0010] In some aspects, the cells produce isoprene at a titer of
greater than about 40 g/L. In some aspects, the cells produce
isoprene at a titer of greater than about 50 g/L. In some aspects,
the cells produce isoprene at a titer of greater than about 60 g/L.
In some aspects, the cells produce isoprene at a titer of greater
than about 70 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 80 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 90 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 100 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 110 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 120 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 130 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 140 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 150 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 160 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 170 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 180 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 190 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 200 g/L. In some aspects, the cells
produce isoprene at a titer between about 40 g/L and about 100 g/L.
In some aspects, the cells produce isoprene at a titer between
about 60 g/L and about 100 g/L. In some aspects, the cells produce
isoprene at a titer between about 60 g/L and about 120 g/L. In some
aspects, the cells produce isoprene at a titer between about 40 g/L
and about 150 g/L. In some aspects, the cells produce isoprene at a
titer between about 40 g/L and about 200 g/L. In some aspects, the
cells produce isoprene at a titer between about 80 g/L and about
150 g/L. In some aspects, the cells produce isoprene at a titer
between about 100 g/L and about 150 g/L. In some aspects, the cells
produce isoprene at a titer between about 100 g/L and about 180
g/L. In some aspects, the cells produce isoprene at a titer between
about 100 g/L and about 200 g/L. In some aspects, the cells produce
isoprene at a titer between about 120 g/L and about 200 g/L. In
some aspects, the cells have an average volumetric productivity of
greater than about 500 mg/L.sub.broth/hr of isoprene. In some
aspects, the cells have an average volumetric productivity greater
than about 1.000 mg/L.sub.broth/hr of isoprene. In some aspects,
the cells have an average volumetric productivity greater than
about 1.500 mg/L.sub.broth/hr of isoprene. In some aspects, the
cells have an average volumetric productivity greater than about
2,000 mg/L.sub.broth/hr of isoprene. In some aspects, the cells
have an average volumetric productivity between about 500
mg/L.sub.broth/hr and about 2,000 mg/L.sub.broth/hr of
isoprene.
[0011] In some aspects, the method further comprises a step of
recycling the permeate back into the same cell culture or into
another cell culture, wherein the cells cultured in the presence of
recycled permeate have greater average specific productivity of
isoprene than the same cells cultured in the absence of recycled
permeate. In some aspects, the cells have about two times the
average specific productivity of isoprene than the same cells
cultured in the absence of recycled permeate. In some aspects, the
cells have about three times the average specific productivity of
isoprene than the same cells cultured in the absence of recycled
permeate. In some aspects, the portion of the culture is removed
continuously. In some aspects, the portion of the culture is
removed discontinuously.
[0012] In some aspects, the isoprene synthase polypeptide is a
plant isoprene synthase polypeptide. In some aspects, the cells
further comprise a heterologous nucleic acid encoding an IDI
polypeptide. In some aspects, the cells further comprise a
chromosomal copy of an endogenous nucleic acid encoding an IDI
polypeptide. In some aspects, the cells further comprise a
heterologous nucleic acid encoding a DXP pathway polypeptide. In
some aspects, the cells further comprise a heterologous nucleic
acid encoding a DXS polypeptide. In some aspects, the cells further
comprise a chromosomal copy of an endogenous nucleic acid encoding
a DXS polypeptide. In some aspects, the cells further comprise one
or more nucleic acids encoding an IDI polypeptide and a DXS
polypeptide or a DXP pathway polypeptide. In some aspects, one
nucleic acid encodes the isoprene synthase polypeptide. IDI
polypeptide, and DXS polypeptide or a DXP pathway polypeptide. In
some aspects, one plasmid encodes the isoprene synthase
polypeptide, IDI polypeptide, and DXS polypeptide. In some aspects,
the cells further comprise a heterologous nucleic acid encoding an
MVA pathway polypeptide. In some aspects, the MVA pathway
polypeptide is a mevalonate kinase (MVK) polypeptide. In some
aspects, the MVK polypeptide is a polypeptide from the genus
Methanosarcina. In some aspects, the Methanosarcina is
Methanosarcina mazei.
[0013] In some aspects, the isoprene synthase polypeptide is a
naturally-occurring polypeptide from the genus Pueraria. In some
aspects, the isoprene synthase polypeptide is a naturally-occurring
polypeptide from Pueraria montana. In some aspects, the isoprene
synthase polypeptide is a naturally-occurring polypeptide from the
genus Populus. In some aspects, the isoprene synthase polypeptide
is a naturally-occurring polypeptide from Populus alba. In some
aspects, the cells further comprise a heterologous nucleic acid
encoding an MVA pathway polypeptide. In some aspects, the MVA
pathway polypeptide is a mevalonate kinase (MVK). In some aspects,
the MVK is from the genus Methanosarcina. In some aspects, the MVK
is from Methanosarcina mazei. In some aspects, the cells are
bacterial cells. In some aspects, the cells are gram-positive
bacterial cells. In some aspects, the cells are Bacillus cells. In
some aspects, the cells are Bacillus subtilis cells. In some
aspects, the cells are gram-negative bacterial cells. In some
aspects, the cells are Escherichia or Pantoea cells. In some
aspects, the cells are Escherichia coli or Pantoea citrea cells. In
some aspects, the cells are fungal cells. In some aspects, the
cells are Trichoderma cells. In some aspects, the cells are
Trichoderma reesei cells. In some aspects, the cells are yeast
cells. In some aspects, the cells are Yarrowia cells. In some
aspects, the cells are Yarrowia lipolytica cells.
[0014] In some aspects, the cells comprise (i) an integrated
nucleic acid encoding the lower MVA pathway from S. cerevisiae
comprising a glucose isomerase promoter and a nucleic acid encoding
mevalonate kinase (MVK); a nucleic acid encoding phosphomevalonate
kinase (PMK); a nucleic acid encoding diphosphomevalonate
decarboxylase (MVD); and a nucleic acid encoding isopentenyl
diphosphate isomerase (IDI); (ii) a nucleic acid encoding P. alba
isoprene synthase; (iii) a nucleic acid encoding M. mazei
mevalonate kinase; and (iv) a nucleic acid encoding the upper MVA
pathway from Enterococcus faecalis, comprising a nucleic acid
encoding an acetoacetyl-Coenzyme A synthase (thiolase) polypeptide;
a nucleic acid encoding a 3-hydroxy-3-methylglutaryl-Coenzyme A
synthase polypeptide; and a nucleic acid encoding a
3-hydroxy-3-methylglutaryl-Coenzyme A reductase polypeptide.
[0015] In another aspect, provided herein are improved methods of
producing isoprene, the methods comprising: (a) culturing cells
comprising a heterologous nucleic acid encoding an isoprene
synthase polypeptide in a fermentor containing growth medium under
suitable culture conditions for the production of isoprene, wherein
the cells either (i) produce isoprene at a titer greater than 40
g/L or (ii) have an average volumetric productivity of isoprene
greater than about 500 mg/L.sub.broth/hr of isoprene; (b) removing
a portion of the cell culture from the fermentor; (c) transferring
the removed portion of the cell culture to a filter; (d) filtering
the removed portion of the cell culture to form: (i) a permeate
comprising spent growth medium; and (ii) a retentate comprising
cells and other culture solids; (e) returning the retentate to the
fermentor; (f) collecting the permeate; and (g) producing isoprene;
wherein the cultured cells undergoing steps (b), (c), (d) and (e)
either (i) produce isoprene at a higher titer, or (ii) have greater
average volumetric productivity of isoprene than the same cells
cultured without undergoing steps (b), (c), (d), and (e).
[0016] In another aspect, provided herein are improved methods of
producing isoprene, the methods comprising: (a) culturing cells
comprising a heterologous nucleic acid encoding an isoprene
synthase polypeptide in a fermentor containing growth medium under
suitable culture conditions for the production of isoprene, wherein
the cells either (i) produce isoprene at a titer greater than 40
g/L or (ii) have an average volumetric productivity of isoprene
greater than about 500 mg/L.sub.broth/hr of isoprene; (b) removing
a portion of the cell culture from the fermentor; (c) transferring
the removed portion of the cell culture to a filter; (d) filtering
the removed portion of the cell culture to form: (i) a permeate
comprising spent growth medium; and (ii) a retentate comprising
cells and other culture solids; (e) returning the retentate to the
fermentor; (f) collecting the permeate; (g) producing isoprene; and
(h) recovering the isoprene; wherein the cultured cells undergoing
steps (b), (c), (d) and (e) either (i) produce isoprene at a higher
titer, or (ii) have greater average volumetric productivity of
isoprene than the same cells cultured without undergoing steps (b),
(c), (d), and (e).
[0017] In some aspects, the fermentor and the filter are connected
by a circulation loop and a circulation pump. In some aspects, the
permeate is collected from the filter by a permeate collection
outlet and a permeate pump and stored in a permeate collection
tank. In some aspects, the permeate collection tank further
comprises a vent to relieve pressure within the tank. In some
aspects, the circulation pump and the permeate pump are peristaltic
pumps. In some aspects, the filter is a microfilter. In some
aspects, the filter is an ultrafilter. In some aspects, the
microfilter is a tangential flow filter. In some aspects, the
tangential flow filter has a filter pore size between about 0.005
.mu.m and about 100 .mu.m. In some aspects, the tangential flow
filter has a filter pore size between about 0.05 .mu.m and about 10
.mu.m. In some aspects, the ultrafilter is a tangential flow
filter. In some aspects, the tangential flow filter has a nominal
molecular weight cutoff (NMWC) greater than about 100,000. In some
aspects, the tangential flow filter has a NMWC greater than about
250,000. In some aspects, the tangential flow filter is a GE
Healthcare Xampler.TM. Ultrafiltration Cartridge having a 500,000
nominal molecular weight cutoff (NMWC) and comprising a hollow
fiber membrane.
[0018] In some aspects, the method further comprises the steps of
(i) monitoring the inlet pressure of the filter with an inlet
pressure gauge (P.sub.in); (ii) monitoring the outlet pressure of
the filter with an outlet pressure gauge (P.sub.out); (iii)
monitoring the pressure in the permeate collection outlet with a
permeate pressure gauge (P.sub.perm); and (iv) determining the
transmembrane pressure (TMP) across the filter. In some aspects,
the method further comprises the step of maintaining positive TMP
across the filter. In some aspects, the fermentor further comprises
an isoprene collection outlet connected to an isoprene storage
tank.
[0019] In some aspects, the cells produce isoprene at a titer of
greater than about 40 g/L. In some aspects, the cells produce
isoprene at a titer of greater than about 50 g/L. In some aspects,
the cells produce isoprene at a titer of greater than about 60 g/L.
In some aspects, the cells produce isoprene at a titer of greater
than about 70 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 80 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 90 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 100 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 110 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 120 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 130 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 140 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 150 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 160 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 170 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 180 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 190 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 200 g/L. In some aspects, the cells
produce isoprene at a titer between about 40 g/L and about 100 g/L.
In some aspects, the cells produce isoprene at a titer between
about 60 g/L and about 100 g/L. In some aspects, the cells produce
isoprene at a titer between about 60 g/L and about 120 g/L. In some
aspects, the cells produce isoprene at a titer between about 40 g/L
and about 150 g/L. In some aspects, the cells produce isoprene at a
titer between about 40 g/L and about 200 g/L. In some aspects, the
cells produce isoprene at a titer between about 80 g/L and about
150 g/L. In some aspects, the cells produce isoprene at a titer
between about 100 g/L and about 150 g/L. In some aspects, the cells
produce isoprene at a titer between about 100 g/L and about 180
g/L. In some aspects, the cells produce isoprene at a titer between
about 100 g/L and about 200 g/L. In some aspects, the cells produce
isoprene at a titer between about 120 g/L and about 200 g/L. In
some aspects, the cells have an average volumetric productivity of
greater than about 500 mg/L.sub.broth/hr of isoprene. In some
aspects, the cells have an average volumetric productivity greater
than about 1.000 mg/L.sub.broth/hr of isoprene. In some aspects,
the cells have an average volumetric productivity greater than
about 1,500 mg/L.sub.broth/hr of isoprene. In some aspects, the
cells have an average volumetric productivity greater than about
2.000 mg/L.sub.broth/hr of isoprene. In some aspects, the cells
have an average volumetric productivity between about 500
mg/L.sub.broth/hr and about 2,000 mg/L.sub.broth/hr of
isoprene.
[0020] In some aspects, the method further comprises the steps of
sterilizing the collected permeate and recycling it back into the
same fermentor or into another fermentor, wherein the cells
cultured in the presence of recycled permeate have greater average
specific productivity of isoprene than the same cells cultured in
the absence of recycled permeate. In some aspects, the cells have
about two times the average specific productivity of isoprene than
the same cells cultured in the absence of recycled permeate. In
some aspects, the cells have about three times the average specific
productivity of isoprene than the same cells cultured in the
absence of recycled permeate. In some aspects, the portion of the
culture is removed continuously. In some aspects, the portion of
the culture is removed discontinuously.
[0021] In some aspects, the isoprene synthase polypeptide is a
plant isoprene synthase polypeptide. In some aspects, the cells
further comprise a heterologous nucleic acid encoding an IDI
polypeptide. In some aspects, the cells further comprise a
chromosomal copy of an endogenous nucleic acid encoding an IDI
polypeptide. In some aspects, the cells further comprise a
heterologous nucleic acid encoding a DXS polypeptide. In some
aspects, the cells further comprise a chromosomal copy of an
endogenous nucleic acid encoding a DXS polypeptide. In some
aspects, the cells further comprise one or more nucleic acids
encoding an IDI polypeptide and a DXS polypeptide. In some aspects,
one nucleic acid encodes the isoprene synthase polypeptide, IDI
polypeptide, and DXS polypeptide. In some aspects, one plasmid
encodes the isoprene synthase polypeptide, IDI polypeptide, and DXS
polypeptide. In some aspects, the cells further comprise a
heterologous nucleic acid encoding an MVA pathway polypeptide. In
some aspects, the MVA pathway polypeptide is a mevalonate kinase
(MVK) polypeptide. In some aspects, the MVK polypeptide is from the
genus Methanosarcina. In some aspects, the MVK is from
Methanosarcina mazei. In some aspects, the isoprene synthase
polypeptide is a naturally-occurring polypeptide from the genus
Pueraria. In some aspects, the isoprene synthase polypeptide is a
naturally-occurring polypeptide from Pueraria montana. In some
aspects, the isoprene synthase polypeptide is a naturally-occurring
polypeptide from the genus Populus. In some aspects, the isoprene
synthase polypeptide is a naturally-occurring polypeptide from
Populus alba. In some aspects, the cells further comprise a
heterologous nucleic acid encoding an MVA pathway polypeptide. In
some aspects, the MVA pathway polypeptide is a mevalonate kinase
(MVK) polypeptide. In some aspects, the MVK polypeptide is from the
genus Methanosarcina. In some aspects, the MVK polypeptide is from
Methanosarcina mazei. In some aspects, the cells are bacterial
cells.
[0022] In some aspects, the cells are gram-positive bacterial
cells. In some aspects, the cells are Bacillus cells. In some
aspects, the cells are Bacillus subtilis cells. In some aspects,
the cells are gram-negative bacterial cells. In some aspects, the
cells are Escherichia or Pantoea cells. In some aspects, the cells
are Escherichia coli or Pantoea citrea cells. In some aspects, the
cells are fungal cells. In some aspects, the cells are Trichoderma
cells. In some aspects, the cells are Trichoderma reesei cells. In
some aspects, the cells are yeast cells. In some aspects, the cells
are Yarrowia cells. In some aspects, the cells are Yarrowia
lipolytica cells.
[0023] In some aspects, the cells comprise (i) an integrated
nucleic acid encoding the lower MVA pathway from S. cerevisiae
comprising a glucose isomerase promoter and a nucleic acid encoding
mevalonate kinase (MVK); a nucleic acid encoding phosphomevalonate
kinase (PMK); a nucleic acid encoding diphosphomevalonate
decarboxylase (MVD); and a nucleic acid encoding isopentenyl
diphosphate isomerase (IDI); (ii) a nucleic acid encoding P. alba
isoprene synthase; (iii) a nucleic acid encoding M. mazei
mevalonate kinase; and (iv) a nucleic acid encoding the upper MVA
pathway from Enterococcus faecalis, comprising a nucleic acid
encoding an acetoacetyl-Coenzyme A synthase (thiolase) polypeptide;
a nucleic acid encoding a 3-hydroxy-3-methylglutaryl-Coenzyme A
synthase polypeptide; and a nucleic acid encoding a
3-hydroxy-3-methylglutaryl-Coenzyme A reductase polypeptide.
BRIEF DESCRIPTION OF THE DRAWINGS
[0024] FIG. 1A shows the MVA and DXP metabolic pathways for
isoprene (based on F. Bouvier et al., Progress in Lipid Res.
44:357-429, 2005). The following description includes alternative
names for each polypeptide in the pathways and a reference that
discloses an assay for measuring the activity of the indicated
polypeptide (each of these references are each hereby incorporated
herein by reference in their entireties). Mevalonate Pathway: AACT;
Acetyl-CoA acetyltransferase, MvaE, EC 2.3.1.9. Assay: J.
Bacteriol. 184:2116-2122, 2002; HMGS; Hydroxymethylglutaryl-CoA
synthase. MvaS, EC 2.3.3.10. Assay: J. Bacteriol. 184:4065-4070,
2002; HMGR; 3-Hydroxy-3-methylglutaryl-CoA reductase, MvaE, EC
1.1.1.34. Assay: J. Bacteriol. 184:2116-2122, 2002; MVK; Mevalonate
kinase, ERG12. EC 2.7.1.36. Assay: Curr Genet 19:9-14, 1991. PMK;
Phosphomevalonate kinase. ERG8, EC 2.7.4.2, Assay: Mol. Cell. Biol.
S11:620-631, 1991; DPMDC; Diphosphomevalonate decarboxylase. MVD1.
EC 4.1.1.33. Assay: Biochemistry 33:13355-13362, 1994; IDI;
Isopentenyl-diphosphate delta-isomerase, IDI1, EC 5.3.3.2, Assay:
J. Biol. Chem. 264:19169-19175, 1989. DXP Pathway: DXS;
1-Deoxyxylulose-5-phosphate synthase, dxs, EC 2.2.1.7. Assay: PNAS
94:12857-62, 1997; DXR; 1-Deoxy-D-xylulose 5-phosphate
reductoisomerase, dxr, EC 2.2.1.7. Assay: Eur. J. Biochem.
269:4446-4457, 2002; MCT; 4-Diphosphocytidyl-2C-methyl-D-erythritol
synthase, IspD, EC 2.7.7.60. Assay: PNAS 97: 6451-6456, 2000; CMK;
4-Diphosphocytidyl-2-C-methyl-D-erythritol kinase. IspE, EC
2.7.1.148. Assay: PNAS 97:1062-1067, 2000; MCS;
2C-Methyl-D-erythritol 2,4-cyclodiphosphate synthase, IspF, EC
4.6.1.12. Assay: PNAS 96:11758-11763, 1999; HDS;
1-Hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase, ispG, EC
1.17.4.3. Assay: J. Org. Chem. 70:9168-9174, 2005; HDR;
1-Hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase. IspH, EC
1.17.1.2. Assay: JACS 126:12847-12855, 2004.
[0025] FIG. 1B illustrates the classical and modified MVA pathways.
1, acetyl-CoA acetyltransferase (AACT); 2. HMG-CoA synthase (HMGS);
3, HMG-CoA reductase (HMGR); 4, mevalonate kinase (MVK); 5,
phosphomevalonate kinase (PMK); 6, diphosphomevalonate
decarboxylase (MVD or DPMDC); 7, isopentenyl diphosphate isomerase
(IDI); 8, phosphomevalonate decarboxylase (PMDC); 9, isopentenyl
phosphate kinase (IPK). The classical MVA pathway proceeds from
reaction 1 through reaction 7 via reactions 5 and 6, while a
modified MVA pathway goes through reactions 8 and 9. P and PP in
the structural formula are phosphate and pyrophosphate,
respectively. This figure was taken from Koga and Morii.
Microbiology and Mol. Biology Reviews 71:97-120, 2007, which is
incorporated herein by reference in its entirety, particular with
respect to nucleic acids and polypeptides of the modified MVA
pathway. The modified MVA pathway is present, for example, in some
archaeal organisms, such as Methanosarcina mazei.
[0026] FIG. 2 is a map of plasmid pET24 P. alba HGS.
[0027] FIG. 3A-B are the nucleotide sequence of plasmid pET24 P.
alba HGS (SEQ ID NO:1).
[0028] FIG. 4 is a schematic diagram showing restriction sites used
for endonuclease digestion to construct plasmid EWL230 and
compatible cohesive ends between BspHI and NcoI sites.
[0029] FIG. 5 is a map of plasmid EWL230.
[0030] FIGS. 6A-B are the nucleotide sequence of plasmid EWL230
(SEQ ID NO:2).
[0031] FIG. 7 is a schematic diagram showing restriction sites used
for endonuclease digestion to construct plasmid EWL244 and
compatible cohesive ends between NsiI and PstI sites.
[0032] FIG. 8 is a map of plasmid EWL244.
[0033] FIGS. 9A-B are the nucleotide sequence of plasmid EWL244
(SEQ ID NO:3).
[0034] FIG. 10A is a map of the M. mazei archaeal Lower Pathway
operon.
[0035] FIGS. 10B-C are the nucleotide sequence of the M. mazei
archaeal Lower Pathway operon (SEQ ID NO:4).
[0036] FIG. 11A is a map of MCM376-MVK from M. mazei archaeal Lower
in pET200D.
[0037] FIGS. 11B-C are the nucleotide sequence of MCM376-MVK from
M. mazei archaeal Lower in pET200D (SEQ ID NO:5).
[0038] FIG. 12 is a map of plasmid pBBRCMPGI1.5-pgl.
[0039] FIGS. 13A-B are the nucleotide sequence of plasmid
pBBRCMPGI1.5-pgl (SEQ ID NO:6).
[0040] FIGS. 14A-F are graphs of isoprene production by E. coli
strain expressing M. mazei mevalonate kinase, P. alba isoprene
synthase, and pgl (RHM11608-2), and grown in fed-batch culture at
the 15-L scale. FIG. 14A shows the time course of optical density
within the 15-L bioreactor fed with glucose. FIG. 14B shows the
time course of isoprene titer within the 15-L bioreactor fed with
glucose. The titer is defined as the amount of isoprene produced
per liter of fermentation broth. Method for calculating isoprene:
cumulative isoprene produced in 59 hrs, g/Fermentor volume at 59
hrs. L [=]g/L broth. FIG. 14C also shows the time course of
isoprene titer within the 15-L bioreactor fed with glucose. Method
for calculating isoprene: .intg.(Instantaneous isoprene production
rate, g/L/hr) dt from t=0 to 59 hours [=]g/L broth. FIG. 14D shows
the time course of total isoprene produced from the 15-L bioreactor
fed with glucose. FIG. 14E shows volumetric productivity within the
15-L bioreactor fed with glucose. FIG. 14F shows carbon dioxide
evolution rate (CER), or metabolic activity profile, within the
15-L bioreactor fed with glucose.
[0041] FIGS. 15A-B are graphs showing analysis of off-gas from
fermentation in 15 L bioreactors. Sample A is strain RM111608-2
sampled at 64.8 hours. Sample B is strain EWL256 was E. coli BL21
(DE3), pCL upper, cmR-gi1.2-yKKDyI, pTrcAlba-mMVK sampled at 34.5
hours. Hydrogen is detected above the baseline
(0.95.times.10.sup.-8 torr) for both samples.
[0042] FIG. 16A shows an exemplary isoprene recovery unit.
[0043] FIG. 16B shows an exemplary isoprene desorption/condensation
setup.
[0044] FIG. 17 shows a GC/FID chromatogram of an isoprene product.
The material was determined to be 99.7% pure.
[0045] FIG. 18A-C show the GC/FID chromatograms of an isoprene
sample before (A) and after treatment with alumina (B) or silica
(C). The isoprene peak is not shown in these chromatograms.
[0046] FIG. 19A shows a map of plasmid pDW34, encoding a truncated
version of P. alba isoprene synthase (MEA variant) under the
control of the PTrc promoter and M. mazei MVK.
[0047] FIG. 19B-D shows the complete nucleotide sequence of plasmid
pDW34 (SEQ ID NO:7).
[0048] FIG. 20 shows the chromosomal organization of E. coli K12
strain MG1655 around the pgl locus. The region deleted in E. coli
BL21 (DE3) compared to E. coli K12 MG655 and restored in strains
CMP215 and CMP258 is shown in brackets. The predicted ORF of the
ybgS gene is circled. A forward arrow (.fwdarw.) indicates the
annealing site of the galMF primer (SEQ ID NO:8). A reverse arrow
(.rarw.) indicates the annealing site of the galMR primer (SEQ ID
NO:9).
[0049] FIG. 21 shows a diagram of an MBR system used in 15-L scale
fermentation to make isoprene gas and to collect permeate
containing spent media. A broth circulation loop delivers fermentor
broth to a tangential flow membrane filter. The membrane, a GE
Healthcare Xampler.TM. Ultrafiltration Cartridge 500,000 NMWC, 1 mm
fiber inner diameter, 60 cm long, 850 sq cm area, hollow fiber
membrane, was chosen based on its suitability for high cell density
E. coli broth. The hold-up volume of the broth circulation loop,
including the membrane, was roughly 250 mL. The part of the
apparatus comprising the loop components, but excluding the
circulation pump, was autoclaved before use. The circulation and
permeate pumps were peristaltic tubing pumps. A pressure gauge was
used to measure P.sub.in, the inlet pressure of the membrane, to
ensure the pressure tolerance of the membrane (roughly 2 bar) was
not exceeded. TMP, defined in the diagram, is a rough measure of
the force that drives permeation. A positive TMP was needed to
collect permeate.
[0050] FIG. 22 shows the operational parameters of an MBR during a
15-L scale run. P.sub.in and TMP were manipulated mainly by
changing circulation pump rate, e.g. a reduction in P.sub.in of
around 20% was achieved at 50 h by lowering circulation pump rate
by around 20%. TMP was steady at about 0.2 bar during permeation.
Due to flow dynamics within the membrane cartridge, TMP was never
zero, even when the permeate rate was zero. The permeate rate was
controlled by adjusting permeate pump rate. Around 8 kg of permeate
was collected in this example.
[0051] FIG. 23 shows a plot of optical density (OD) in reactor
broth in a 15-L scale fermentation for an MBR fermentation and a
non-MBR control. The OD during MBR operation rose from 195 to 305,
whereas the OD of the non-MBR control declined from 195 to 175
during the same period. OD was measured by the 550-nm absorbance of
a broth sample. Higher OD indicates a higher concentration of
cells, cell debris, and other suspended solids. The fermentation
method is described in Example 4.
[0052] FIG. 24 shows a plot of isoprene specific productivity in a
15-L scale run for an MBR fermentation and a non-MBR control. The
MBR did not change the specific productivity of cells compared to
that of a non-MBR control. The specific productivity is the rate of
isoprene production on a cell mass basis. The similarity between
the MBR and the non-MBR control runs suggests the MBR operation did
not significantly alter cell physiology. The fermentation method is
described in Example 4. Specific productivity was calculated using
equations in Example 4.
[0053] FIG. 25 shows a plot of isoprene gas titer in a 15-L scale
run for an MBR fermentation and a non-MBR control. The MBR
increased titer by around 16% compared to a non-MBR control. A
higher titer means more isoprene is produced per reactor volume,
which leads to a lower production cost. The fermentation method is
described in Example 4.
[0054] FIG. 26 shows a plot of total isoprene gas production in a
15-L scale run for an MBR fermentation and a non-MBR control. The
MBR increased total production of isoprene gas by around 17%
compared to a non-MBR control over the same fermentation time. The
fermentation method is described in Example 4. The equations used
to calculate total isoprene production are described in Example
4.
[0055] FIG. 27 shows a plot of volumetric productivity of isoprene
in a 15-L scale run for an MBR fermentation and a non-MBR control.
The volumetric productivity was higher during operation of the MBR
compared to that of the non-MBR control during the same period. A
higher volumetric productivity means a higher rate of isoprene
production on a volume basis, which leads to lower production cost.
The fermentation method is described in Example 4. Volumetric
productivity was calculated using equations in Example 4.
[0056] FIG. 28 shows a plot of bioreactor broth weights in 15-L
scale run fermentor runs. To maintain reactor weight, a membrane
permeate was extracted in the MBR run, while whole broth (draw-off)
was removed in the non-MBR control run. In this example, around 8
kg of permeate was collected in the MBR run, and around 7 kg of
draw-off, in the non-MBR control. The fermentation method is
described in Example 4.
[0057] FIG. 29 shows a plot of the increase in specific
productivity of isoprene gas in a fed-batch culture by
supplementing with spent media: More than a three-fold increase in
isoprene specific productivity was achieved by supplementing the
culture medium with 30% by weight of spent media (clarified broth
supernatant), despite around 25% lesser growth. A higher specific
productivity means that more isoprene is produced per cell mass per
time. The result suggests that MBR permeate, which contains spent
media, can be used to enhance specific productivity of cells,
thereby reducing production cost. The experimental method is
described in Example 5.
DETAILED DESCRIPTION OF THE INVENTION
[0058] A membrane bioreactor (MBR) can enhance fermentative
production of isoprene gas by combining fermentation with recycling
of select broth components that would otherwise be discarded. An
MBR includes a liquid fermentation bioreactor culturing
isoprene-producing cells operated in conjunction with a membrane
filter, such as a crossflow filter or a tangential flow filter. The
MBR filters fermentation broth and returns the non-permeating
component (filter "retentate") to the reactor, effectively
increasing reactor concentration of cells, cell debris, and other
broth solids, while maintaining specific productivity of the cells.
This substantially improves titer, total production, and volumetric
productivity of isoprene, leading to lower capital and operating
costs.
[0059] The liquid filtrate ("permeate") is not returned to the
reactor and thus provides a beneficial reduction in reactor volume,
similar to collecting a broth draw-off. However, unlike a broth
draw-off, the collected permeate is a clarified liquid that can be
easily sterilized by filtration after storage in an ordinary
vessel. Thus, the permeate can be readily reused as a nutrient
and/or water recycle source, further reducing operating costs. A
permeate, which contains soluble "spent medium," may be added to
the same or another fermentation to enhance isoprene
production.
[0060] The MBR is a potentially scalable and advantageous mode of
the methods of producing isoprene from renewable resources
described elsewhere (see. e.g., International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007. US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716). Besides providing a
significantly higher isoprene titer than otherwise possible and
increasing volumetric productivity, the MBR produces a clarified
permeate which may be used as a nutrient and as a water source,
thereby reducing raw material consumption and improving process
sustainability.
[0061] Accordingly, in one aspect, provided herein are improved
methods of producing isoprene comprising: (a) culturing cells
comprising a heterologous nucleic acid encoding an isoprene
synthase polypeptide under suitable culture conditions for the
production of isoprene, wherein the cells either (i) produce
isoprene at a titer greater than 40 g/L or (ii) have an average
volumetric productivity of isoprene greater than about 500
mg/L.sub.broth/hr of isoprene; (b) removing a portion of the
culture; (c) filtering the removed portion of the culture to
produce a permeate and a retentate; (d) returning the retentate to
the culture; (e) producing isoprene; and optionally (f) recovering
the isoprene; wherein the cultured cells undergoing steps (b), (c),
and (d) either (i) produce isoprene at a higher titer, or (ii) have
greater average volumetric productivity of isoprene than the same
cells cultured without undergoing steps (b), (c), and (d).
[0062] In another aspect, provided herein are improved methods of
producing isoprene comprising: (a) culturing cells comprising a
heterologous nucleic acid encoding an isoprene synthase polypeptide
in a fermentor containing growth medium under suitable culture
conditions for the production of isoprene, wherein the cells either
(i) produce isoprene at a titer greater than 40 g/L or (ii) have an
average volumetric productivity of isoprene greater than about 500
mg/L.sub.broth/hr of isoprene; (b) removing a portion of the cell
culture from the fermentor; (c) transferring the removed portion of
the cell culture to a filter; (d) filtering the removed portion of
the cell culture to form: (i) a permeate comprising spent growth
medium; and (ii) a retentate comprising cells and other culture
solids; (e) returning the retentate to the fermentor; (f)
collecting the permeate; (g) producing isoprene; and (h) recovering
the isoprene; wherein the cultured cells undergoing steps (b), (c),
(d) and (e) either (i) produce isoprene at a higher titer, or (ii)
have greater average volumetric productivity of isoprene than the
same cells cultured without undergoing steps (b), (c), (d), and
(e).
General Techniques
[0063] The practice of the present invention will employ, unless
otherwise indicated, conventional techniques of molecular biology
(including recombinant techniques), microbiology, cell biology,
biochemistry, and immunology, which are within the skill of the
art. Such techniques are explained fully in the literature,
"Molecular Cloning: A Laboratory Manual", second edition (Sambrook
et al., 1989); "Oligonucleotide Synthesis" (M. J. Gait, ed., 1984);
"Animal Cell Culture" (R. I. Freshney, ed., 1987); "Methods in
Enzymology" (Academic Press. Inc.); "Current Protocols in Molecular
Biology" (F. M. Ausubel et al., eds., 1987, and periodic updates);
"PCR: The Polymerase Chain Reaction", (Mullis et al., eds., 1994).
Singleton et al., Dictionary of Microbiology and Molecular Biology
2nd ed., J. Wiley & Sons (New York. N.Y. 1994), and March,
Advanced Organic Chemistry Reactions. Mechanisms and Structure 4th
ed., John Wiley & Sons (New York, N.Y. 1992), provide one
skilled in the art with a general guide to many of the terms used
in the present application.
[0064] Genetically engineered cell cultures in bioreactors have
produced isoprene more efficiently, in larger quantities, in higher
purities and/or with unique impurity profiles, e.g., as described
in International Publication No. WO 2009/076676, U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102), WO
2010/003007, US Publ. No. 2010/0048964. WO 2009/132220, and US
Publ. No. 2010/0003716.
DEFINITIONS
[0065] The term "isoprene" refers to 2-methyl-1,3-butadiene
(CAS#78-79-5). Isoprene can be the direct and final volatile C5
hydrocarbon product from the elimination of pyrophosphate from
3,3-dimethylallyl pyrophosphate (DMAPP). In some cases, it may not
involve the linking or polymerization of an IPP molecule(s) to a
DMAPP molecule(s). The term "isoprene" is not generally intended to
be limited to its method of production unless indicated otherwise
herein.
[0066] As used herein, "biologically produced isoprene" or
"bioisoprene" is isoprene produced by any biological means, such as
produced by genetically engineered cell cultures, natural
microbials, plants or animals. A bioisoprene composition usually
contains fewer hydrocarbon impurities than isoprene produced from
petrochemical sources and often requires minimal treatment in order
to be of polymerization grade. A bioisoprene composition also has a
different impurity profile from a petrochemically produced isoprene
composition.
[0067] As used herein, the term "permeate" refers to filtrate
(i.e., spent growth medium) produced by filtering the contents of a
fermentor or bioreactor containing growth medium and cells (i.e.,
containing cultured cells), for example, by crossflow filtration.
The cells can be any of the exemplary isoprene-producing cells or
cell types described herein, including, for example, those that
comprise one or more heterologous nucleic acids encoding an
isoprene synthase polypeptide, a DXS polypeptide, an IDI
polypeptide, and/or an MVA pathway polypeptide operably linked to a
promoter.
[0068] As used herein, the term "retentate" refers to solids
retained on a filter (i.e., cells, debris and other culture solids)
after filtering the contents of a fermentor or bioreactor
containing growth medium and cells (i.e., containing cultured
cells), for example, by crossflow filtration. The cells can be any
of the exemplary isoprene-producing cells or cell types described
herein, including, for example, those that comprise one or more
heterologous nucleic acids encoding an isoprene synthase
polypeptide, a DXS polypeptide, an IDI polypeptide, and/or an MVA
pathway polypeptide operably linked to a promoter.
[0069] As used herein, the terms "polypeptide" and "polypeptides"
include polypeptides, proteins, peptides, fragments of
polypeptides, and fusion polypeptides.
[0070] As used herein, an "isolated polypeptide" is not part of a
library of polypeptides, such as a library of 2, 5, 10, 20, 50 or
more different polypeptides and is separated from at least one
component with which it occurs in nature. An isolated polypeptide
can be obtained, for example, by expression of a recombinant
nucleic acid encoding the polypeptide. An isolated polypeptide can
be a non-naturally occurring polypeptide.
[0071] By "heterologous polypeptide" is meant a polypeptide whose
amino acid sequence is not identical to that of another polypeptide
naturally expressed in the same host cell. In particular, a
heterologous polypeptide is not identical to a wild-type
polypeptide that is found in the same host cell in nature.
[0072] As used herein, a "nucleic acid" refers to two or more
deoxyribonucleotides and/or ribonucleotides covalently joined
together in either single or double-stranded form.
[0073] By "recombinant nucleic acid" is meant a nucleic acid of
interest that is free of one or more nucleic acids (e.g., genes)
which, in the genome occurring in nature of the organism from which
the nucleic acid of interest is derived, flank the nucleic acid of
interest. The term therefore includes, for example, a recombinant
DNA which is incorporated into a vector, into an autonomously
replicating plasmid or virus, or into the genomic DNA of a
prokaryote or eukaryote, or which exists as a separate molecule
(e.g., a cDNA, a genomic DNA fragment, or a cDNA fragment produced
by PCR or restriction endonuclease digestion) independent of other
sequences. In some cases a recombinant nucleic acid is a nucleic
acid that encodes a non-naturally occurring polypeptide.
[0074] By "heterologous nucleic acid" is meant a nucleic acid whose
nucleic acid sequence is not identical to that of another nucleic
acid naturally found in the same host cell. In particular, a
heterologous nucleic acid is not identical to a wild-type nucleic
acid that is found in the same host cell in nature.
[0075] As used herein, a "vector" means a construct that is capable
of delivering, and desirably expressing one or more nucleic acids
of interest in a host cell. Examples of vectors include, but are
not limited to, plasmids, viral vectors, DNA or RNA expression
vectors, cosmids, and phage vectors.
[0076] As used herein, an "expression control sequence" means a
nucleic acid sequence that directs transcription of a nucleic acid
of interest. An expression control sequence can be a promoter, such
as a constitutive or an inducible promoter, or an enhancer. An
"inducible promoter" is a promoter that is active under
environmental or developmental regulation. The expression control
sequence is operably linked to the nucleic acid segment to be
transcribed.
[0077] The term "selective marker" or "selectable marker" refers to
a nucleic acid capable of expression in a host cell that allows for
ease of selection of those host cells containing an introduced
nucleic acid or vector. Examples of selectable markers include, but
are not limited to, antibiotic resistance nucleic acids (e.g.,
kanamycin, ampicillin, carbenicillin, gentamicin, hygromycin,
phleomycin, bleomycin, neomycin, or chloramphenicol) and/or nucleic
acids that confer a metabolic advantage, such as a nutritional
advantage on the host cell. Exemplary nutritional selective markers
include those markers known in the art as amdS, argB, and pyr4.
[0078] Unless defined otherwise herein, all technical and
scientific terms used herein have the same meaning as commonly
understood by one of ordinary skill in the art to which this
invention pertains. Although any methods and materials similar or
equivalent to those described herein find use in the practice of
the present invention, the preferred methods and materials are
described herein. Accordingly, the terms defined immediately below
are more fully described by reference to the Specification as a
whole. All documents cited are, in relevant part, incorporated
herein by reference in their entirety. However, the citation of any
document is not to be construed as an admission that it is prior
art with respect to the present invention.
[0079] As used herein, the singular terms "a," "an," and "the"
include the plural reference unless the context clearly indicates
otherwise.
[0080] It is intended that every maximum numerical limitation given
throughout this specification includes every lower numerical
limitation, as if such lower numerical limitations were expressly
written herein. Every minimum numerical limitation given throughout
this specification will include every higher numerical limitation,
as if such higher numerical limitations were expressly written
herein. Every numerical range given throughout this specification
will include every narrower numerical range that falls within such
broader numerical range, as if such narrower numerical ranges were
all expressly written herein.
Methods for the Increased Production of Bioisoprene
[0081] Provided herein are improved methods of producing isoprene.
In some aspects, the improved methods comprise (a) culturing cells
comprising a heterologous nucleic acid encoding an isoprene
synthase under culture conditions suitable for the production of
isoprene, wherein the cells either (i) produce isoprene at a titer
greater than 40 g/L or (ii) have an average volumetric productivity
greater than about 500 mg L.sub.broth/hr of isoprene; (b) removing
a portion of the culture; (c) filtering the removed portion of the
culture to produce a permeate and a retentate; (d) returning the
retentate to the culture; (e) producing isoprene; and optionally
(f) recovering the isoprene; wherein the cultured cells undergoing
steps (b), (c), and (d) either (i) produce isoprene at a higher
titer, or (ii) have greater average volumetric productivity of
isoprene than the same cells cultured without undergoing steps (b),
(c), and (d). In some aspects, the cells are cultured in a
fermentor, bioreactor, or other vessel suitable for commercial
scale cell culture. In some aspects, the fermentor, bioreactor, or
cell culture vessel is stainless steel, glass or copper. In some
aspects, the fermentor, bioreactor, or cell culture vessel further
comprises an isoprene collection outlet connected to an isoprene
storage tank. In some aspects, the isoprene collection outlet
further comprises a valve to control the flow of isoprene through
the isoprene collection outlet.
[0082] In some aspects, the improved methods comprise (a) culturing
cells comprising a heterologous nucleic acid encoding an isoprene
synthase in a fermentor containing growth medium under culture
conditions suitable for the production of isoprene, wherein the
cells either (i) produce isoprene at a titer greater than 40 g/L or
(ii) have an average volumetric productivity greater than about 500
mg/L.sub.broth/hr of isoprene; (b) removing a portion of the cell
culture from the fermentor; (c) transferring the removed portion of
the cell culture to a filter; (d) filtering the removed portion of
the cell culture to form: (i) a permeate comprising spent growth
medium; and (ii) a retentate comprising cells and other culture
solids; (e) returning the retentate to the fermentor; (f)
collecting the permeate; (g) producing isoprene; and optionally (h)
recovering the isoprene; wherein the cultured cells undergoing
steps (b), (c), (d) and (e) either (i) produce isoprene at a higher
titer, or (ii) have greater average volumetric productivity of
isoprene than the same cells cultured without undergoing steps (b),
(c), (d) and (e). In some aspects, the cells are cultured in a
fermentor, bioreactor, or other vessel suitable for commercial
scale cell culture. In some aspects, the fermentor, bioreactor, or
cell culture vessel is stainless steel, glass or copper. In some
aspects, the fermentor, bioreactor, or cell culture vessel further
comprises an isoprene collection outlet connected to an isoprene
storage tank. In some aspects, the isoprene collection outlet
further comprises a valve to control the flow of isoprene through
the isoprene collection outlet. In some aspects, the isoprene
collection outlet comprises any suitable flexible tubing or rigid
tubing described herein.
[0083] In some aspects, the fermentor, bioreactor, or cell culture
vessel is connected to the filter by a circulation loop and a
circulation pump. In some aspects, the circulation loop further
comprises one or more valves to control the flow of material (i.e.,
of a portion of the cell culture or of the retentate) through the
circulation loop. Generally, any type of pump having the ability to
precisely regulate or control flow rate and pressure can be used
with the methods described herein. In some aspects, the circulation
pump comprises a positive displacement pump, such as a peristaltic
pump, a reciprocating pump, or a rotary pump. In some aspects, the
circulation pump is a peristaltic pump. In some aspects, the
circulation pump is a velocity pump, such as a centrifugal pump, a
radial flow pump, an axial flow pump, a mixed flow pump, or a
gravity pump. In some aspects, the circulation pump is a
centrifugal pump.
[0084] In some aspects, the circulation loop comprises flexible
tubing. In some aspects, the flexible tubing is polyvinyl chloride
(PVC), polyurethane (e.g., Superthane.RTM.), silicone (e.g.,
Silcon.RTM.), thermoplastic rubber (TPR; e.g., Suprene.RTM.),
fluoropolymer, polyethylene, polypropylene (e.g., Prolite.RTM.),
latex or metal tubing. In some aspects, the PVC tubing is braid
reinforced (e.g., Nylobrade.RTM.), steel wire reinforced (e.g.,
Vardex.RTM.), or spiral reinforced (e.g., Newflex.RTM.). In some
aspects, the polyurethane tubing is braid-reinforced (e.g.,
Urebrade.RTM. Pneumatic). In some aspects, the silicone tubing is
braid reinforced (e.g., Silbrade.RTM.), platinum-cured medical
grade tubing (e.g., Silcon.RTM. Med-X), or polyester and wire
reinforced (e.g., Silvac.RTM.). In some aspects, the fluoropolymer
tubing is polytetrafluoroethylene (PTFE; e.g., CONTEF.TM.),
fluorinated ethylene propylene (FEP; e.g., Coiltef.TM.),
perfluoroalkoxy (PFA; e.g., Coiltef.TM.), ethylene
tetrafluoroethylene (ETFE), ethylene chloro-trifluoroethylene
(ECTFE), polyvinylidene fluoride (PVDF) polyetherimide (PEI), or
polyetheretherketone (PEEK). In some aspects, the polyethylene
tubing is linear low density polyethylene tubing (LLDPE; e.g.,
Zeliter.TM.).
[0085] In some aspects, the circulation loop comprises rigid tubing
or pipe. In some aspects, the rigid tubing is metal. In some
aspects, the metal is carbon steel, stainless steel, galvanized
steel, copper, brass, or any other suitable metal or alloy. In some
aspects, the rigid tubing is plastic. In some aspects, the plastic
is polyvinyl chloride (PVC), chlorinated polyvinyl chloride (CPVC),
fiber reinforced plastic (FRP), reinforced polymer mortar (RPMP),
polypropylene (PP), polyethylene (PE), cross-linked high density
polyethylene (PEX), polybutylene (PB), high density polyurethane,
acrylonitrile butadiene styrene (ABS), or any other suitable
material.
[0086] In some aspects, the permeate is collected from the filter
by a permeate collection outlet and a permeate pump and stored in a
permeate collection tank. In some aspects, the permeate collection
outlet further comprises a valve to control the flow of permeate
through the permeate collection outlet. In some aspects, the
permeate collection outlet comprises any suitable flexible tubing
or rigid tubing described herein. In some aspects, the permeate
collection outlet further comprises a permeate pressure gauge to
monitor the pressure in the permeate collection outlet
(P.sub.perm). Generally, any type of pump having the ability to
precisely regulate or control flow rate and pressure can be used
with the methods described herein. In some aspects, the permeate
pump comprises a positive displacement pump, such as a peristaltic
pump, a reciprocating pump, or a rotary pump. In some aspects, the
permeate pump is a peristaltic pump. In some aspects, the permeate
pump is a velocity pump, such as a centrifugal pump, a radial flow
pump, an axial flow pump, a mixed flow pump, or a gravity pump. In
some aspects, the permeate pump is a centrifugal pump. In some
aspects, the permeate collection tank further comprises a vent to
relieve pressure within the tank.
[0087] In some aspects, the improved method further comprises a
step of recycling the permeate back into the same cell culture or
into another culture. Recycling the permeate can allow for
increased production of isoprene over a period of time, for
example, more isoprene made per L.sub.broth per hour. Accordingly,
in one aspect, the cells cultured in the presence of recycled
permeate have greater average specific productivity of isoprene
than the same cells cultured in the absence of recycled permeate.
In some aspects, the cells have about two times the average
specific productivity of isoprene than the same cells cultured in
the absence of recycled permeate. In some aspects, the cells have
about three times the average specific productivity of isoprene
than the same cells cultured in the absence of recycled permeate.
In some aspects, the permeate is sterilized before being recycled
back into the same cell culture or into another cell culture. In
some aspects, the permeate is sterilized by filtration. In some
aspects, the permeate is sterilized by autoclaving. In some
aspects, the permeate is sterilized by ultraviolet or gamma
irradiation. In some aspects, the permeate is not sterilized before
being recycled back into the same cell culture or into another cell
culture.
[0088] One advantage of this system described herein is that a
minimal amount of the desired product (i.e., isoprene) is lost
through the recycling or discarding of the permeate. In one aspect,
at least about 50% of the isoprene that is produced in the
fermentor before the circulation commences is recoverable after the
circulation has been completed and thus is not lost in the
recycling or discarding of permeate. In another aspect, at least
about 55%, at least about 60%, at least about 65%, at least about
70%, at least about 75%, at least about 80%, at least about 85%, at
least about 90%, at least about 95%, at least about 96%, at least
about 97%, at least about 98%, at least about 99%, at least about
99.5%, at least about 99.6%, at least about 99.7%, at least about
99.8%, or at least about 99.9% of the isoprene produced in the
fermentor is recoverable and not lost in the permeate.
[0089] In some aspects, the circulation loop further comprises an
inlet pressure gauge to monitor the inlet pressure (P.sub.in) of
the filter. In some aspects, the circulation loop further comprises
an outlet gauge to monitor the outlet pressure (P.sub.out) of the
filter. In some aspects, the circulation loop further comprises an
inlet pressure gauge to monitor the inlet pressure (P.sub.in) of
the filter and an outlet gauge to monitor the outlet pressure
(P.sub.out) of the filter. In some aspects, the improved method
further comprises the steps of: (i) monitoring the inlet pressure
of the filter with an inlet pressure gauge (P.sub.in); (ii)
monitoring the outlet pressure of the filter with an outlet
pressure gauge (P.sub.out); and (iii) monitoring the pressure in
the permeate collection outlet with a permeate pressure gauge
(P.sub.perm) to determine the transmembrane pressure across the
filter.
[0090] In some aspects, the filtering is by microfiltration. In
some aspects, the microfiltering is by crossflow filtration. In
some aspects, the filtering is by ultrafiltration. In some aspects,
the ultrafiltering is by crossflow filtration. In crossflow
filtration, the solution to be filtered is passed tangentially
across the filter membrane at positive transmembrane pressure (TMP)
relative to the permeate side. A proportion of the material which
is smaller than the membrane pore size passes through the membrane
as filtrate (i.e., permeate), while the rest of the solution
remains on the feed side of the membrane as retentate. With
crossflow filtration, the tangential motion of the bulk of the
fluid across the membrane causes trapped particles or solids left
on the filter surface to be rubbed off, so a crossflow filter can
operate continuously at relatively high solids loads without
fouling. In addition, the retentate remains in the form of a mobile
slurry, suitable for returning to the fermentor via the circulation
loop. In some aspects, the filtering is by centrifugation or
spin-filtration. In some aspects, the filtering is by vortex-flow
filtration. In some aspects, the filtering is by hydrocyclone. In
any of the aspects described herein, the filtration is by
microfiltration. In any of the aspects described herein, the
filtration is by ultrafiltration.
[0091] In some aspects, the filtering is by microfiltration. In
some aspects, the microfiltration is crossflow filtration. In some
aspects, the crossflow filtration is tangential flow filtration. In
some aspects, the tangential flow filter comprises a membrane
configuration selected from the group consisting of a hollow fiber
membrane, a spiral wound membrane, a tubular membrane, or a
plate-frame membrane. In some aspects, the tangential flow filter
comprises a hollow fiber membrane. In some aspects, the hollow
fiber membrane, the spiral wound membrane, the tubular membrane, or
the plate-frame membrane comprises a polyethersulfone (PES)
membrane, a polysulfone (PS) membrane, a polyvinylidene difluoride
(PVDF) membrane, a polyarylsulfone membrane, a polyamide membrane,
a polypropylene membrane, a polyethylene membrane, a
polytetrafluoroethylene (PTFE) membrane, a cellulose acetate
membrane, a polyacrylonitrile membrane, a vinyl copolymer membrane,
a cellulose membrane, a regenerated cellulose membrane, a
polycarbonate membrane, a ceramic membrane, a steel membrane, or a
stainless steel membrane.
[0092] The pore size of a microfiltration membrane, such as a
tangential flow membrane, can vary depending on the membrane
material and application. Any of the membrane configurations and
membrane types described herein can have filter pore sizes in
various ranges.
[0093] In some aspects, the tangential flow filter has a filter
pore size suitable for use with any of the exemplary
isoprene-producing cells or cell types described herein, including,
for example, those that comprise one or more heterologous nucleic
acids encoding an isoprene synthase polypeptide, a DXS polypeptide,
an IDI polypeptide and/or an MVA pathway polypeptide operably
linked to a promoter. In some aspects, the tangential flow filter
has a filter pore size between about 0.005 .mu.m and about 100
.mu.m. In some aspects, the tangential flow filter has a filter
pore size between about 0.005 .mu.m and about 50 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 0.005 .mu.m and about 10 .mu.m. In some aspects, the
tangential flow filter has a filter pore size between about 0.005
.mu.m and about 5 .mu.m. In some aspects, the tangential flow
filter has a filter pore size between about 0.005 .mu.m and about 2
.mu.m. In some aspects, the tangential flow filter has a filter
pore size between about 0.005 .mu.m and about 1 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 0.05 .mu.m and about 100 .mu.m. In some aspects, the
tangential flow filter has a filter pore size between about 0.05
.mu.m and about 50 .mu.m. In some aspects, the tangential flow
filter has a filter pore size between about 0.05 .mu.m and about 10
.mu.m. In some aspects, the tangential flow filter has a filter
pore size between about 0.05 .mu.m and about 5 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 0.05 .mu.m and about 2 .mu.m. In some aspects, the tangential
flow filter has a filter pore size between about 0.05 .mu.m and
about 1 .mu.m. In some aspects, the tangential flow filter has a
filter pore size between about 0.5 .mu.m and about 100 .mu.m. In
some aspects, the tangential flow filter has a filter pore size
between about 0.5 .mu.m and about 50 .mu.m. In some aspects, the
tangential flow filter has a filter pore size between about 0.5
.mu.m and about 10 .mu.m. In some aspects, the tangential flow
filter has a filter pore size between about 0.5 .mu.m and about 5
.mu.m. In some aspects, the tangential flow filter has a filter
pore size between about 0.5 .mu.m and about 2 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 0.5 .mu.m and 1 .mu.m. In some aspects, the tangential flow
filter has a filter pore size between about 1 .mu.m and about 10
.mu.m. In some aspects, the tangential flow filter has a filter
pore size between about 1 .mu.m and about 50 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 1 .mu.m and about 100 .mu.m. In some aspects, the tangential
flow filter has a filter pore size between about 5 .mu.m and about
10 .mu.m. In some aspects, the tangential flow filter has a filter
pore size between about 5 .mu.m and about 50 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 5 .mu.m and about 100 .mu.m. In some aspects, the tangential
flow filter has a filter pore size between about 0.05 .mu.m and
about 0.5 .mu.m. In some aspects, the tangential flow filter has a
filter pore size between about 0.5 .mu.m and about 1 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 1 .mu.m and about 5 .mu.m. In some aspects, the tangential
flow filter has a filter pore size between about 5 microns and
about 10 microns. In some aspects, the tangential flow filter has a
filter pore size between about 10 microns and about 50 microns. In
some aspects, the tangential flow filter has a filter pore size
between about 10 microns and about 100 microns.
[0094] In some aspects, the filtering is by ultrafiltration. In
some aspects, the ultrafiltration is crossflow filtration. In some
aspects, the crossflow filtration is tangential flow filtration. In
some aspects, the tangential flow filter comprises a membrane
configuration selected from the group consisting of a hollow fiber
membrane, a spiral wound membrane, a tubular membrane, or a
plate-frame membrane. In some aspects, the tangential flow filter
comprises a hollow fiber membrane. In some aspects, the hollow
fiber membrane, the spiral wound membrane, the tubular membrane, or
the plate-frame membrane comprises a polyethersulfone (PES)
membrane, a polysulfone (PS) membrane, a polyvinylidene difluoride
(PVDF) membrane, a polyarylsulfone membrane, a polyamide membrane,
a polypropylene membrane, a polyethylene membrane, a
polytetrafluoroethylene (PTFE) membrane, a cellulose acetate
membrane, a polyacrylonitrile membrane, a vinyl copolymer membrane,
a cellulose membrane, a regenerated cellulose membrane, a
polycarbonate membrane, a ceramic membrane, a steel membrane, or a
stainless steel membrane.
[0095] The nominal molecular weight cutoff (NMWC) of an
ultrafiltration membrane, such as a tangential flow membrane, can
vary depending on the membrane material and application. Any of the
membrane configurations and membrane types described herein can
have NMWCs in various ranges.
[0096] In some aspects, the tangential flow filter has a nominal
molecular weight cutoff (NMWC) suitable for use with any of the
exemplary isoprene-producing cells or cell types described herein,
including, for example, those that comprise one or more
heterologous nucleic acids encoding an isoprene synthase
polypeptide, a DXS polypeptide, an IDI polypeptide, DXP pathway
polypeptide and/or an MVA pathway polypeptide operably linked to a
promoter. In some aspects the tangential flow filter has an NMWC
between 1000 and 750,000. In some aspects, the tangential flow
filter has an NMWC greater than 1000. In some aspects, the
tangential flow filter has an NMWC greater than 5000. In some
aspects, the tangential flow filter has an NMWC greater than
10,000. In some aspects, the tangential flow filter has an NMWC
greater than 15,000. In some aspects, the tangential flow filter
has an NMWC greater than 20,000. In some aspects, the tangential
flow filter has an NMWC greater than 25,000. In some aspects, the
tangential flow filter has an NMWC greater than 50,000. In some
aspects, the tangential flow filter has an NMWC greater than
75,000. In some aspects, the tangential flow filter has an NMWC
greater than 100,000. In some aspects, the tangential flow filter
has an NMWC greater than 150,000. In some aspects, the tangential
flow filter has an NMWC greater than 200,000. In some aspects, the
tangential flow filter has an NMWC greater than 250,000. In some
aspects, the tangential flow filter has an NMWC greater than
300,000. In some aspects, the tangential flow filter has an NMWC
greater than 350,000. In some aspects, the tangential flow filter
has an NMWC greater than 400,000. In some aspects, the tangential
flow filter has an NMWC greater than 450,000. In some aspects, the
tangential flow filter has an NMWC greater than 500,000. In some
aspects, the tangential flow filter has an NMWC greater than
600,000. In some aspects, the tangential flow filter has an NMWC
greater than 750,000.
[0097] In some aspects, the tangential flow filter is a GE
Healthcare Xampler.TM. Ultrafiltration Cartridge (GE Healthcare
Bio-Sciences, Corp., Piscataway. NJ) having a 500,000 nominal
molecular weight cutoff (NMWC), comprising a hollow fiber membrane
having a 1 mm inner diameter. In some aspects, the tangential flow
filter is an OPTISEP.RTM. 3000 filter module (NCSRT, Inc., Apex,
N.C.), an OPTISEP.RTM.7000 filter module, or an OPTISEP.RTM. 11000
filter module using a filter having a molecular weight cutoff
suitable for use with any of the exemplary isoprene-producing cells
or cell types described herein, including, for example, those that
comprise one or more heterologous nucleic acids encoding an
isoprene synthase polypeptide, a DXS polypeptide, an IDI
polypeptide, and/or an MVA pathway polypeptide operably linked to a
promoter.
[0098] In some aspects, the filter is a tangential flow filter has
a nominal molecular weight cutoff (NMWC) suitable for use with any
of the exemplary isoprene-producing cells or cell types described
herein, including, for example, those that comprise one or more
heterologous nucleic acids encoding an isoprene synthase
polypeptide, a DXS polypeptide, an IDI polypeptide, a DXP pathway
polypeptide and/or an MVA pathway polypeptide operably linked to a
promoter. In some aspects the tangential flow filter has an NMWC
between 1000 and 750,000. In some aspects the tangential flow
filter has an NMWC between 10,000 and 750,000. In some aspects the
tangential flow filter has an NMWC between 100,000 and 750,000. In
some aspects the tangential flow filter has an NMWC between 250,000
and 750,000. In some aspects, the tangential flow filter has an
NMWC greater than 1000. In some aspects, the tangential flow filter
has an NMWC greater than 5000. In some aspects, the tangential flow
filter has an NMWC greater than 10,000. In some aspects, the
tangential flow filter has an NMWC greater than 15,000. In some
aspects, the tangential flow filter has an NMWC greater than
20,000. In some aspects, the tangential flow filter has an NMWC
greater than 25,000. In some aspects, the tangential flow filter
has an NMWC greater than 50,000. In some aspects, the tangential
flow filter has an NMWC greater than 75,000. In some aspects, the
tangential flow filter has an NMWC greater than 100,000. In some
aspects, the tangential flow filter has an NMWC greater than
150,000. In some aspects, the tangential flow filter has an NMWC
greater than 200,000. In some aspects, the tangential flow filter
has an NMWC greater than 250,000. In some aspects, the tangential
flow filter has an NMWC greater than 300,000. In some aspects, the
tangential flow filter has an NMWC greater than 350,000. In some
aspects, the tangential flow filter has an NMWC greater than
400,000. In some aspects, the tangential flow filter has an NMWC
greater than 450,000. In some aspects, the tangential flow filter
has an NMWC greater than 500,000. In some aspects, the tangential
flow filter has an NMWC greater than 600,000. In some aspects, the
tangential flow filter has an NMWC greater than 750,000.
[0099] In some aspects, the fermentor, bioreactor, or cell culture
vessel lacks a circulation loop and a circulation pump, and the
filtering is by a submerged membrane bioreactor. In some aspects,
the submerged membrane bioreactor comprises a filtration module
immersed in the cell culture within the fermentor, bioreactor, or
cell culture vessel. In some aspects, the filtration module
comprises a filter and a permeate side in fluid contact with the
cell culture only through the filter. In some aspects, the filter
comprises a comprises a polyethersulfone (PES) membrane, a
polysulfone (PS) membrane, a polyvinylidene difluoride (PVDF)
membrane, a polyarylsulfone membrane, a polyamide membrane, a
polypropylene membrane, a polyethylene membrane, a
polytetrafluoroethylene (PTFE) membrane, a cellulose acetate
membrane, a polyacrylonitrile membrane, a vinyl copolymer membrane,
a cellulose membrane, a regenerated cellulose membrane, a
polycarbonate membrane, a ceramic membrane, a steel membrane, or a
stainless steel membrane.
[0100] In some aspects, the filter in the submerged membrane
bioreactor is an ultrafilter having a nominal molecular weight
cutoff (NMWC) suitable for use with any of the exemplary
isoprene-producing cells or cell types described herein, including,
for example, those that comprise one or more heterologous nucleic
acids encoding an isoprene synthase polypeptide, a DXS polypeptide,
an IDI polypeptide and/or an MVA pathway polypeptide operably
linked to a promoter. In some aspects the filter has an NMWC
between 1000 and 750,000. In some aspects, the filter has an NMWC
greater than 1000. In some aspects, the filter has an NMWC greater
than 5000. In some aspects, the filter has an NMWC greater than
10,000. In some aspects, the filter has an NMWC greater than
15,000. In some aspects, the filter has an NMWC greater than
20,000. In some aspects, the filter has an NMWC greater than
25,000. In some aspects, the filter has an NMWC greater than
50,000. In some aspects, the filter has an NMWC greater than
75,000. In some aspects, the filter has an NMWC greater than
100,000. In some aspects, the filter has an NMWC greater than
150,000. In some aspects, the filter has an NMWC greater than
200,000. In some aspects, the filter has an NMWC greater than
250,000. In some aspects, the filter has an NMWC greater than
300,000. In some aspects, the filter has an NMWC greater than
350,000. In some aspects, the filter has an NMWC greater than
400,000. In some aspects, the filter has an NMWC greater than
450,000. In some aspects, the filter has an NMWC greater than
500,000. In some aspects, the filter has an NMWC greater than
600,000. In some aspects, the filter has an NMWC greater than
750,000.
[0101] In some aspects, the filter in the submerged membrane
bioreactor is a microfilter having a filter pore size suitable for
use with any of the exemplary isoprene-producing cells or cell
types described herein, including, for example, those that comprise
one or more heterologous nucleic acids encoding an isoprene
synthase polypeptide, a DXS polypeptide, an IDI polypeptide, a DXP
pathway polypeptide and/or an MVA pathway polypeptide operably
linked to a promoter. In some aspects, the filter has a filter pore
size between about 0.005 .mu.m and about 100 .mu.m. In some
aspects, the filter has a filter pore size between about 0.005
.mu.m and about 50 .mu.min. In some aspects, the filter has a
filter pore size between about 0.005 .mu.m and about 10 .mu.m. In
some aspects, the filter has a filter pore size between about 0.005
.mu.m and about 5 .mu.m. In some aspects, the filter has a filter
pore size between about 0.005 .mu.m and about 2 .mu.m. In some
aspects, the filter has a filter pore size between about 0.005
.mu.m and about 1 .mu.m. In some aspects, the filter has a filter
pore size between about 0.05 .mu.m and about 100 .mu.m. In some
aspects, the filter has a filter pore size between about 0.05 .mu.m
and about 50 .mu.m. In some aspects, the filter has a filter pore
size between about 0.05 .mu.m and about 10 .mu.m. In some aspects,
the filter has a filter pore size between about 0.05 .mu.m and
about 5 .mu.m. In some aspects, the filter has a filter pore size
between about 0.05 .mu.m and about 2 .mu.m. In some aspects, the
filter has a filter pore size between about 0.05 .mu.m and about 1
.mu.m. In some aspects, the filter has a filter pore size between
about 0.5 .mu.m and about 100 .mu.m. In some aspects, the filter
has a filter pore size between about 0.5 .mu.m and about 50 .mu.m.
In some aspects, the filter has a filter pore size between about
0.5 .mu.m and about 10 .mu.m. In some aspects, the filter has a
filter pore size between about 0.5 .mu.m and about 5 .mu.m. In some
aspects, the tangential flow filter has a filter pore size between
about 0.5 .mu.m and about 2 .mu.m. In some aspects, the filter has
a filter pore size between about 0.5 .mu.m and 1 .mu.m. In some
aspects, the filter has a filter pore size between about 1 .mu.m
and about 10 .mu.m. In some aspects, the filter has a filter pore
size between about 1 .mu.m and about 50 .mu.m. In some aspects, the
filter has a filter pore size between about 1 .mu.m and about 100
.mu.m. In some aspects, the filter has a filter pore size between
about 5 .mu.m and about 10 .mu.m. In some aspects, the filter has a
filter pore size between about 5 .mu.m and about 50 .mu.m. In some
aspects, the filter has a filter pore size between about 5 .mu.m
and about 100 .mu.m. In some aspects, the filter has a filter pore
size between about 0.05 .mu.m and about 0.5 .mu.m. In some aspects,
the filter has a filter pore size between about 0.5 .mu.m and about
1 .mu.m. In some aspects, the filter has a filter pore size between
about 1 .mu.m and about 5 .mu.m. In some aspects, the filter has a
filter pore size between about 5 microns and about 10 microns. In
some aspects, the filter has a filter pore size between about 10
microns and about 50 microns. In some aspects, the filter has a
filter pore size between about 10 microns and about 100
microns.
[0102] In some aspects, the filtration module further comprises a
permeate collection outlet and a permeate pump. In some aspects,
the filtration module further comprises a permeate collection tank.
In some aspects, the permeate pump comprises a positive
displacement pump, such as a peristaltic pump, a reciprocating
pump, or a rotary pump. In some aspects, the permeate pump is a
peristaltic pump. In some aspects, the permeate pump is a velocity
pump, such as a centrifugal pump, a radial flow pump, an axial flow
pump, a mixed flow pump, or a gravity pump. In some aspects, the
permeate pump is a centrifugal pump. In some aspects, the permeate
collection tank further comprises a vent to relieve pressure within
the tank.
[0103] In some aspects, the improved method further comprises the
step of maintaining a positive transmembrane pressure, calculated
as follows: TMP=([P.sub.in+P.sub.out]/2)-P.sub.perm). In some
aspects, the improved method further comprises the step of cleaning
the filter by inverting the TMP (i.e., making the TMP negative).
Inverting the TMP causes the permeate to flow back into the
solution to be filtered, thereby lifting any solids fouling the
filter off the surface of the membrane and improving flow through
the filter and the circulation loop. Inverting the TMP usually
requires pressurizing the permeate side of the membrane. Inverting
the TMP is more commonly applied to ceramic and steel membrane
filters, which are less susceptible to damage due to their
intrinsic strength. Pressurization of the permeate may be achieved
by connecting the permeate line to compressed air or water, among
other methods. See, for example, Danisco application WO 2009/035700
for exemplary teachings on specific ways to invert TMP in a
spiral-wound polymeric membrane
[0104] In some aspects, the residence time within the filtration
unit is 25 seconds and the glucose concentration within the
fermentation broth is between 3 and 25 g/L. In some aspects, the
residence time within the filtration unit is 10 seconds and the
glucose concentration within the fermentation broth is between 1
and 3 g/L. In some aspects, the residence time within the
filtration unit is between 5 and 60 seconds and the glucose
concentration within the fermentation broth is between 0.2 and 25
g/L.
[0105] In some aspects, removal of a portion of the culture first
begins when the culture reaches a target volume. In some aspects,
the target volume is determined empirically. In some aspects, the
target volume is 1/2 (one-half), 1/3 (one-third), 1/4
(one-quarter), 1/5 (one-fifth), 1/6 (one-sixth), 1/7 (one-seventh),
1/8 (one-eighth), 1/9 (one ninth), 1/10 (one tenth), or less of the
total volume of the fermentor, bioreactor, or cell culture vessel.
In some aspects, the target volume is the working capacity of the
fermentor, bioreactor, or cell culture vessel being used to culture
the cells. In some aspects, removal of a portion of the culture
first begins at 5 hours, 10 hours, 15 hours, 20 hours, 25 hours, 30
hours, 35 hours, or more after the start of cell culture (i.e.,
after the start of fermentation).
[0106] Continuous operation of the circulation loop costs energy
(pumping against pressure) and adds stress to the cells. Thus, the
option of delaying or suspending filtration, i.e. harvesting spent
media at particular times during the fermentation or at intervals
instead of continuously, may provide economic benefit as well as
potentially improve fermentation outcome. In some aspects, the
portion of the culture is removed continuously from the fermentor,
bioreactor, or cell culture vessel. In some aspects, the portion of
the culture is continuously removed at a rate of 1 ml/minute, 5
ml/minute, 10 ml/minute, 15 ml/minute, 20 ml/minute, 25 ml/minute,
30 ml/minute, 35 ml/minute, 40 ml/minute, 45 ml/minute, 50
ml/minute, 100 ml/minute, 250 ml/minute, 500 ml/minute, 1000
ml/minute or more. In some aspects, the portion of the culture is
continuously removed at a rate of 1 ml/15 minutes, 5 ml/15 minutes,
10 ml/15 minutes, 15 ml/15 minutes, 20 ml/15 minutes, 25 ml/15
minutes, 30 ml/15 minutes, 35 ml/15 minutes, 40 ml/15 minutes, 45
ml/15 minutes, 50 ml/15 minutes, 100 ml/15 minutes, 250 ml/15
minutes, 500 ml/15 minutes, 1000 ml/15 minutes or more. In some
aspects, the portion of the culture is continuously removed at a
rate of 1 ml/30 minutes, 5 ml/30 minutes, 10 ml/30 minutes, 15
ml/30 minutes, 20 ml/30 minutes, 25 ml/30 minutes, 30 ml/30
minutes, 35 ml/30 minutes, 40 ml/30 minutes, 45 ml/30 minutes, 50
ml/30 minutes, 100 ml/30 minutes, 250 ml/30 minutes, 500 ml/30
minutes, 1000 ml/30 minutes or more. In some aspects, the portion
of the culture is continuously removed at a rate of 1 ml/60
minutes, 5 ml/60 minutes, 10 ml/60 minutes, 15 ml/60 minutes, 20
ml/60 minutes, 25 ml/60 minutes, 30 ml/60 minutes, 35 ml/60
minutes, 40 ml/60 minutes, 45 ml/60 minutes, 50 ml/60 minutes, 100
ml/60 minutes, 250 ml/60 minutes, 500 ml/60 minutes, 1000 ml/60
minutes or more. In some aspects, the portion of the culture is
continuously removed at a rate of 1 g/minute, 2 g/minute, 3
g/minute, 4 g/minute, 5 g/minute, 6 g/minute, 7 g/minute, 8
g/minute, 9 g/minute, 10 g/minute, 20 g/minute, 30 g/minute, 40
g/minute, 50 g/minute, 60 g/minute, 70 g/minute, 80 g/minute, 90
g/minute, 100 g/minute or more. In some aspects, the portion of the
culture is continuously removed at a rate of 1 g/l 5 minutes, 2
g/15 minutes, 3 g/15 minutes, 4 g/15 minutes, 5 g/15 minutes, 6
g/15 minutes, 7 g/15 minutes, 8 g/15 minutes, 9 g/15 minutes, 10
g/15 minutes, 20 g/15 minutes, 30 g/15 minutes, 40 g/15 minutes 50
g/15 minutes, 60 g/15 minutes, 70 g/15 minutes, 80 g/15 minutes, 90
g/15 minutes, 100 g/15 minutes or more. In some aspects, the
portion of the culture is continuously removed at a rate of 1 g/30
minutes, 2 g/30 minutes, 3 g/30 minutes, 4 g/30 minutes, 5 g/30
minutes, 6 g/30 minutes, 7 g/30 minutes, 8 g/30 minutes, 9 g/30
minutes, 10 g/30 minutes, 20 g/30 minutes, 30 g/30 minutes 40 g/30
minutes, 50 g/30 minutes, 60 g/30 minutes, 70 g/30 minutes, 80 g/30
minutes, 90 g/30 minutes, 100 g/30 minutes or more. In some
aspects, the portion of the culture is continuously removed at a
rate of 1 g/60 minutes, 2 g/60 minutes, 3 g/60 minutes, 4 g/60
minutes, 5 g/60 minutes, 6 g/60 minutes, 7 g/60 minutes, 8 g/60
minutes, 9 g/60 minutes, 10 g/60 minutes, 20 g/60 minutes, 30 g/60
minutes, 40 g/60 minutes, 50 g/60 minutes, 60 g/60 minutes, 70 g/60
minutes, 80 g/60 minutes, 90 g/60 minutes, 100 g/60 minutes or
more. In some aspects, the portion of the culture is continuously
removed at a rate of 0.2 kg/minute, 0.4 kg/minute, 0.6 kg/minute,
0.8 kg/minute, 1.0 kg/minute, 1.2 kg/minute, 1.4 kg/minute, 1.6
kg/minute, 1.8 kg/minute, 2.0 kg/minute, 3.0 kg/minute, 4.0
kg/minute, 5.0 kg/minute or more. In some aspects, the portion of
the culture is continuously removed at a rate of 0.2 kg/15 minutes,
0.4 kg/15 minutes, 0.6 kg/15 minutes, 0.8 kg/15 minutes, 1.0 kg/15
minutes, 1.2 kg/15 minutes, 1.4 kg/15 minutes, 1.6 kg/15 minutes,
1.8 kg/15 minutes, 2.0 kg/15 minutes, 3.0 kg/15 minutes, 4.0 kg/15
minutes, 5.0 kg/15 minutes or more. In some aspects, the portion of
the culture is continuously removed at a rate of 0.2 kg/30 minutes,
0.4 kg/30 minutes, 0.6 kg/30 minutes, 0.8 kg/30 minutes, 1.0 kg/30
minutes, 1.2 kg/30 minutes, 1.4 kg/30 minutes, 1.6 kg/30 minutes,
1.8 kg/30 minutes, 2.0 kg/30 minutes, 3.0 kg/30 minutes, 4.0 kg/30
minutes, 5.0 kg/30 minutes or more. In some aspects, the portion of
the culture is continuously removed at a rate of 0.2 kg/60 minutes,
0.4 kg/60 minutes, 0.6 kg/60 minutes, 0.8 kg/60 minutes, 1.0 kg/60
minutes, 1.2 kg/60 minutes, 1.4 kg/60 minutes, 1.6 kg/60 minutes,
1.8 kg/60 minutes, 2.0 kg/60 minutes, 3.0 kg/60 minutes, 4.0 kg/60
minutes, 5.0 kg/60 minutes or more.
[0107] In some aspects, the portion of the culture is removed
discontinuously from the fermentor, bioreactor, or cell culture
vessel, at a desired time interval. In some aspects, a portion of
the culture is removed from the fermentor, bioreactor, or cell
culture vessel, every 5 minutes, every 10 minutes, every 15
minutes, every 20 minutes, every 25 minutes, every 30 minutes,
every 35 minutes, every 40 minutes, every 45 minutes, every 50
minutes, every 55 minutes, every 60 minutes, or more. In some
aspects, 1 ml, 5 ml, 10 ml, 15 ml, 20 ml, 25 ml, 30 ml, 35 ml, 40
ml, 45 ml, 50 ml, 75 ml, 100 ml, 125 ml, 150 ml, 175 ml, 200 ml,
225 ml, 250 ml, or more is removed from the culture at each
interval. In some aspects, 0.2 kg, 0.4 kg, 0.6 kg, 0.8 kg, 1.0 kg,
1.2 kg, 1.4 kg, 1.6 kg, 1.8 kg, 2.0 kg, or more is removed from the
culture at each interval.
[0108] In some aspects, the cells cultured in any of the improved
methods described herein are any of the isoprene-producing cells
described herein that comprise one or more heterologous nucleic
acids encoding an isoprene synthase polypeptide, a DXS polypeptide,
an IDI polypeptide, a DXP pathway polypeptide and/or an MVA pathway
polypeptide operably linked to a promoter. In some aspects, the
cells comprising a heterologous nucleic acid encoding an isoprene
synthase either (i) produce isoprene at a titer greater than 40 g/L
or (ii) have an average volumetric productivity greater than about
500 mg/L.sub.broth/hr of isoprene.
[0109] In some aspects, the DXP pathway polypeptide is selected
from the group consisting of DXS (1-deoxy-D-xylulose-5-phosphate
synthase), DXR (1-deoxy-D-xylulose-5-phosphate reductoisomerase),
MCT (4-diphosphocytidyl-2C-methyl-D-erythritol synthase). CMK
(4-diphosphocytidyl-2-C-methyl-D-erythritol kinase), MCS
(2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase). HDS
(1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase), HDR
(1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase), and IDI
polypeptides.
[0110] In some aspects, the MVA pathway polypeptide is an upper MVA
pathway polypeptide.
[0111] In some aspects, the upper MVA pathway polypeptide is
selected from the group consisting of: (i) an acetoacetyl-Coenzyme
A synthase (thiolase) polypeptide; (ii) a
3-hydroxy-3-methylglutaryl-Coenzyme A synthase polypeptide; and
(iii) a 3-hydroxy-3-methylglutaryl-Coenzyme A reductase
polypeptide. In some aspects, the upper MVA pathway polypeptide is
from the genus Enterococcus. In some aspects, the upper MVA pathway
polypeptide is from Enterococcus faecalis. In some aspects, the
upper MVA pathway polypeptide comprises an acetoacetyl-Coenzyme A
synthase (thiolase) polypeptide, a
3-hydroxy-3-methylglutaryl-Coenzyme A reductase polypeptide and a
3-hydroxy-3-methylglutaryl-Coenzyme A synthase polypeptide from
Enterococcus faecalis.
[0112] In some aspects, the MVA pathway polypeptide is a lower MVA
pathway polypeptide. In some aspects, the lower MVA pathway
polypeptide is selected from the group consisting of: (i)
mevalonate kinase (MVK); (ii) phosphomevalonate kinase (PMK); (iii)
diphosphomevalonate decarboxylase (MVD); and (iv) isopentenyl
diphosphate isomerase (IDI). In some aspects, the lower MVA pathway
polypeptide is from the genus Methanosarcina. In some aspects, the
lower MVA pathway polypeptide is from Methanosarcina mazei. In some
aspects, the lower MVA pathway polypeptide comprises an MVK
polypeptide from Methanosarcina mazei. In some aspects, the lower
MVA pathway polypeptide comprises an MVK polypeptide, a PMK
polypeptide, an MVD polypeptide, and an IDI polypeptide from
Saccharomyces cerevisiae. In some aspects, the lower MVA
polypeptide comprises an MVK polypeptide from Methanosarcina mazei
and an MVK polypeptide, a PMK polypeptide, an MVD polypeptide, and
an IDI polypeptide from Saccharomyces cerevisiae.
[0113] In some aspects, the isoprene synthase polypeptide is a
naturally-occurring polypeptide from the genus Pueraria. In some
aspects, the isoprene synthase polypeptide is a naturally-occurring
polypeptide from Pueraria montana. In some aspects, the isoprene
synthase polypeptide is a naturally-occurring polypeptide from the
genus Populus. In some aspects, the isoprene synthase polypeptide
is a naturally-occurring polypeptide from Populus alba.
[0114] In some aspects, the upper MVA pathway polypeptide comprises
an acetoacetyl-Coenzyme A synthase (thiolase) polypeptide, a
3-hydroxy-3-methylglutaryl-Coenzyme A reductase polypeptide and a
3-hydroxy-3-methylglutaryl-Coenzyme A synthase polypeptide from
Enterococcus faecalis; the lower MVA polypeptide comprises an MVK
polypeptide from Methanosarcina mazei and an MVK polypeptide, a PMK
polypeptide, an MVD polypeptide, and an IDI polypeptide from
Saccharomyces cerevisiae; and the isoprene synthase polypeptide is
from Populus alba.
[0115] In some aspects, the cells produce isoprene at a titer of
greater than about 40 g/L. In some aspects, the cells produce
isoprene at a titer of greater than about 50 g/L. In some aspects,
the cells produce isoprene at a titer of greater than about 60 g/L.
In some aspects, the cells produce isoprene at a titer of greater
than about 70 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 80 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 90 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 100 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 110 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 120 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 130 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 140 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 150 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 160 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 170 g/L. In some aspects, the cells
produce isoprene at a titer of greater than about 180 g/L. In some
aspects, the cells produce isoprene at a titer of greater than
about 190 g/L. In some aspects, the cells produce isoprene at a
titer of greater than about 200 g/L. In some aspects, the cells
produce isoprene at a titer between about 40 g/L and about 100 g/L.
In some aspects, the cells produce isoprene at a titer between
about 60 g/L and about 100 g/L. In some aspects, the cells produce
isoprene at a titer between about 60 g/L and about 120 g/L. In some
aspects, the cells produce isoprene at a titer between about 40 g/L
and about 150 g/L. In some aspects, the cells produce isoprene at a
titer between about 40 g/L and about 200 g/L. In some aspects, the
cells produce isoprene at a titer between about 80 g/L and about
150 g/L. In some aspects, the cells produce isoprene at a titer
between about 100 g/L and about 150 g/L. In some aspects, the cells
produce isoprene at a titer between about 100 g/L and about 180
g/L. In some aspects, the cells produce isoprene at a titer between
about 100 g/L and about 200 g/L. In some aspects, the cells produce
isoprene at a titer between about 120 g/L and about 200 g/L. In
some aspects, the cells have an average volumetric productivity of
greater than about 500 mg/L.sub.broth/hr of isoprene. In some
aspects, the cells have an average volumetric productivity greater
than about 1.000 mg/L.sub.broth/hr of isoprene. In some aspects,
the cells have an average volumetric productivity greater than
about 1,500 mg/L.sub.broth/hr of isoprene. In some aspects, the
cells have an average volumetric productivity greater than about
2.000 mg/L.sub.broth/hr of isoprene. In some aspects, the cells
have an average volumetric productivity between about 500
mg/L.sub.broth/hr and about 2,000 mg/L.sub.broth/hr of
isoprene.
[0116] In some aspects, the isoprene synthase polypeptide is a
plant isoprene synthase polypeptide. In some aspects, the cells
further comprise a heterologous nucleic acid encoding an IDI
polypeptide. In some aspects, the cells further comprise a
chromosomal copy of an endogenous nucleic acid encoding an IDI
polypeptide. In some aspects, the cells further comprise a
heterologous nucleic acid encoding a DXS polypeptide. In some
aspects, the cells further comprise a heterologous nucleic acid
encoding a DXP pathway polypeptide. In some aspects, the cells
further comprise a chromosomal copy of an endogenous nucleic acid
encoding a DXS polypeptide. In some aspects, the cells further
comprise one or more nucleic acids encoding an IDI polypeptide and
a DXS polypeptide or a DXP pathway polypeptide. In some aspects,
one nucleic acid encodes the isoprene synthase polypeptide, IDI
polypeptide, and DXS polypeptide or a DXP pathway polypeptide. In
some aspects, one plasmid encodes the isoprene synthase
polypeptide. IDI polypeptide, and DXS polypeptide or a DXP pathway
polypeptide. In some aspects, the cells further comprise a
heterologous nucleic acid encoding an MVA pathway polypeptide. In
some aspects, the cells further comprise a chromosomal copy of an
endogenous nucleic acid encoding an MVA pathway polypeptide. In
some aspects, the MVA pathway polypeptide is a mevalonate kinase
(MVK). In some aspects, the MVK is a polypeptide from the genus
Methanosarcina. In some aspects, the MVK is a polypeptide from
Methanosarcina mazei.
[0117] In some aspects, the isoprene synthase polypeptide is a
naturally-occurring polypeptide from the genus Pueraria. In some
aspects, the isoprene synthase polypeptide is a naturally-occurring
polypeptide from Pueraria montana. In some aspects, the isoprene
synthase polypeptide is a naturally-occurring polypeptide from the
genus Populus. In some aspects, the isoprene synthase polypeptide
is a naturally-occurring polypeptide from Populus alba. In some
aspects, the cells further comprise a heterologous nucleic acid
encoding an MVA pathway polypeptide. In some aspects, the MVA
pathway polypeptide is a mevalonate kinase (MVK). In some aspects,
the MVK is a polypeptide from the genus Methanosarcina. In some
aspects, the MVK is a polypeptide from Methanosarcina mazei. In
some aspects, the cells are bacterial cells. In some aspects, the
cells are gram-positive bacterial cells. In some aspects, the cells
are Bacillus cells. In some aspects, the cells are Bacillus
subtilis cells. In some aspects, the cells are gram-negative
bacterial cells. In some aspects, the cells are Escherichia or
Pantoea cells. In some aspects, the cells are Escherichia coli or
Pantoea citrea cells. In some aspects, the cells are fungal cells.
In some aspects, the cells are Trichoderma cells. In some aspects,
the cells are Trichoderma reesei cells. In some aspects, the cells
are yeast cells. In some aspects, the cells are Yarrowia cells. In
some aspects, the cells are Yarrowia lipolytica cells.
Exemplary Methods for Isolating Nucleic Acids
[0118] Isoprene synthase, DXS, IDI, DXP pathway polypeptides. MVA
pathway polypeptides. PGL, hydrogenase, hydrogenase maturation
and/or transcription factor nucleic acids can be isolated using
standard methods. Methods of obtaining desired nucleic acids from a
source organism of interest (such as a bacterial genome) are common
and well known in the art of molecular biology (see, for example,
WO 2004/033646 and references cited therein). Standard methods of
isolating nucleic acids, including PCR amplification of known
sequences, synthesis of nucleic acids, screening of genomic
libraries, screening of cosmid libraries are described in
International Publication No. WO 2009/076676, U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102), WO
2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716).
Exemplary Promoters and Vectors
[0119] Any of the isoprene synthase, DXS, DXP pathway polypeptides,
IDI, MVA pathway polypeptides, PGL, hydrogenase, hydrogenase
maturation and/or transcription factor nucleic acids described
herein can be included in one or more vectors. Accordingly, also
described herein are vectors with one more nucleic acids encoding
any of the isoprene synthase, DXS, IDI, DXP pathway polypeptides,
MVA pathway polypeptides, PGL, hydrogenase, hydrogenase maturation
and/or transcription factor polypeptides that are described herein.
In some aspects, the vector contains a nucleic acid under the
control of an expression control sequence. In some aspects, the
expression control sequence is a native expression control
sequence. In some aspects, the expression control sequence is a
non-native expression control sequence. In some aspects, the vector
contains a selective marker or selectable marker. In some aspects,
an isoprene synthase. DXS, IDI, DXP pathway, MVA pathway, PGL,
hydrogenase, hydrogenase maturation, or transcription regulatory
nucleic acid integrates into a chromosome of the cells without a
selectable marker.
[0120] Suitable vectors are those which are compatible with the
host cell employed. Suitable vectors can be derived, for example,
from a bacterium, a virus (such as bacteriophage T7 or a M-13
derived phage), a cosmid, a yeast, or a plant. Suitable vectors can
be maintained in low, medium, or high copy number in the host cell.
Protocols for obtaining and using such vectors are known to those
in the art (see, for example, Sambrook et al., Molecular Cloning: A
Laboratory Manual, 2.sup.nd ed., Cold Spring Harbor, 1989).
Suitable vectors compatible with the cells and methods described
herein are described in International Publication No. WO
2009/076676. U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716).
[0121] Promoters are well known in the art. Any promoter that
functions in the host cell can be used for expression of an
isoprene synthase. DXS, DXP pathway. IDI, MVA pathway, PGL,
hydrogenase, hydrogenase maturation and/or transcription factor
nucleic acid in the host cell. Initiation control regions or
promoters, which are useful to drive expression of isoprene
synthase, DXS, DXP pathway, IDI, MVA pathway. PGL, hydrogenase,
hydrogenase maturation and/or transcription factor nucleic acids in
various host cells are numerous and familiar to those skilled in
the art (see, for example, WO 2004/033646 and references cited
therein). Virtually any promoter capable of driving these nucleic
acids can be used including a glucose isomerase promoter (see, for
example, U.S. Pat. No. 7,132,527 and references cited therein).
Suitable promoters compatible with the cells and methods described
herein are described in International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716).
[0122] In some aspects, the expression vector also includes a
termination sequence. Termination control regions may also be
derived from various genes native to the host cell. In some
aspects, the termination sequence and the promoter sequence are
derived from the same source. Suitable termination sequences
compatible with the cells and methods described herein are
described in International Publication No. WO 2009/076676 A2 and
U.S. patent application Ser. No. 12/335,071, both of which are
incorporated herein by reference.
[0123] An isoprene synthase, DXS, DXP pathway, IDI, MVA pathway.
PGL, hydrogenase, hydrogenase maturation and/or transcription
factor nucleic acid can be incorporated into a vector, such as an
expression vector, using standard techniques (Sambrook et al.,
Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, 1982).
Suitable techniques compatible with the cells and methods described
herein are described in International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716).
[0124] In some aspects, it may be desirable to over-express
isoprene synthase, DXP pathway polypeptides, IDI, MVA pathway
polypeptides, PGL, hydrogenase, hydrogenase maturation and/or
transcription factor nucleic acids at levels far higher than
currently found in naturally-occurring cells. In some aspects, it
may be desirable to under-express (e.g., mutate, inactivate, or
delete) isoprene synthase. DXP pathway polypeptides. IDI, MVA
pathway polypeptides, PGL, hydrogenase, hydrogenase maturation, or
transcription factor polypeptide-encoding nucleic acids at levels
far below that those currently found in naturally-occurring cells.
Suitable methods for over- or under-expressing the isoprene
synthase. DXP pathway polypeptides, IDI, MVA pathway polypeptides.
PGL, hydrogenase, hydrogenase maturation and/or transcription
factor nucleic acids compatible with cells and methods described
herein are described in International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716).
Exemplary Source Organisms
[0125] Isoprene synthase, DXP pathway. IDI, MVA pathway, PGL,
hydrogenase, hydrogenase maturation and/or transcription factor
nucleic acids (and their encoded polypeptides) can be obtained from
any organism that naturally contains isoprene synthase, DXP
pathway, IDI, MVA pathway, PGL, hydrogenase, hydrogenase maturation
and/or transcription factor nucleic acids. As noted above, isoprene
is formed naturally by a variety of organisms, such as bacteria,
yeast, plants, and animals. Organisms contain the MVA pathway. DXP
pathway, or both the MVA and DXP pathways for producing isoprene
(FIGS. 1A and 1B). Thus, DXP pathway nucleic acids can be obtained,
e.g., from any organism that contains the DXP pathway or contains
both the MVA and DXP pathways. IDI and isoprene synthase nucleic
acids can be obtained, e.g., from any organism that contains the
MVA pathway. DXP pathway, or both the MVA and DXP pathways. MVA
pathway nucleic acids can be obtained. e.g., from any organism that
contains the MVA pathway or contains both the MVA and DXP pathways.
Hydrogenase nucleic acids can be obtained, e.g., from any organism
that oxidizes hydrogen or reduces hydrogen ions. Fermentation side
product genes can be obtained or identified, e.g., from any
organism that undergoes oxygen-limited or anaerobic respiration,
such as glycolysis.
[0126] The nucleic acid sequence of the isoprene synthase, DXP
pathway. IDI, MVA pathway, PGL, hydrogenase, hydrogenase maturation
and/or transcription factor nucleic acids can be isolated from a
bacterium, fungus, plant, algae, or cyanobacterium. Exemplary
source organisms include, for example, yeasts, such as species of
Saccharomyces (e.g., S. cerevisiae) or species of Yarrowia (e.g.,
Yarrowia lipolytica), other fungi, such as species of Trichoderma
(e.g., T. reesei), bacteria, such as species of Bacillus (e.g., B.
subtilis), species of Escherichia (e.g., E. coli), species of
Methanosarcina (e.g., Methanosarcina mazei) or species of Pantoea
(e.g., P. citrea), plants, such as kudzu or poplar (e.g., Populus
alba x tremula CAC35696) or aspen (e.g., Populus tremuloides).
Exemplary host organisms are described in U.S. Provisional Patent
Application No. 61/187,959, International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716.
Exemplary Host Cells
[0127] A variety of host cells can be used to express isoprene
synthase. DXS, IDI, DXP pathway polypeptides, MVA pathway
polypeptides, hydrogenase, hydrogenase maturation and/or
transcription factor polypeptides and to co-produce isoprene and
hydrogen in the methods described herein. Exemplary host cells
include cells from any of the organisms listed in the prior section
under the heading "Exemplary Source Organisms." The host cell may
be a cell that naturally produces isoprene or a cell that does not
naturally produce isoprene. In some aspects, the host cell
naturally produces isoprene using the DXP pathway, and an isoprene
synthase. DXS, and/or IDI nucleic acid is added to enhance
production of isoprene using this pathway. In some aspects, the
host cell naturally produces isoprene using the MVA pathway, and an
isoprene synthase and/or one or more MVA pathway nucleic acids are
added to enhance production of isoprene using this pathway. In some
aspects, the host cell naturally produces isoprene using the DXP
pathway and one or more MVA pathway nucleic acids are added to
produce isoprene using part or all of the MVA pathway as well as
the DXP pathway. In some aspects, the host cell naturally produces
isoprene using both the DXP and MVA pathways and one or more
isoprene synthase. DXS, IDI, or MVA pathway nucleic acids are added
to enhance production of isoprene by one or both of these
pathways.
[0128] Various types of host cells suitable for use with the
methods described herein, including cells that naturally produce
isoprene using both the DXP and MVA pathways, are discussed in
International Publication No. WO 2009/076676. U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102), WO
2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716. Non-limiting host cells include;
Escherichia coli (E. coli), Panteoa citrea, Bacillus subtilis,
Yarrowia lipolytica, and Trichoderma reesei.
Exemplary Transformation Methods
[0129] Isoprene synthase, DXS, IDI, MVA pathway, PGL, hydrogenase,
hydrogenase maturation and/or transcription factor nucleic acids or
vectors containing them can be inserted into a host cell (e.g., a
plant cell, a fungal cell, a yeast cell, or a bacterial cell
described herein) using standard techniques for introduction of a
DNA construct or vector into a host cell, such as transformation,
electroporation, nuclear microinjection, transduction, transfection
(e.g., lipofection mediated or DEAE-Dextrin mediated transfection
or transfection using a recombinant phage virus), incubation with
calcium phosphate DNA precipitate, high velocity bombardment with
DNA-coated microprojectiles, and protoplast fusion. General
transformation techniques are known in the art (see. e.g., Current
Protocols in Molecular Biology (F. M. Ausubel et al. (eds.) Chapter
9, 1987; Sambrook et al., Molecular Cloning: A Laboratory Manual,
2.sup.nd ed., Cold Spring Harbor, 1989; and Campbell el al., Curr.
Genet. 16:53-56, 1989). The introduced nucleic acids may be
integrated into chromosomal DNA or maintained as extrachromosomal
replicating sequences. Transformants can be selected by any method
known in the art. Suitable methods for selecting transformants are
described in U.S. Provisional Patent Application No. 61/187,959,
International Publication No. WO 2009/076676. U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102). WO
2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716.
Exemplary Cell Culture Media
[0130] By "cells in culture" is meant two or more cells in a
solution (e.g., a cell growth medium) that allows the cells to
undergo one or more cell divisions. "Cells in culture" do not
include plant cells that are part of a living, multicellular plant
containing cells that have differentiated into plant tissues. In
various aspects, the cell culture includes at least or about 10,
20, 50, 100, 200, 500, 1,000, 5,000, 10,000 or more cells.
[0131] Any carbon source can be used to cultivate the host cells.
The term "carbon source" refers to one or more carbon-containing
compounds capable of being metabolized by a host cell or organism.
For example, the cell medium used to cultivate the host cells may
include any carbon source suitable for maintaining the viability or
growing the host cells.
[0132] Various carbon sources suitable for culturing isoprene
producing cells according to the methods described herein are
described in International Application Publication WO 2009/076676
A2 and in U.S. patent application Ser. No. 12/335,071, both of
which are incorporated herein by reference in their entireties.
[0133] In some aspects, cells are cultured in a standard medium
containing physiological salts and nutrients (see, e.g., Pourquie,
J. et al., Biochemistry and Genetics of Cellulose Degradation, eds.
Aubert et al., Academic Press, pp. 71-86, 1988 and Ilmen et al.,
Appl. Environ. Microbiol. 63:1298-1306, 1997). Exemplary growth
media are common commercially prepared media such as Luria Bertani
(LB) broth, Sabouraud Dextrose (SD) broth, or Yeast medium (YM)
broth. Other defined or synthetic growth media may also be used,
and the appropriate medium for growth of particular host cells are
known by someone skilled in the art of microbiology or fermentation
science.
[0134] In addition to an appropriate carbon source, the cell medium
desirably contains suitable minerals, salts, cofactors, buffers,
and other components known to those skilled in the art suitable for
the growth of the cultures or the enhancement of isoprene
production (see, for example, WO 2004/033646 and references cited
therein and WO 96/35796 and references cited therein). In some
aspects where an isoprene synthase, DXS, IDI, and/or MVA pathway
nucleic acid is under the control of an inducible promoter, the
inducing agent (e.g., a sugar, metal salt or antimicrobial), is
desirably added to the medium at a concentration effective to
induce expression of an isoprene synthase, DXS, IDI, DXP pathway
polypeptides and/or MVA pathway polypeptides. In some aspects, cell
medium has an antibiotic (such as kanamycin) that corresponds to
the antibiotic resistance nucleic acid (such as a kanamycin
resistance nucleic acid) on a vector that has one or more isoprene
synthase, DXS, IDI, DXP pathway nucleic acids or MVA pathway
nucleic acids.
Exemplary Cell Culture Conditions
[0135] Materials and methods suitable for the maintenance and
growth of bacterial cultures are well known in the art. Exemplary
techniques may be found in Manual of Methods for General
Bacteriology Gerhardt et al., eds.), American Society for
Microbiology, Washington, D.C. (1994) or Brock in Biotechnology: A
Textbook of Industrial Microbiology, Second Edition (1989) Sinauer
Associates, Inc., Sunderland, Mass. In some aspects, the cells are
cultured in a culture medium under conditions permitting the
expression of one or more isoprene synthase, DXS, IDI, DXP pathway
polypeptides or MVA pathway polypeptides encoded by a nucleic acid
inserted into the host cells.
[0136] Standard cell culture conditions are suitable for culturing
the cells (see, for example, WO 2004/033646 and references cited
therein). Cells are grown and maintained at an appropriate
temperature, gas mixture, and pH (such as at about 20.degree. C. to
about 37.degree. C., at about 6% to about 84% CO.sub.2, and at a pH
between about 5 to about 9). In some aspects, cells are grown at
35.degree. C. in an appropriate cell medium. In some aspects, e.g.,
cultures are cultured at approximately 28.degree. C. in appropriate
medium in shake cultures or fermentors until the desired amount of
isoprene and hydrogen co-production is achieved. In some aspects,
the pH ranges for fermentation are between about pH 5.0 to about pH
9.0 (such as about pH 6.0 to about pH 8.0 or about 6.5 to about
7.0). Reactions may be performed under aerobic, anoxic, or
anaerobic conditions based on the requirements of the host
cells.
[0137] Standard culture conditions and modes of fermentation, such
as batch, fed-batch, or continuous fermentation, are described in
International Publication No. WO 2009/076676, U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102), WO
2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716. Batch and Fed-Batch fermentations are
common and well known in the art and examples may be found in
Brock, Biotechnology: A Textbook of Industrial Microbiology, Second
Edition (1989) Sinauer Associates, Inc.
[0138] In some aspects, a constitutive or leaky promoter (such as a
Trc promoter) is used and a compound (such as IPTG) is not added to
induce expression of the isoprene synthase, DXS, IDI, DXP pathway
nucleic acid(s) or MVA pathway nucleic acid(s) operably linked to
the promoter. In some aspects, a compound (such as IPTG) is added
to induce expression of the isoprene synthase. DXS, IDI, DXP
pathway nucleic acid(s) or MVA pathway nucleic acid(s) operably
linked to the promoter.
Exemplary Isoprene Synthase Polypeptides and Nucleic Acids
[0139] In some aspects, the E. coli cells comprise a heterologous
nucleic acid encoding an isoprene synthase polypeptide. In some
aspects, the isoprene synthase polypeptide or nucleic acid is from
the family Fabaceae, such as the Faboideae subfamily. In some
aspects, the isoprene synthase polypeptide or nucleic acid is a
polypeptide or nucleic acid from Pueraria montana (kudzu) (Sharkey
et al., Plant Physiology 137: 700-712, 2005), Pueraria lobata,
poplar (such as Populus alba, Populus nigra, Populus trichocarpa,
or Populus alba x tremula (CAC35696) Miller et al., Planta
213:483-487, 2001) aspen (such as Populus tremuloides) Silver et
al., JBC 270(22): 13010-1316, 1995), or English Oak (Quercus robur)
(Zimmer et al., WO 98/02550). In some aspects, the isoprene
synthase polypeptide or nucleic acid is a naturally-occurring
isoprene synthase polypeptide or nucleic acid. In some aspects, the
isoprene synthase polypeptide or nucleic acid is not a
naturally-occurring isoprene synthase polypeptide or nucleic acid.
Exemplary isoprene synthase polypeptides and nucleic acids and
methods of measuring isoprene synthase activity are described in
more detail in International Publication No. WO 2009/076676, U.S.
patent application Ser. No. 12/335,071 (US Publ. No. 2009/0203102).
WO 2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716.
Exemplary DXP Pathway Polypeptides and Nucleic Acids
[0140] Exemplary DXP pathways polypeptides include, but are not
limited to any of the following polypeptides: DXS polypeptides, DXR
polypeptides, MCT polypeptides, CMK polypeptides. MCS polypeptides.
HDS polypeptides. HDR polypeptides, IDI polypeptides, and
polypeptides (e.g., fusion polypeptides) having an activity of one,
two, or more of the DXP pathway polypeptides. In particular. DXP
pathway polypeptides include polypeptides, fragments of
polypeptides, peptides, and fusions polypeptides that have at least
one activity of a DXP pathway polypeptide. Exemplary DXP pathway
nucleic acids include nucleic acids that encode a polypeptide,
fragment of a polypeptide, peptide, or fusion polypeptide that has
at least one activity of a DXP pathway polypeptide. Exemplary DXP
pathway polypeptides and nucleic acids include naturally-occurring
polypeptides and nucleic acids from any of the source organisms
described herein as well as mutant polypeptides and nucleic acids
of any of the source organisms described herein.
[0141] Exemplary DXS polypeptides include polypeptides, fragments
of polypeptides, peptides, and fusions polypeptides that have at
least one activity of a DXS polypeptide. Standard methods (such as
those described herein) can be used to determine whether a
polypeptide has DXS polypeptide activity by measuring the ability
of the polypeptide to convert pyruvate and
D-glyceraldehyde-3-phosphate into 1-deoxy-D-xylulose-5-phosphate in
vitro, in a cell extract, or in vivo. Exemplary DXS polypeptides
and nucleic acids and methods of measuring DXS activity are
described in more detail in International Publication No. WO
2009/076676. U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716.
[0142] In particular, DXS polypeptides convert pyruvate and
D-glyceraldehyde 3-phosphate into 1-deoxy-d-xylulose 5-phosphate
(DXP). Standard methods can be used to determine whether a
polypeptide has DXS polypeptide activity by measuring the ability
of the polypeptide to convert pyruvate and D-glyceraldehyde
3-phosphate in vitro, in a cell extract, or in vivo.
[0143] DXR polypeptides convert 1-deoxy-d-xylulose 5-phosphate
(DXP) into 2-C-methyl-D-erythritol 4-phosphate (MEP). Standard
methods can be used to determine whether a polypeptide has DXR
polypeptide activity by measuring the ability of the polypeptide to
convert DXP in vitro, in a cell extract, or in vivo.
[0144] MCT polypeptides convert 2-C-methyl-D-erythritol 4-phosphate
(MEP) into 4-(cytidine 5'-diphospho)-2-methyl-D-erythritol
(CDP-ME). Standard methods can be used to determine whether a
polypeptide has MCT polypeptide activity by measuring the ability
of the polypeptide to convert MEP in vitro, in a cell extract, or
in vivo.
[0145] CMK polypeptides convert 4-(cytidine
5'-diphospho)-2-C-methyl-D-erythritol (CDP-ME) into
2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol
(CDP-MEP). Standard methods can be used to determine whether a
polypeptide has CMK polypeptide activity by measuring the ability
of the polypeptide to convert CDP-ME in vitro, in a cell extract,
or in vivo.
[0146] MCS polypeptides convert 2-phospho-4-(cytidine
5'-diphospho)-2-C-methyl-D-erythritol (CDP-MEP) into
2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP or cMEPP).
Standard methods can be used to determine whether a polypeptide has
MCS polypeptide activity by measuring the ability of the
polypeptide to convert CDP-MEP in vitro, in a cell extract, or in
vivo.
[0147] HDS polypeptides convert 2-C-methyl-D-erythritol
2,4-cyclodiphosphate (ME-CPP or cMEPP) into
(E)-4-hydroxy-3-methylbut-2-en-1-yl diphosphate (HMBPP or HDMAPP).
Standard methods can be used to determine whether a polypeptide has
HDS polypeptide activity by measuring the ability of the
polypeptide to convert ME-CPP or cMEPP in vitro, in a cell extract,
or in vivo.
[0148] HDR polypeptides convert (E)-4-hydroxy-3-methylbut-2-en-1-yl
diphosphate (HMBPP or HDMAPP) into isopentenyl diphosphate (IPP)
and dimethylallyl diphosphate (DMAPP). Standard methods can be used
to determine whether a polypeptide has HDR polypeptide activity by
measuring the ability of the polypeptide to convert HMBPP or HDMAPP
in vitro, in a cell extract, or in vivo.
[0149] IDI polypeptides convert isopentenyl diphosphate into
dimethylallyl disphosphate. Standard methods can be used to
determine whether a polypeptide has IDI polypeptide activity by
measuring the ability of the polypeptide to convert isopentenyl
diphosphate in vitro, in a cell extract, or in vivo.
Exemplary IDI Polypeptides and Nucleic Acids
[0150] Isopentenyl diphosphate isomerase polypeptides
(isopentenyl-diphosphate delta-isomerase or IDI) catalyses the
interconversion of isopentenyl diphosphate (IPP) and dimethyl allyl
diphosphate (DMAPP) (e.g., converting IPP into DMAPP and/or
converting DMAPP into IPP). Exemplary IDI polypeptides include
polypeptides, fragments of polypeptides, peptides, and fusions
polypeptides that have at least one activity of an IDI polypeptide.
Standard methods (such as those described herein) can be used to
determine whether a polypeptide has IDI polypeptide activity by
measuring the ability of the polypeptide to interconvert IPP and
DMAPP in vitro, in a cell extract, or in vivo. Exemplary IDI
polypeptides and nucleic acids and methods of measuring IDI
activity are described in more detail in International Publication
No. WO 2009/076676, U.S. patent application Ser. No. 12/335,071 (US
Publ. No. 2009/0203102). WO 2010/003007. US Publ. No. 2010/0048964.
WO 2009/132220, and US Publ. No. 2010/0003716.
Exemplary MVA Pathway Polypeptides and Nucleic Acids
[0151] Exemplary MVA pathway polypeptides include acetyl-CoA
acetyltransferase (AA-CoA thiolase) polypeptides,
3-hydroxy-3-methylglutaryl-CoA synthase (HMG-CoA synthase)
polypeptides, 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA
reductase) polypeptides, mevalonate kinase (MVK) polypeptides,
phosphomevalonate kinase (PMK) polypeptides, diphosphomevalonate
decarboxylase (MVD) polypeptides, phosphomevalonate decarboxylase
(PMDC) polypeptides, isopentenyl phosphate kinase (IPK)
polypeptides, IDI polypeptides, and polypeptides (e.g., fusion
polypeptides) having an activity of two or more MVA pathway
polypeptides. In particular. MVA pathway polypeptides include
polypeptides, fragments of polypeptides, peptides, and fusions
polypeptides that have at least one activity of an MVA pathway
polypeptide. Exemplary MVA pathway polypeptides and nucleic acids
and methods of measuring IDI activity are described in more detail
in International Publication No. WO 2009/076676, U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102), WO
2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716.
[0152] In some aspects, the cells contain the upper MVA pathway,
which includes AA-CoA thiolase. HMG-CoA synthase, and HMG-CoA
reductase nucleic acids. In some aspects, the cells contain the
lower MVA pathway, which includes MVK, PMK, MVD, and IDI nucleic
acids. In some aspects, the cells contain an entire MVA pathway
that includes AA-CoA thiolase, H-IMG-CoA synthase, HMG-CoA
reductase, MVK, PMK, MVD, and IDI nucleic acids. In some aspects,
the cells contain an entire MVA pathway that includes AA-CoA
thiolase, HMG-CoA synthase, HMG-CoA reductase, MVK, PMDC, IPK, and
IDI nucleic acids.
[0153] The improved methods described herein can also be used to
produce isoprene and a co-product, such as hydrogen. Exemplary
hydrogenase polypeptides and nucleic acids, polypeptides and
nucleic acids for genes related to production of fermentation side
products, and polypeptides and nucleic acids for genes relating to
hydrogen reuptake can also be used with the compositions and
methods described in. Such polypeptides and nucleic acids are
described in U.S. Provisional Patent Application No. 61/141,652,
U.S. Provisional Patent Application No. 61/187,934, US Publ. No.
2010/0196988. WO 2010/078457. International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716.
Isoprene Compositions Produced from Renewable Resources
[0154] Isoprene compositions produced from renewable resources
(e.g. bioisoprene) are distinguished from petro-isoprene
compositions in that bioisoprene is produced with other
bio-byproducts (compounds derived from the biological sources
and/or associated the biological processes that are obtained
together with bioisoprene) that are not present or present in much
lower levels in petro-isoprene compositions, such as alcohols,
aldehydes, ketone and the like. The bio-byproducts may include, but
are not limited to, ethanol, acetone, methanol, acetaldehyde,
methacrolein, methyl vinyl ketone, 2-methyl-2-vinyloxirane, cis-
and trans-3-methyl-1,3-pentadiene, a C5 prenyl alcohol (such as
3-methyl-3-buten-1-ol or 3-methyl-2-buten-1-ol), 2-heptanone,
6-methyl-5-hepten-2-one, 2,4,5-trimethylpyridine,
2,3,5-trimethylpyrazine, citronellal, methanethiol, methyl acetate,
1-propanol, diacetyl, 2-butanone, 2-methyl-3-buten-2-ol, ethyl
acetate, 2-methyl-1-propanol, 3-methyl-1-butanal,
3-methyl-2-butanone, 1-butanol, 2-pentanone, 3-methyl-1-butanol,
ethyl isobutyrate, 3-methyl-2-butenal, butyl acetate, 3-methylbutyl
acetate, 3-methyl-3-buten-1-yl acetate, 3-methyl-2-buten-1-yl
acetate, 3-hexen-1-ol, 3-hexen-1-yl acetate, limonene, geraniol
(trans-3,7-dimethyl-2,6-octadien-1-ol), citronellol
(3,7-dimethyl-6-octen-1-ol), (E)-3,7-dimethyl-1,3,6-octatriene,
(Z)-3,7-dimethyl-1,3,6-octatriene, 2,3-cycloheptenopyridine, or a
linear isoprene polymer (such as a linear isoprene dimer or a
linear isoprene trimer derived from the polymerization of multiple
isoprene units). Products derived from bioisoprene contain one or
more of the bio-byproducts or compounds derived from any of the
by-products. In addition, products derived from bioisoprene may
contain compounds formed from these by-products during subsequent
chemical conversion. Examples of such compounds include those
derived from Diels-Alder cycloaddition of dienophiles to isoprene,
or the oxidation of isoprene.
[0155] Isoprene compositions produced from renewable resources
including particular byproducts or impurities are described in more
detail in U.S. Provisional Patent Application No. 61/187,959, U.S.
application Ser. No. 12/818,090, PCT/US10/039088, International
Publication No. WO 2009/076676. U.S. patent application Ser. No.
12/335,071 (US Publ. No. 2009/0203102). WO 2010/003007. US Publ.
No. 2010/0048964. WO 2009/132220, and US Publ. No.
2010/0003716.
Exemplary Purification Methods
[0156] In some aspects, any of the methods described herein further
include a step of recovering the isoprene. Additional examples of
efficient methods for the production and recovery of isoprene are
described in U.S. Provisional Patent Application Ser. Nos.
61/187,959 and 61/187,934, International Publication No. WO
2009/076676, U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007, US Publ. No. 2010/0048964, WO
2009/132220, and US Publ. No. 2010/0003716. Additional examples of
efficient methods for the production and recovery of isoprene and a
coproduct, such as hydrogen, are described in U.S. Provisional
Patent Application Nos. 61/141,652, 61/187,934, and 61/187,959, and
International Publication No. WO 2009/076676. U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102), WO
2010/003007. US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716. In addition, recovery may be achieved by
absorption stripping as described in U.S. application Ser. No.
12/969,440.
Other Techniques
[0157] Isoprene production in cells by the methods described herein
can be increased by decoupling isoprene production from cell
growth, as described in U.S. Provisional Patent Application Ser.
No. 61/187,959. U.S. patent application Ser. No. 12/496,573.
International Publication No. WO 2009/076676. U.S. patent
application Ser. No. 12/335,071 (US Publ. No. 2009/0203102). WO
2010/003007, US Publ. No. 2010/0048964, WO 2009/132220, and US
Publ. No. 2010/0003716. The safety of methods of producing isoprene
in cells by the methods described herein can be improved by
producing isoprene within safe operating ranges, as described in
U.S. Provisional Patent Application Ser. No. 61/187,959, U.S.
patent application Ser. No. 12/496,573, International Publication
No. WO 2009/076676, U.S. patent application Ser. No. 12/335,071 (US
Publ. No. 2009/0203102). WO 2010/003007. US Publ. No. 2010/0048964,
WO 2009/132220, and US Publ. No. 2010/0003716. Cell viability at
high isoprene titers, such as those achieved by the improved
methods of producing isoprene described herein, can be improved as
described in U.S. Provisional Patent Application Ser. No.
61/187,959, International Publication No. WO 2009/076676. U.S.
patent application Ser. No. 12/335,071 (US Publ. No. 2009/0203102).
WO 2010/003007. US Publ. No. 2010/0048964. WO 2009/132220, and US
Publ. No. 2010/0003716.
[0158] Additional examples of efficient methods for the production
and recovery of isoprene are described in U.S. Provisional Patent
Application Ser. No. 61/187,959, International Publication No. WO
2009/076676. U.S. patent application Ser. No. 12/335,071 (US Publ.
No. 2009/0203102), WO 2010/003007. US Publ. No. 2010/0048964, WO
2009/132220, US Publ. No. 2010/0003716 and U.S. application Ser.
No. 12/969,440. Additional examples of efficient methods for the
production and recovery of isoprene and a coproduct, such as
hydrogen, are described in U.S. Provisional Patent Application No.
61/141,652, U.S. Provisional Patent Application No. 61/187,934, US
Publ. No. 2010/0196977, and WO 2010/078457.
[0159] The invention can be further understood by reference to the
following examples, which are provided by way of illustration and
are not meant to be limiting.
EXAMPLES
Example 1
Construction of E. coli strains expressing the S. cerevisiae
gi1.2KKDyI operon, P. alba isoprene synthase, M. mazei mevalonate
kinase, pCL Upper MVA (E. faecalis mvaE and mvaS) and ybhE
(pgl)
[0160] (i) Construction of strain EWL201 (BL21, Cm-GI1.2-KKDyI)
[0161] E. coli BL21 (Novagen brand, EMD Biosciences, Inc.) was a
recipient strain, transduced with MCM331 P1 lysate (lysate prepared
according to the method described in Ausubel, et al., Current
Protocols in Molecular Biology, John Wiley and Sons, Inc.). MCM331
cells contain chromosomal construct gi1.2KKDyI encoding S.
cerevisiae mevalonate kinase, mevalonate phosphate kinase,
mevalonate pyrophosphate decarboxylase, and IPP isomerase (i.e.,
the gi1.2-KKDyI operon from S. cerevisiae). Transductants were
selected for by spreading cells onto L Agar and 20 .mu.g/.mu.l
chloramphenicol. The plates were incubated overnight at 30.degree.
C. Analysis of transductants showed no colonies on control plates
(water+cells control plate for reversion and water and P1 lysate
control plate for lysate contamination.
[0162] Four transductants were picked and used to inoculate 5 mL L
Broth and 20 .mu.g/.mu.l chloramphenicol. The cultures were grown
overnight at 30.degree. C. with shaking at 200 rpm. To make genomic
DNA preps of each transductant for PCR analysis, 1.5 mL of
overnight cell culture were centrifuged. The cell pellet was
resuspended with 400 .mu.l Resuspension Buffer (20 mM Tris, 1 mM
EDTA, 50 mM NaCl, pH 7.5) and 4 .mu.l RNase, DNase-free (Roche) was
added. The tubes were incubated at 37.degree. C. for 30 minutes
followed by the addition of 4 .mu.l 10% SDS and 4 .mu.l of 10 mg/ml
Proteinase K stock solution (Sigma-Aldrich). The tubes were
incubated at 37.degree. C. for 1 hour. The cell lysate was
transferred into 2 ml Phase Lock Light Gel tubes (Eppendorf) and
200 .mu.l each of saturated phenol pH 7.9 (Ambion Inc.) and
chloroform were added. The tubes were mixed well and
microcentrifuged for 5 minutes. A second extraction was done with
400 .mu.l chloroform and the aqueous layer was transferred to a new
eppendorf tube. The genomic DNA was precipitated by the addition of
1 ml of 100% ethanol and centrifugation for 5 minutes. The genomic
DNA pellet was washed with 1 ml 70% ethanol. The ethanol was
removed and the genomic DNA pellet was allowed to air dry briefly.
The genomic DNA pellet was resuspended with 200 id TE.
[0163] Using Pfu Ultra II DNA polymerase (Stratagene) and 200
ng/.mu.l of genomic DNA as template, 2 different sets of PCR
reaction tubes were prepared according to manufacturer's protocol.
For set 1, primers MCM130 and GB Cm-Rev (Table 1) were used to
ensure transductants were successfully integrated into the attTn7
locus. PCR parameters for set 1 were 95.degree. C. for 2 minutes
(first cycle only), 95.degree. C. for 25 seconds, 55.degree. C. for
25 seconds, 72.degree. C. for 25 seconds (repeat steps 2-4 for 28
cycles), 72.degree. C. for 1 minute. For set 2, primers MVD For and
MVD Rev (Table 1) were used to ensure that the gi1.2-KKDyI operon
integrated properly. PCR parameters for set 2 were 95.degree. C.
for 2 minutes (first cycle only), 95.degree. C. for 25 seconds,
55.degree. C. for 25 seconds, 72.degree. C. for 10 seconds (repeat
steps 2-4 for 28 cycles), 72.degree. C. for 1 minute. Analysis of
PCR amplicons on a 1.2% E-gel (Invitrogen Corp.) showed that all 4
transductant clones were correct. One was picked and designated as
strain EWL201.
(ii) Construction of Strain EWL204 (BL21, Loopout-GI1.2-KKDyI)
[0164] The chloramphenicol marker was looped out of strain EWL201
using plasmid pCP20 as described by Datsenko and Wanner (2000)
(Datsenko et al., Proc Natl. Acad. Sci USA 97:6640-6645, 2000).
One-step inactivation of chromosomal genes in Escherichia coli K-12
using PCR products. (Datsenko et al., PNAS 97:6640-6645, 2000).
EWL201 cells were grown in L Broth to midlog phase and then washed
three times in ice-cold, sterile water. An aliquot of 50
.mu.g/.mu.l of cell suspension was mixed with 1 .mu.l of pCP20 and
the cell suspension mixture was electroporated in a 2 mm cuvette
(Invitrogen Corp.) at 2.5 Volts and 25 .mu.Fd using a Gene Pulser
Electroporator (Bio-Rad Inc.). 1 ml of LB was immediately added to
the cells, then transferred to a 14 ml polypropylene tube
(Sarstedt) with a metal cap. Cells were allowed to recover by
growing for 1 hour at 30.degree. C. Transformants were selected on
L Agar and 20 .mu.g/.mu.l chloramphenicol and 50 .mu.g/.mu.l
carbenicillin and incubated at 30.degree. C. overnight. The next
day, a single clone was grown in 10 ml L Broth and 50 .mu.g/.mu.l
carbenicillin at 30.degree. C. until early log phase. The
temperature of the growing culture was then shifted to 42.degree.
C. for 2 hours. Serial dilutions were made, the cells were then
spread onto LA plates (no antibiotic selection), and incubated
overnight at 30.degree. C. The next day, 20 colonies were picked
and patched onto L Agar (no antibiotics) and LA and 20 .mu.g/.mu.l
chloramphenicol plates. Plates were then incubated overnight at
30.degree. C. Cells able to grow on LA plates, but not LA and 20
.mu.g/.mu.l chloramphenicol plates, were deemed to have the
chloramphenicol marker looped out (picked one and designated as
strain EWL204).
(iii) Construction of Plasmid pEWL230 (pTrc P. alba)
[0165] Generation of a synthetic gene encoding Populus alba
isoprene synthase (P. alba HGS) was outsourced to DNA2.0 Inc.
(Menlo Park, Calif.) based on their codon optimization method for
E. coli expression. The synthetic gene was custom cloned into
plasmid pET24a (Novagen brand, EMD Biosciences, Inc.) and delivered
lyophilized (FIGS. 2, 3A-B; SEQ ID NO:1).
[0166] A PCR reaction was performed to amplify the P. alba isoprene
synthase (P. alba HGS) gene using pET24 P. alba HGS as the
template, primers MCM182 and MCM 192, and Herculase II Fusion DNA
polymerase (Stratagene) according to manufacturer's protocol. PCR
conditions were as follows: 95.degree. C. for 2 minutes (first
cycle only), 95.degree. C. for 25 seconds, 55.degree. C. for 20
seconds, 72.degree. C. for 1 minute, repeat for 25 cycles, with
final extension at 72.degree. C. for 3 minutes. The P. alba
isoprene synthase PCR product was purified using QIAquick PCR
Purification Kit (Qiagen Inc.).
[0167] P. alba isoprene synthase PCR product was then digested in a
20 .mu.l reaction containing 1 .mu.l BspHI endonuclease (New
England Biolabs) with 2 .mu.l 10.times.NEB Buffer 4. The reaction
was incubated for 2 hours at 37.degree. C. The digested PCR
fragment was then purified using the QIAquick PCR Purification Kit.
A secondary restriction digest was performed in a 20 .mu.l reaction
containing 1 .mu.l PstI endonuclease (Roche) with 2 .mu.l 10.times.
Buffer H. The reaction was incubated for 2 hours at 37.degree. C.
The digested PCR fragment was then purified using the QIAquick PCR
Purification Kit. Plasmid pTrcHis2B (Invitrogen Corp.) was digested
in a 20 .mu.l reaction containing 1 .mu.l NcoI endonuclease
(Roche), 1 .mu.l PstI endonuclease, and 2 .mu.l 10.times. Buffer H.
The reaction was incubated for 2 hours at 37.degree. C. The
digested pTrcHis2B vector was gel purified using a 1.2% E-gel
(Invitrogen Corp.) and extracted using the QIAquick Gel Extraction
Kit (Qiagen) (FIG. 4). Using the compatible cohesive ends of BspHI
and NcoI sites, a 20 .mu.l ligation reaction was prepared
containing 5 .mu.l P. alba isoprene synthase insert, 2 .mu.l pTrc
vector, 1 .mu.l T4 DNA ligase (New England Biolabs), 2 .mu.l
10.times. ligase buffer, and 10 .mu.l ddH.sub.2O. The ligation
mixture was incubated at room temperature for 40 minutes. The
ligation mixture was desalted by floating a 0.025 .mu.m
nitrocellulose membrane filter (Millipore) in a petri dish of
ddH.sub.2O and applying the ligation mixture gently on top of the
nitrocellulose membrane filter for 30 minutes at room temperature.
MCM446 cells (see Section II) were grown in LB to midlog phase and
then washed three times in ice-cold, sterile water. An aliquot of
50 .mu.l of cell suspension was mixed with 5 .mu.l of desalted pTrc
P. alba HGS ligation mix. The cell suspension mixture was
electroporated in a 2 mm cuvette at 2.5 Volts and 25 .mu.Fd using a
Gene Pulser Electroporator. 1 ml of LB is immediately added to the
cells, then transferred to a 14 ml polypropylene tube (Sarstedt)
with a metal cap. Cells were allowed to recover by growing for 2
hours at 30.degree. C. Transformants were selected on L Agar and 50
.mu.g/.mu.l carbenicillin and 10 mM mevalonic acid and incubated at
30.degree. C. The next day, 6 transformants were picked and grown
in 5 ml L Broth and 50 .mu.g/.mu.l carbenicillin tubes overnight at
30.degree. C. Plasmid preps were performed on the overnight
cultures using QIAquick Spin Miniprep Kit (Qiagen). Due to the use
of BL21 cells for propagating plasmids, a modification of washing
the spin columns with PB Buffer 5.times. and PE Buffer 3.times. was
incorporated to the standard manufacturer's protocol for achieving
high quality plasmid DNA. Plasmids were digested with PstI in a 20
.mu.l reaction to ensure the correct sized linear fragment. All 6
plasmids were the correct size and shipped to Quintara Biosciences
(Berkeley, Calif.) for sequencing with primers MCM65, MCM66, EL1000
(Table 1). DNA sequencing results showed all 6 plasmids were
correct. One plasmid was picked designated as plasmid EWL230 (FIGS.
5, 6A-B; SEQ ID NO:2).
iv) Construction of Plasmid pEWL244 (pTrc P. alba-mMVK)
[0168] A PCR reaction was performed to amplify the Methanosarcina
mazei (M. mazei) MVK gene using MCM376 as the template (see section
(v) below), primers MCM65 and MCM77 (see Table 1), and Pfu Ultra II
Fusion DNA polymerase (Stratagene) according to manufacturer's
protocol. PCR conditions were as follows: 95.degree. C. for 2
minutes (first cycle only), 95.degree. C. for 25 seconds,
55.degree. C. for 25 seconds, 72.degree. C. for 18 seconds, repeat
for 28 cycles, with final extension at 72.degree. C. for 1 minute.
The M. mazei MVK PCR product was purified using QIAquick PCR
Purification Kit (Qiagen Inc.).
[0169] The M. mazei MVK PCR product was then digested in a 40 .mu.l
reaction containing 8 .mu.l PCR product, 2 .mu.l PmneI endonuclease
(New England Biolabs), 4 .mu.l 10.times.NEB Buffer 4, 4 .mu.l
10.times.NEB BSA, and 22 .mu.l of ddH.sub.2O. The reaction was
incubated for 3 hours at 37.degree. C. The digested PCR fragment
was then purified using the QIAquick PCR Purification Kit. A
secondary restriction digest was performed in a 47 .mu.l reaction
containing 2 .mu.l NsiI endonuclease (Roche), 4.7 .mu.l 10.times.
Buffer H, and 40 .mu.l of PmeI digested M. mazei MVK fragment. The
reaction was incubated for 3 hours at 37.degree. C. The digested
PCR fragment was then gel purified using a 1.2% E-gel and extracted
using the QIAquick Gel Extraction Kit. Plasmid EWL230 was digested
in a 40 .mu.l reaction containing 10 .mu.l plasmid, 2 .mu.l PmeI
endonuclease, 4 .mu.l 10.times.NEB Buffer 4, 4 .mu.l 10.times.NEB
BSA, and 20 .mu.l of ddH.sub.2O. The reaction was incubated for 3
hours at 37.degree. C. The digested PCR fragment was then purified
using the QIAquick PCR Purification Kit. A secondary restriction
digest was performed in a 47 .mu.l reaction containing 2 .mu.l PstI
endonuclease, 4.7 .mu.l 10.times. Buffer H, and 40 .mu.l of PmeI
digested EWL230 linear fragment. The reaction was incubated for 3
hours at 37.degree. C. The digested PCR fragment was then gel
purified using a 1.2% E-gel and extracted using the QIAquick Gel
Extraction Kit (FIG. 7). Using the compatible cohesive ends of NsiI
and PstI sites, a 20 .mu.l ligation reaction was prepared
containing 8 .mu.l M. mazei MVK insert, 3 .mu.l EWL230 .mu.plasmid,
1 .mu.l T4 DNA ligase, 2 .mu.l 10.times. ligase buffer, and 6 .mu.l
ddH.sub.2O. The ligation mixture was incubated overnight at
16.degree. C. The next day, the ligation mixture was desalted by
floating a 0.025 .mu.m nitrocellulose membrane filter in a petri
dish of ddH.sub.2O and applying the ligation mixture gently on top
of the nitrocellulose membrane filter for 30 minutes at room
temperature. MCM446 cells were grown in LB to midlog phase and then
washed three times in ice-cold, sterile water. An aliquot of 50
.mu.l of cell suspension was mixed with 5 .mu.l of desalted pTrc P.
alba-mMVK ligation mix. The cell suspension mixture was
electroporated in a 2 mm cuvette at 2.5 Volts and 25 .mu.Fd using a
Gene Pulser Electroporator. 1 ml of LB is immediately added to the
cells, then the cells are transferred to a 14 ml polypropylene tube
with a metal cap. Cells were allowed to recover by growing for 2
hour at 30.degree. C. Transformants were selected on LA and 50
.mu.g/.mu.l carbenicillin and 5 mM mevalonic acid plates and
incubated at 30.degree. C. The next day, 6 transformants were
picked and grown in 5 ml LB and 50 .mu.g/.mu.l carbenicillin tubes
overnight at 30.degree. C. Plasmid preps were performed on the
overnight cultures using QIAquick Spin Miniprep Kit. Due to the use
of BL21 cells for propagating plasmids, a modification of washing
the spin columns with PB Buffer 5.times. and PE Buffer 3.times. was
incorporated to the standard manufacturer's protocol for achieving
high quality plasmid DNA. Plasmids were digested with PstI in a 20
.mu.l reaction to ensure the correct sized linear fragment. Three
of the 6 plasmids were the correct size and shipped to Quintara
Biosciences for sequencing with primers MCM65, MCM66, EL1000,
EL1003, and EL1006 (Table 1). DNA sequencing results showed all 3
plasmids were correct. One was picked and designated as plasmid
EWL244 (FIGS. 8 and 9A-B; SEQ ID NO:3).
v) Construction of Plasmid MCM376-MVK from M. mazei Archaeal Lower
in pET200D.
[0170] The MVK ORF from the M. mazei archaeal Lower Pathway operon
(FIGS. 10A-C; SEQ ID NO:4) was PCR amplified using primers MCM161
and MCM162 (Table 1) using the Invitrogen Platinum 1-HiFi PCR mix.
45 .mu.L of PCR mix was combined with 1 .mu.L template, 1 .mu.L, of
each primer at 10 .mu.M, and 2 .mu.L water. The reaction was cycled
as follows: 94.degree. C. for 2:00 minutes; 30 cycles of 94.degree.
C. for 0:30 minutes, 55.degree. C. for 0:30 minutes and 68.degree.
C. for 1:15 minutes; and then 72.degree. C. for 7:00 minutes, and
4.degree. C. until cool. 3 .mu.L of this PCR reaction was ligated
to Invitrogen pET200D plasmid according to the manufacturer's
protocol. 3 .mu.L of this ligation was introduced into Invitrogen
TOP 10 cells, and transformants were selected on LA/kan50. A
plasmid from a transformant was isolated and the insert sequenced,
resulting in MCM376 (FIGS. 11A-C).
vi) Construction of Strain EWL251 (BL21 (DE3), Cm-GI1.2-KKDyI, pTrc
P. alba-mMVK)
[0171] MCM331 cells (which contain chromosomal construct gi
1.2KKDyI encoding S. cerevisiae mevalonate kinase, mevalonate
phosphate kinase, mevalonate pyrophosphate decarboxylase, and IPP
isomerase) were grown in LB to midlog phase and then washed three
times in ice-cold, sterile water. Mixed 50 .mu.l of cell suspension
with 1 .mu.l of plasmid EWL244. The cell suspension mixture was
electroporated in a 2 mm cuvette at 2.5 Volts and 25 .mu.Fd using a
Gene Pulser Electroporator. 1 ml of LB is immediately added to the
cells, and then the cells were transferred to a 14 ml polypropylene
tube with a metal cap. Cells were allowed to recover by growing for
2 hours at 30.degree. C. Transformants were selected on LA and 50
.mu.g/.mu.l carbenicillin and 5 mM mevalonic acid plates and
incubated at 37.degree. C. One colony was selected and designated
as strain EWL251.
vii) Construction of Strain EWL256 (BL21 (DE3), Cm-GI1.2-KKDyI,
pTrc P. alba-mMVK, pCL Upper MVA)
[0172] EWL251 cells were grown in LB to midlog phase and then
washed three times in ice-cold, sterile water. Mixed 50 .mu.l of
cell suspension with 1 .mu.l of plasmid MCMS2 (comprising pCL
PutcUpperPathway (also known as "pCL, Upper MVA"), encoding E.
faecalis mvaE and mvaS). Plasmid pCL Ptrc Upper Pathway was
constructed as described in Example 8 of International Publication
No. WO 2009/076676 A2 and U.S. patent application Ser. No.
12/335,071, both of which are incorporated herein by reference in
their entireties. The cell suspension mixture was electroporated in
a 2 mm cuvette at 2.5 Volts and 25 .mu.Fd using a Gene Pulser
Electroporator. 1 ml of LB was immediately added to the cells.
Cells were then transferred to a 14 ml polypropylene tube with a
metal cap. Cells were allowed to recover by growing for 2 hours at
30.degree. C. Transformants were selected on LA and 50 .mu.g/.mu.l
carbenicillin and 50 .mu.g/.mu.l spectinomycin plates and incubated
at 37.degree. C. One colony was picked and designated as strain
EWL256.
TABLE-US-00001 TABLE 1 Primer Sequences Primer name Primer sequence
MCM130 ACCAATTGCACCCGGCAGA (SEQ ID NO: 10) GB Cm
GCTAAAGCGCATGCTCCAGAC (SEQ ID NO: 11) Rev MVD GACTGGCCTCAGATGAAAGC
(SEQ ID NO: 12) For MVD CAAACATGTGGCATGGAAAG (SEQ ID NO: 13) Rev
MCM182 GGGCCCGTTTAAACTTTAACTAGACTCTGCAG TTAGCGTTCAAACGGCAGAA (SEQ
ID NO: 14) MCM192 CGCATGCATGTCATGAGATGTAGCGTGTCCACCGAAAA (SEQ ID
NO: 15) MCM65 ACAATTTCACACAGGAAACAGC (SEQ ID NO: 16) MCM66
CCAGGCAAATTCTGTTTTATCAG (SEQ ID NO: 17) EL1000
GCACTGTCTTTCCGTCTGCTGC (SEQ ID NO: 18) MCM165
GCGAACGATGCATAAAGGAGGTAAAAAAACATGGTATCC TGTTCTGCGCCGGGTAAGATTTACCTG
(SEQ ID NO: 19) MCM177 GGGCCCGTTTAAACTTTAACTAGACTTTAATCTACTTTCA
GACCTTGC (SEQ ID NO: 20) EL1003 GATAGTAACGGCTGCGCTGCTACC (SEQ ID
NO: 21) EL1006 GACAGCTTATCATCGACTGCACG (SEQ ID NO: 22) MCM161
CACCATGGTATCCTGTTCTGCG (SEQ ID NO: 23) MCM162
TTAATCTACTTTCAGACCTTGC (SEQ ID NO: 24)
viii) Construction of Strain RM111608-2 (Cm-GI1.2-KKDyI, pTrc P.
alba-mMVK, pCL Upper MVA, pBBRCMPGI1.5-Pgl)
[0173] The BL21 strain of E. coli producing isoprene (EWL256) was
constructed with constitutive expression of the ybhE gene (encoding
E. coli 6-phosphogluconolactonase) on a replicating plasmid
pBBRIMCS5 (Gentamycin) (obtained from Dr. K. Peterson, Louisiana
State University).
[0174] FRT-based recombination cassettes, and plasmids for
Red/ET-mediated integration and antibiotic marker loopout were
obtained from Gene Bridges GmbH (Germany). Procedures using these
materials were carried out according to Gene Bridges protocols.
Primers Pgl-F (SEQ ID NO:25) and PglGI1.5-R (SEQ ID NO:26) were
used to amplify the resistance cassette from the FRT-gb2-Cm-FRT
template using Stratagene Herculase II Fusion kit according to the
manufacturer's protocol. The PCR reaction (50 .mu.L final volume)
contained: 5 .mu.L buffer, 1 .mu.L template DNA (FRT-gb2-Cm-F from
Gene Bridges), 10 pmols of each primer, and 1.5 .mu.L 25 mM dNTP
mix, made to 50 .mu.L with dH.sub.2O. The reaction was cycled as
follows: 1.times.2 minutes, 95.degree. C. then 30 cycles of (30
seconds at 95.degree. C.; 30 seconds at 63.degree. C.; 3 minutes at
72.degree. C.).
[0175] The resulting PCR product was purified using the
QIAquick.RTM. PCR Purification Kit (Qiagen) and electroporated into
electrocompetent MG1655 cells harboring the pRed-ET
recombinase-containing plasmid as follows. MG 1655 cells were
prepared for electroporation by growing in 5 mLs of L broth to and
OD.sub.600.about.0.6 at 30.degree. C. The cells were induced for
recombinase expression by the addition of 4% arabinose and allowed
to grow for 30 minutes at 30.degree. C. followed by 30 minutes of
growth at 37.degree. C. An aliquot of 1.5 mLs of the cells was
washed 3-4 times in ice cold dH.sub.2O. The final cell pellet was
resuspended in 40 .mu.L of ice cold dH.sub.2O and 2-5 .mu.L of the
PCR product was added. The electroporation was carried out in 1-mm
gap cuvettes, at 1.3 kV in a Gene Pulser Electroporator (Bio-Rad
Inc.). Cells were recovered for 1-2 hours at 30.degree. C. and
plated on L agar containing chloramphenicol (5 .mu.g/mL). Five
transformants were analyzed by PCR and sequencing using primers
flanking the integration site (2 primer sets: pgl and 49 rev and
3'EcoRV-pglstop; Bottom Pgb2 and Top GB's CMP (946)). A correct
transformant was selected and this strain was designated MG1655
GI1.5-pgl::CMP.
[0176] The chromosomal DNA of MG1655 GI1.5-pgl::CMP was used as
template to generate a PCR fragment containing the FRT-CM P-FRT-GI
1.5-ybhE construct. This construct was cloned into pBBR1MCS5
(Gentamycin) as follows. The fragment, here on referred to as
CMP-GI1.5-pgl, was amplified using the 5' primer Pglconfirm-F (SEQ
ID NO:27) and 3' primer 3' EcoRV-pglstop (SEQ ID NO:28). The
resulting fragment was cloned using the Invitrogen TOPO-Blunt
cloning kit into the plasmid vector pCR-Blunt II-TOPO as suggested
from the manufacturer. The NsiI fragment harboring the
CMP-GI1.5-pgl fragment was cloned into the PstI site of pBBR1 MCS5
(Gentamycin). A 20 .mu.l ligation reaction was prepared containing
5 .mu.l CMP-GI1.5-pgl insert, 2 .mu.l pBBR1MCS5 (Gentamycin)
vector, 1 .mu.l T4 DNA ligase (New England Biolabs), 2 .mu.l
10.times. ligase buffer, and 10 .mu.l ddH.sub.2O. The ligation
mixture was incubated at room temperature for 40 minutes then 2-4
.mu.L were electroporated into electrocompetent Top10 cells
(Invitrogen) using the parameters disclosed above. Transformants
were selected on L agar containing 10 .mu.g/ml chloramphenicol and
5 .mu.g/ml Gentamycin. The sequence of the selected clone was
determined using a number of the primers described above as well as
with the in-house T3 and Reverse primers provided by Sequetech, CA.
This plasmid was designated pBBRCMPGI 1.5-pgl (FIGS. 12, 13A-B and
SEQ ID NO:6).
[0177] Plasmid pBBRCMPGI1.5-pgl was electroporated into EWL256, as
described herein and transformants were plated on L agar containing
Chloramphenicol (10 .mu.g/mL). Gentamycin (5 .mu.g/mL),
spectinomycin (50 .mu.g/mL), and carbenicillin (50 .mu.g/mL). One
transformant was selected and designated strain RM11608-2.
TABLE-US-00002 Primers: Pgl-F (SEQ ID NO: 25)
5'-ACCGCCAAAAGCGACTAATTTTAGCTGTTACAGTCAGTTGAATTAAC
CCTCACTAAAGGGCGGCCGC-3' PglGI1.5-R (SEQ ID NO: 26)
5'-GCTGGCGATATAAACTGTTTGCTTCATGAATGCTCCTTTGGGTTACC
TCCGGGAAACGCGGTTGATTTGTTTAGTGGTTGAATTATTTGCTCAGGAT
GTGGCATAGTCAAGGGCGTGACGGCTCGCTAATACGACTCACTATAGGGC TCGAG-3' 3'
EcoRV-pglstop: (SEQ ID NO: 28) 5'-CTT GAT ATC TTA GTG TGC GTT AAC
CAC CAC pgl +49 rev: (SEQ ID NO: 29) CGTGAATTTGCTGGCTCTCAG Bottom
Pgb2: (SEQ ID NO: 30) GGTTTAGTTCCTCACCTTGTC Top GB's CMP (946):
(SEQ ID NO: 31) ACTGAAACGTTTTCATCGCTC Pglconfirm-F (SEQ ID NO: 27)
5'-ACCGCCAAAAGCGACTAATTTTAGCT-3'
Example 2
Improvement of Isoprene Production by Constitutive Expression of
vbhE (Pgl) in E. coli
[0178] This example shows production of isoprene in a strain
constitutively expressing E. coli vbhE (pgl) compared to a control
strain expressing ybhE at wild-type levels (i.e., EWL256). The gene
ybhE (pgl) encodes E. coli 6-phosphogluconolactonase that
suppresses posttranslational gluconylation of heterologously
expressed proteins and improves product solubility and yield while
also improving biomass yield and flux through the pentose phosphate
pathway (Aon et al., Applied and Environmental Microbiology
74(4):950-958, 2008).
i) Small Scale Analysis
[0179] Media Recipe (per liter fermentation media):
K.sub.2HPO.sub.4 13.6 g. KH.sub.2PO.sub.4 13.6 g.
MgSO.sub.4*7H.sub.2O 2 g, citric acid monohydrate 2 g, ferric
ammonium citrate 0.3 g, (NH.sub.4).sub.2SO.sub.4 3.2 g, yeast
extract 1 g, 1000.times. Trace Metals Solution 1 ml. All of the
components were added together and dissolved in diH.sub.2O. The pH
was adjusted to 6.8 with ammonium hydroxide (30%) and brought to
volume. Media was filter-sterilized with a 0.22 micron filter.
Glucose 5.0 g and antibiotics were added after sterilization and pH
adjustment.
1000.times. Trace Metal Solution (per liter fermentation media):
Citric Acid*H.sub.2O 40 g, MnSO.sub.4*H.sub.2O 30 g, NaCl 10 g,
FeSO.sub.4*7H.sub.2O 1 g. CoCl.sub.6*H.sub.2O 1 g, ZnSO.sub.4
7H.sub.2O 1 g, CuSO.sub.4*5H.sub.2O 100 mg, H.sub.3BO.sub.3 100 mg.
NaMoO.sub.4*2H.sub.2O 100 mg. Each component is dissolved one at a
time in diH.sub.2O. The pH is adjusted to 3.0 with HCl/NaOH, and
then the solution is brought to volume and filter-sterilized with a
0.22 micron filter.
(a) Experimental Procedure
[0180] Isoprene production was analyzed by growing the strains in a
Cellerator.TM. from MicroReactor Technologies, Inc. The working
volume in each of the 24 wells was 4.5 mL. The temperature was
maintained at 30.degree. C., the pH setpoint was 7.0, the oxygen
flow setpoint was 20 seem and the agitation rate was 800 rpm. An
inoculum of E. coli strain taken from a frozen vial was streaked
onto an LB broth agar plate (with antibiotics) and incubated at
30.degree. C. A single colony was inoculated into media with
antibiotics and grown overnight. The bacteria were diluted into 4.5
mL of media with antibiotics to reach an optical density of 0.05
measured at 550 nm.
[0181] Off-gas analysis of isoprene was performed using a gas
chromatograph-mass spectrometer (GC-MS) (Agilent) headspace assay.
Sample preparation was as follows: 100 .mu.L of whole broth was
placed in a sealed GC vial and incubated at 30.degree. C. for a
fixed time of 30 minutes. Following a heat kill step, consisting of
incubation at 70.degree. C. for 5 minutes, the sample was loaded on
the GC.
[0182] Optical density (OD) at a wavelength of 550 nm was obtained
using a microplate reader (Spectramax) during the course of the
run. Specific productivity was obtained by dividing the isoprene
concentration (.mu.g/L) by the OD reading and the time (hour).
[0183] The two strains EWL256 and RM111608-2 were assessed at 200
and 400 .mu.M IPTG induction levels. Samples were analyzed for
isoprene production and cell growth (OID550) at 1, 2.5, 4.75, and 8
hours post-induction. Samples were done in duplicate.
(b) Results
[0184] The example demonstrated that at 2 different concentrations
of IPTG the strain expressing the ybhE (pgl) had a dramatic 2-3
fold increase in specific productivity of isoprene compared to the
control strain.
ii) Isoprene Fermentation from E. coli Expressing Cm-GI1.2-KKDyI,
M. mazei Mevalonate Kinase, P. alba Isoprene Synthase, and ybhE
(Pgl) (RM111608-2) and Grown in Fed-Batch Culture at the 15-L
Scale
[0185] Medium Recipe (per liter fermentation medium): KZ1-HPO.sub.4
7.5 g. MgSO.sub.4*7H.sub.2O 2 g. citric acid monohydrate 2 g,
ferric ammonium citrate 0.3 g, yeast extract 0.5 g, 1000.times.
Modified Trace Metal Solution 1 ml. All of the components were
added together and dissolved in diH.sub.2O. This solution was
autoclaved. The pH was adjusted to 7.0 with ammonium hydroxide
(30%) and q.s. to volume. Glucose 10 g, thiamine*HCl 0.1 g. and
antibiotics were added after sterilization and pH adjustment.
[0186] 1000.times. Modified trace Metal Solution: Citric
Acids*H.sub.2O 40 g, MnSO.sub.4*1H.sub.2O 30 g, NaCl 10 g,
FeSO.sub.4*7H.sub.2O 1 g. CoCl.sub.2*6H.sub.2O 1 g,
ZnSO.sub.4*7H.sub.2O 1 g, CuSO.sub.4*5H.sub.2O 100 mg,
H.sub.3BO.sub.3 100 mg, NaMoO.sub.4*2H.sub.2O 100 mg. Each
component is dissolved one at a time in Di H.sub.2O, pH to 3.0 with
HCl/NaOH, then q.s. to volume and filter sterilized with a 0.22
micron filter
[0187] Fermentation was performed in a 15-L bioreactor with BL21
(DE3) E. coli cells containing the upper mevalonic acid (MVA)
pathway (pCL Upper), the integrated lower MVA pathway (gi
1.2KKDyI), high expression of mevalonate kinase from M. mazei and
isoprene synthase from P. alba (pTrcAlba-mMVK), and high expression
of E. coli pgl (pBBR-pgl). This example was carried out to monitor
isoprene formation from glucose at the desired fermentation pH 7.0
and temperature 34.degree. C. A frozen vial of the E. coli strain
was thawed and inoculated into tryptone-yeast extract medium. After
the inoculum grew to OD 1.0, measured at 550 nm, 500 mL was used to
inoculate a 15-L bioreactor bringing the initial volume to 5-L.
[0188] Glucose was fed at an exponential rate until cells reached
the stationary phase. After this time the glucose feed was
decreased to meet metabolic demands. The total amount of glucose
delivered to the bioreactor during the 40 hour (59 hour)
fermentation was 3.1 kg (4.2 kg at 59 hour). Induction was achieved
by adding IPTG. The IPTG concentration was brought to 110 .mu.M
when the optical density at 550 nm (OD.sub.550) reached a value of
4. The IPTG concentration was raised to 192 .mu.M when OD.sub.550
reached 150. The OD.sub.550 profile within the bioreactor over time
is shown in FIG. 14A. The isoprene level in the off gas from the
bioreactor was determined using a Hiden mass spectrometer. The
isoprene titer increased over the course of the fermentation to a
maximum value of 33.2 g/L at 40 hours (48.6 g/L at 59 hours) (FIG.
14B). The isoprene titer increased over the course of the
fermentation to a maximum value of 40.0 g/L at 40 hours (60.5 g/L
at 59 hours) (FIG. 14C). The total amount of isoprene produced
during the 40-hour (59-hour) fermentation was 281.3 g (451.0 g at
59 hours) and the time course of production is shown in FIG. 14D.
The time course of volumetric productivity is shown in FIG. 14E and
shows that an average rate of 1.0 g/L/hr was maintained between 0
and 40 hours (1.4 g/L/hour between 19 and 59 hour). The metabolic
activity profile, as measured by CER, is shown in FIG. 14F. The
molar yield of utilized carbon that went into producing isoprene
during fermentation was 19.6% at 40 hours (23.6% at 59 hours). The
weight percent yield of isoprene from glucose was 8.9% at 40 hours
(10.7% at 59 hours).
Example 3
Recovery of Isoprene Produced from Renewable Resources
[0189] Isoprene was recovered from a set of four 15-L scale
fermentations in a two-step operation involving stripping of
isoprene from the fermentation off-gas stream by adsorption to
activated carbon, followed by off-line steam desorption and
condensation to give liquid bioisoprene (FIGS. 16A and 16B). The
total amount of isoprene produced by the four fermentors was 1150 g
(16.9 mol), of which 953 g (14 mol, 83%) was adsorbed by the carbon
filters. Following the steam desorption/condensation step, the
amount of liquid isoprene recovered was 810 g, corresponding to an
overall recovery yield of 70%. The recovered isoprene was analyzed
for the presence of impurities.
Analysis and Impurity Profile of Isoprene Liquid Produced from
Renewable Resources
[0190] Recovered bioisoprene liquid was analyzed by GC/MS and gas
chromatography/flame ionization detection (GC/FID) to determine the
nature and levels of impurities. The product was determined to be
>99.5% pure and contained several dominant impurities in
addition to many minor components. The GC/FID chromatogram is
depicted in FIG. 17, and the typical levels of impurities are shown
in Table 2. The impurity profile was similar to other bioisoprene
batches produced on this scale.
TABLE-US-00003 TABLE 2 Summary of the nature and levels of
impurities seen in several batches of isoprene produced from
renewable resources. Retention Time (min) Compound GC/MS GC/FID
Conc. Range Ethanol 1.59 11.89 <50 ppm Acetone 1.624 12.673
<100 ppm Methacrolein 1.851 15.369 <200 ppm Methyl vinyl
ketone 1.923 16.333 <20 ppm Ethyl acetate 2.037 17.145 100 to
800 ppm 3-Methyl-1,3- 2.27 18.875 50 to 500 ppm pentadiene Methyl
vinyl oxirane 2.548 19.931 <100 ppm Isoprenol 2.962 21.583
<500 ppm 3-methyl-1-butanol 2.99 21.783 <50 ppm 3-hexen-1-ol
4.019 24.819 <100 ppm Isopentenyl acetate 4.466 25.733 200 to
1000 ppm 3-hexen-1-yl acetate 5.339 27.223 <400 ppm limonene
5.715 27.971 <500 ppm Other cyclics 5.50-6.50 27.5-28.0 <200
ppm
Purification of Isoprene Produced from Renewable Resources by
Treatment with Adsorbents
[0191] Adsorbents are widely used by industry for the removal of
trace impurities from hydrocarbon feedstocks. Suitable adsorbents
include zeolite, alumina and silica-based materials. Isoprene can
be substantially purified by passage over silica gel, and to a
lesser extent with alumina. FIG. 18 shows the GC/FID chromatograms
of an isoprene sample before (A) and after treatment with alumina
(B) or silica (C). The Selexsorb.TM. adsorbent products from BASF
is one of the adsorbents of choice for the removal of polar
impurities from isoprene produced from renewable resources.
Specifically, the Selexsorb CD and CDX products are preferred given
their proven utility for removal of polar impurities from isoprene
and butadiene feedstocks.
Example 4
Increased Production of Isoprene Gas Using a Membrane Bioreactor
System
[0192] I. Construction of E. coli Strain CM P234
[0193] P1 transduction enables movement of up to 100 kb of DNA
between bacterial strains (Thomason et al. 2007). A 17,257 bp
deletion in E. coli BL21 (DE3) was replaced by moving a piece of
the bacterial chromosome from E. coli K12 MG 1655 to E. coli BL21
(DE3) using P1 transduction.
[0194] Two strategies were used employing different selectable
markers to identify colonies containing the recombined bacterial
chromosome. First, we inserted an antibiotic marker in a gene close
to the 17,257 bp sequence to be transferred, whose deletion was not
likely to be detrimental to the strain. A strain containing that
antibiotic marker will likely have the 17,257 bp piece of bacterial
chromosome transduced at the same time as the marker. In this case,
we inserted a gene encoding kanamycin resistance ("kan.sup.R") into
the vbgS gene, encoding a 126 amino acid protein of unknown
function. Second, since it is known that a number of genes involved
in utilization of galactose are close to pgl in the 17,257 bp piece
to be transduced into E. coli BL21 (DE3), colonies transduced with
a P1 lysate obtained from E. coli K12 MG1655 (which contains the
17,257 bp sequence deleted in E. coli BL21 (DE3)) and isolated in
M9 medium (6 g/L Na.sub.2HPO.sub.4, 3 g/L KH.sub.2PO.sub.4, 0.5 g/L
NaCl, 0.5 g/L NH.sub.4Cl, 0.1 mM CaCl.sub.2, 2 mM MgSO.sub.4)
containing 0.4% (w/v) galactose will likely contain the 17,257 bp
piece of bacterial chromosome.
[0195] Primers MCM120 (SEQ ID NO:32) and MCM224 (SEQ ID NO:33) were
used to amplify the chloramphenicol resistance ("Cm.sup.R")
cassette from the GeneBridges FRT-gb2-Cm-FRT template using the
Stratagene Herculase.TM. II Fusion kit (Agilent Technologies,
Stratagene Products Division, La Jolla, Calif.) according to the
manufacturer's protocol. Four 50 .mu.L PCR reactions were cycled as
follows: 95.degree. C./2 minutes; 30 cycles of 95.degree. C./20
seconds, 55.degree. C./20 seconds, 72.degree. C./1 minute; and
72.degree. C./3 minutes. Reactions were then cooled to 4.degree. C.
The four reactions were pooled, loaded onto a Qiagen PCR column
according to the manufacturer's protocol and eluted with 60 .mu.L
elution buffer ("EB") at 55.degree. C.
[0196] Plasmid pRedET-carbenicillin.sup.R (GeneBridges, Heidelberg,
Germany) was electroporated into E. coli BL21 (DE3) strain MCM446
(Cm.sup.R, gi1.6mKKDyI A1-3) using standard procedures.
Transformants were recovered by shaking for one hour in SOC medium
at 30.degree. C. and then selected on LB+50 .mu.g/mL carbenicillin
("LB/carb50") plates at 30.degree. C. overnight. A
carbenicillin-resistant colony was frozen as strain MCM508.
[0197] Strain MCM508 was grown from a fresh streak in 5 mL
LB/carb50 at 30.degree. C. to an OD.sub.600 of .about.0.5. At that
point, 40 mM L-arabinose was added, and the culture was incubated
at 37.degree. C. for 1.5 hours. Cells were then harvested by
centrifugation, electroporated with 3 .mu.L of purified amplicons
as described above, and then recovered in 500 .mu.L SOC medium at
37.degree. C. for 1.5-3 hours. Transformants were selected on LB+10
.mu.g/mL kanamycin (LB/kan10) plates at 37.degree. C.
[0198] Recombination of the amplicon at the target locus was
confirmed by PCR with primers GB-DW (SEQ ID NO:34) and MCM208 (SEQ
ID NO:35). The resulting amplicons were sequenced to identify four
clones having the sequences listed below. Four
carbenicillin-sensitive clones were frozen as strains
MCM518-MCM521.
[0199] Strains MCM518-MCM521 were re-streaked onto LB/kan10) and
grown overnight at 37.degree. C. Colonies of strains MCM518-MCM521
were picked, cultured in LB/kan10 at 37.degree. C. and
electrotransformed with plasmid pCP20, which encodes the yeast Flp
recombinase, chloramphenicol and ampicillin resistance genes and
confers temperature sensitive replication on host cells
(Cherepanov, P. P. et al., Gene 158(1):9-14 (1995)). Cells were
recovered in 500 .mu.L SOC medium by shaking at 30.degree. C. for 1
hour. Transformants were selected on LB/carb50 plates at 30.degree.
C. overnight. The following morning a colony from each plate was
grown at 30.degree. C. in LB/carb50 medium until visibly turbid.
The culture was then shifted to 37.degree. C. for at least 3 hours.
Cells were streaked from that culture onto LB plates and grown
overnight at 37.degree. C.
[0200] The following day colonies were patched to LB, LB/carb50 and
LB/kan10. Clones that were sensitive to both carbenicillin and
kanamycin (i.e., which could not grow on carb50 and kan10) were
cultured in liquid LB and frozen as strains MCM528-MCM531.
TABLE-US-00004 TABLE 3 E. coli strains Strain Description Parent
MCM508 BL21 gi1.6-mKKDyI + predet.-carb MCM446 MCM518 BL21
neo-PL.6-mKKDyI, clone 10 MCM508 MCM519 BL21 neo-PL.0-mKKDyI, clone
11 MCM508 MCM520 BL21 neo-PL.0-mKKDyI (bad RBS in MCM508 front of
mMVK), clone 13 MCM521 BL21 neo-PL.2-mKKDyI, clone 15 MCM508 MCM528
BL21 PL.6-mKKDyI, neo.sup.R looped out MCM518 MCM529 BL21
PL.0-mKKDyI, neo.sup.R looped out MCM519 MCM530 BL21 PL.0-mKKDyI
(bad RBS in MCM520 front of mMVK), neo.sup.R looped out MCM531 BL21
PL.2-mKKDyI, neo.sup.R looped out MCM521
TABLE-US-00005 TABLE 4 Primer sequences Primer name Sequence(5'
.fwdarw. 3') MCM120 aaagtagccgaagatgacggtttgtcacatggagttggcaggat
gtttgattaaaagcAATTAACCCTCACTAAAGGGCGG (SEQ ID NO: 32) MCM224
taaatcttacccggcgcagaacaggataccatgtttttttacct
cctttgcaccttcatggtggtcagtgcgtcctgctgatgtgctc
agtatcaccgccagtggtatttaNgtcaacaccgccagagata
atttatcaccgcagatggttatctgtatgttttttatatgaatt
taatacgactcactatagggctcg (SEQ ID NO: 33) GB-DW
aaagaccgaccaagcgacgtctga (SEQ ID NO: 34) MCM208
GCTCTGAATAGTGATAGAGTCA (SEQ ID NO: 35)
[0201] The assemblies integrated into the chromosomes of strains
MCM518-MCM521 include new P.sub.L promoters derived from
bacteriophage lambda (.lamda.) and the very beginning of the mMVK
ORF, with sequences from the Gene Bridges FRT-gb2-Cm-FRT cassette
integrated upstream of the promoter/mMVK assembly, as well as the
remainder of the mMVK ORF followed by the rest of the lower MVA
pathway integron from strain MCM508.
[0202] Promoter/mMVK sequence integrated into MCM518 (SEQ ID
NO:36):
TABLE-US-00006 aaagaccgaccaagcgacgtctgagagctccctggcgaattcggtaccaa
taaaagagctttattttcatgatctgtgtgttggtttttgtgtgcggcgc
ggaagttcctattctctagaaagtataggaacttcctcgagccctatagt
gagtcgtattaaattcatataaaaaacatacagataaccatctgcggtga
taaattatctctggcggtgttgacataaataccactggcggtgatactga
gcacatcagcaggacgcactgaccaccatgaaggtgcaaaggaggtaaaa
aaacatggtatcctgttctgcgccgggtaagatttacctgttcggtgaac
acgccgtagtttatggcgaaactgcaattgcgtgtgcggtggaactgcgt
acccgtgttcgcgcggaactcaatgactctatcactattcagagc
[0203] Promoter/mMVK sequence integrated into MCM519 (SEQ ID
NO:37):
TABLE-US-00007 aaagaccgaccaagcgacgtctgagagctccctggcgaattcggtaccaa
taaaagagctttattttcatgatctgtgtgttggtttttgtgtgcggcgc
ggaagttcctattctctagaaagtataggaacttcctcgagccctatagt
gagtcgtattaaattcatataaaaaacatacagataaccatctgcggtga
taaattatctctggcggtgttgacctaaataccactggcggtgatactga
gcacatcagcaggacgcactgaccaccatgaaggtgcaaaggaggtaaaa
aaacatggtatcctgttctgcgccgggtaagatttacctgttcggtgaac
acgccgtagtttatggcgaaactgcaattgcgtgtgcggtggaactgcgt
acccgtgttcgcgcggaactcaatgactctatcactattcagagc
[0204] Promoter/mMVK sequence integrated into MCM520 (SEQ ID
NO:38):
TABLE-US-00008 aaagaccgaccaagcgacgtctgagagctccctggcgaattcggtaccaa
taaaagagctttattttcatgatctgtgtgttggtttttgtgtgcggcgc
ggaagttcctattctctagaaagtataggaacttcctcgagccctatagt
gagtcgtattaaattcatataaaaaacatacagataaccatctgcggtga
taaattatctctggcggtgttgacctaaataccactggcggtgatactga
gcacatcagcaggacgcactgaccaccatgaaggtgcaaaggtaaaaaaa
catggtatcctgttctgcgccgggtaagatttacctgttcggtgaacacg
ccgtagtttatggcgaaactgcaattgcgtgtgcggtggaactgcgtacc
cgtgttcgcgcggaactcaatgactctatcactattcagagc
[0205] Promoter/mMVK sequence integrated into MCM521 (SEQ ID
NO:39):
TABLE-US-00009 aaagaccgaccaagcgacgtctgagagctccctggcgaattcggtaccaa
taaaagagctttattttcatgatctgtgtgttggtttttgtgtgcggcgc
ggaagttcctattctctagaaagtataggaacttcctcgagccctatagt
gagtcgtattaaattcatataaaaaacatacagataaccatctgcggtga
taaattatctctggcggtgttgacgtaaataccactggcggtgatactga
gcacatcagcaggacgcactgaccaccatgaaggtgcaaaggaggtaaaa
aaacatggtatcctgttctgcgccgggtaagatttacctgttcggtgaac
acgccgtagtttatggcgaaactgcaattgcgtgtgcggtggaactgcgt
acccgtgttcgcgcggaactcaatgactctatcactattcagagc
[0206] Next, E. coli strain DW199, an isoprene-producing E. coli
strain harboring the truncated version of P. alba isoprene synthase
(the MEA variant) under control of the PTrc promoter, was
constructed.
[0207] The plasmid harboring truncated P. alba isoprene synthase
(IspS) was constructed by Quikchange.TM. (Agilent Technologies,
Stratagene Products Division, La Jolla, Calif.) PCR mutagenesis
from the template pEWL244 (also referred to as pTrc-P.
alba(MEA)-mMVK (the construction of which is described in Example
10 of U.S. patent application Ser. No. 12/335,071, which is
incorporated herein by reference in its entirety). The PCR reaction
contained the following components: 1 .mu.l pEWL244 (encoding pTrc
P. alba-mMVK), 5 .mu.l 10.mu. PfuUltra High Fidelity buffer, 1
.mu.l 100 mM dNTPs, 1 .mu.l 50 .mu.M QC EWL244 MEA F primer (SEQ ID
NO: 40), 1 .mu.l 50 .mu.M QC EWL244 MEA R primer (SEQ ID NO:41), 2
.mu.l DMSO, 1 .mu.l PfuUltra High Fidelity polymerase (Agilent
Technologies, Stratagene Products Division, La Jolla, Calif.), and
39 .mu.l diH.sub.2O. The PCR reaction was cycled as follows:
95.degree. C./1 minute; and 18 cycles of 95.degree. C./30 seconds,
55.degree. C./1 minute, 68.degree. C./7.3 minutes. The reaction was
then cooled to 4.degree. C.
[0208] The PCR product was visualized by gel electrophoresis using
an E-gel (Invitrogen, Carlsbad, Calif.), and then treated with 1
.mu.l DpnI restriction endonuclease (Roche. South San Francisco,
Calif.) for three hours at 37.degree. C. Ten .mu.l of the PCR
product were then de-salted using a microdialysis membrane
(MilliPore, Billerica, Mass.) and transformed into electrocompetent
E. coli strain MCM531 (prepared as described above) using standard
molecular biology techniques. Cells were recovered in one ml of LB
medium for 1.5 hours at 30.degree. C., plated onto LB-agar plates
containing 50 .mu.g/ml carbenicillin and 5 mM mevalonic acid, and
then incubated overnight at 37.degree. C. The next day, positive
colonies (of strain DW 195, see below) were selected for growth,
plasmid purification (Qiagen, Valencia, Calif.), confirmed by DNA
sequencing (Quintara Biosciences. Berkeley, Calif.) with the
primers listed below. The final plasmid, pDW34 (FIG. 19A-D; SEQ ID
NO: 156), was confirmed to carry the open reading frame that
encodes the truncated version of P. alba IspS.
[0209] Strain DW199 was generated by transformation of pDW34 and
MCM82 (the construction of which is described in Example 8 of U.S.
patent application Ser. No. 12/335,071, which is incorporated
herein by reference in its entirety) into electrocompetent MCM531
(prepared as described above). Cells were recovered in 1 ml of LB
medium for 1 hour at 37.degree. C., plated on LB agar plates
containing 50 .mu.g/ml spectinomycin and 50 .mu.g/ml carbenicillin,
and then incubated overnight at 37.degree. C. The next day,
antibiotic resistant colonies of strain DW 199 were chosen for
further study.
TABLE-US-00010 TABLE 5 Primers Primer Name Sequence(5' .fwdarw. 3')
QC EWL244 gaggaataaaccatggaagctcgtcgttct MEA F (SEQ ID NO: 40) QC
EWL244 agaacgacgagcttccatggtttattcctc MEA R (SEQ ID NO: 41) EL-1006
gacagcttatcatcgactgcacg (SEQ ID NO: 42) EL-1000
gcactgtctttccgtctgctgc (SEQ ID NO: 43) A-rev ctcgtacaggctcaggatag
(SEQ ID NO: 44) A-rev-2 ttacgtcccaacgctcaact (SEQ ID NO: 45) QB1493
cttcggcaacgcatggaaat (SEQ ID NO: 46) MCM208 gctctgaatagtgatagagtca
(SEQ ID NO: 35) MCM66 ccaggcaaattctgttttatcag (SEQ ID NO: 47) (aka
pTrc Reverse)
TABLE-US-00011 TABLE 6 Strains Strain Background Plasmid Resistance
Genotype DW195 MCM531 pDW34 Carb BL21 (Novagen) PL.2mKKDyI, pTrc-P.
alba(MEA)-mMVK DW199 MCM531 pDW34 Carb/Spec BL21 (Novagen) MCM82
PL.2mKKDyI, pTrc-P. alba(MEA)-mMVK, pCL pTrc-Upper
[0210] This example describes the construction of E. coli strains
CMP215, CMP258, and CMP234, all of which are derived from BL21
transduced with P1 phage containing E. coli MG1655 genomic DNA and
selected for recombination of a 17.257 bp piece present in MG 1655
but absent in BL21 and BL21 (DE3).
[0211] A P1 lysate was made of strain JW0736, in which the ybgS
gene was replaced with a kanamycin resistance gene
("Kan.sup.R")(i.e., ybgS::Kan.sup.R mutation) from the Keio
collection (Baba et al. 2006). That lysate was used to infect
strain MCM531 (described above), producing strain CMP215. The
genotype of CMP215 was confirmed by PCR using primers galM R
(5'-GTC AGG CTG GAA TAC TCT TCG-3': SEQ ID NO:9) and galM F (5'-GAC
GCT TITC GCC AAG TCA GG-3'; SEQ ID NO:8). Those primers anneal to
the galM gene, as shown on FIG. 20, but only produce a PCR product
from E. coli BL21 (DE3) chromosomal DNA having the 17,257 bp
deletion.
[0212] Integration of the 17,257 bp fragment following P1
transduction was verified by PCR with the following protocol. One
bacterial colony was stirred in 30 .mu.l H.sub.2O and heated to
95.degree. C. for 5 minutes. The resulting solution was spun down
and 2 .mu.l of the supernatant used as template in the following
PCR reaction: 2 .mu.l colony in H.sub.2O, 5 .mu.l Herculase.RTM.
Buffer, 1 .mu.l 100 mM dNTPs, 1 .mu.l 10 .mu.M Forward primer, 1
.mu.l 10 .mu.M Reverse primer, 0.5 .mu.l of Herculase.RTM. Enhanced
DNA Polymerase (Agilent Technologies, Stratagene Products Division,
La Jolla, Calif.), and 39.5 .mu.l diH.sub.2O. The PCR reaction was
cycled in a PCR Express Thermal Cycler (Thermo Hybaid, Franklin,
Mass.) as follows: 95.degree. C./2 minutes; 30 cycles of 95.degree.
C./30 seconds, 52.degree. C./30 seconds, 72.degree. C./60 seconds;
and 72 C/17 minutes. The reaction was then cooled to 4.degree. C.
The annealing temperature of 52.degree. C. was 3.degree. C. lower
than the lower T.sup.m of the primer pair. The size of the
resulting PCR fragment was determined on a pre-cast 0.8% E-gel.RTM.
(Invitrogen. Carlsbad, Calif.), using DNA Molecular Weight Marker X
(75-12,216 bp)(Roche Diagnostics, Mannheim, Germany) as size
marker. Successful transduction was also confirmed by the ability
of strain CMP215 to grow on galactose.
[0213] Alternatively, a lysate of E. coli MG 1655 was used to
transduce strain MCM531 (described above). A colony selected on M9
medium supplemented with 0.4% (w/v) galactose was named CMP258.
Presence of the 17,257 bp region containing pgl was confirmed by
PCR using primers galM R (SEQ ID NO:9) and galM F (SEQ ID NO:8),
essentially as described above.
[0214] Strain CMP215 was cotransformed by electroporation with
plasmids pCLPtrcUpperPathway expressing mvaE and mvaS (prepared as
described in Example 8 of U.S. patent application Ser. No.
12/335,071, which is incorporated herein by reference in its
entirety) and pDW34 (containing a truncated P. alba isoprene
synthase and M. mazei mevalonate kinase, as described above).
Transformants were selected on LB agar plates including 50 .mu.g/ml
carbenicillin+50 .mu.g/ml spectinomycin. One colony was picked and
named CMP234.
[0215] II. Fermentation Using an MBR Increases Isoprene
Production
[0216] Increased production of isoprene: 15 L fed-batch
fermentation with E. coli strain CMP234 in a membrane bioreactor
system. E. coli BL21 (DE3) strain CMP234 (constructed as described
above) overexpresses M. mazei mevalonate kinase and P. alba
isoprene synthase and contains an integrated copy of
6-phosphogluconolactonase (PGL) derived from E. coli K12 strain MG
1655. Isoprene was produced by CMP234 cells grown in fed-batch
culture at 15-L scale in a membrane bioreactor (MBR) in minimal
medium.
[0217] Medium Recipe (Per L):
[0218] 7.5 g K.sub.2HPO.sub.4, 2 g MgSO.sub.4*7H.sub.2O, 2 g citric
acid monohydrate, 0.3 g ferric ammonium citrate, 0.5 g yeast
extract, and 1 mL 1000.times. Modified Trace Metal Solution (recipe
below) were dissolved together in distilled, deionized water
(diH.sub.2O) and heat-sterilized at 123.degree. C. for 20 minutes.
The pH was adjusted to 7.0 with 28% ammonium hydroxide brought up
to final volume with sterile water. 10 g glucose, 8 mL Vitamin
Solution (recipe below) and appropriate antibiotics were added
after sterilization and pH adjustment.
[0219] 1000.times. Modified Trace Metal Solution (Per L):
[0220] 40 g Citric Acid*H.sub.2O z, 30 g MnSO.sub.4*H.sub.2O, 10 g
NaCl, 1 g FeSO.sub.4*7H.sub.2O, 1 g CoCl.sub.2*6H.sub.2O, 1 g
ZnSO.sub.4*7H.sub.2O, 100 mg CuSO.sub.4*5H.sub.2O, 100 mg
H.sub.3BO.sub.3, and 100 mg NaMoO.sub.4*2H.sub.2O were dissolved
one at a time in diH.sub.2O. The pH was adjusted to 3.0 with
HCl/NaOH, and the solution was brought up to final volume and
sterilized using a 0.22-.mu.m filter.
[0221] Vitamin Solution (Per L):
[0222] 1 g Thiamine hydrochloride, 1 g D-(+)-biotin, 1 g nicotinic
acid, 4.8 g D-pantothenic acid, and 4.0 g pyridoxine hydrochloride
were dissolved one at a time in diH.sub.2O. The pH was adjusted to
3.0 with HCl/NaOH, and the solution was brought up to final volume
and sterilized using a 0.22-.mu.m filter.
[0223] Macro Salt Solution (Per L):
[0224] 296 g MgSO.sub.4*7O, 296 g citric acid monohydrate, and 49.6
g ferric ammonium citrate were dissolved together in water, brought
up to final volume, and sterilized using a 0.22 .mu.m filter.
[0225] Glucose Feed Solution (Per Kg):
[0226] 0.57 kg Glucose, 0.38 kg diH.sub.2O, 7.5 g K.sub.2HPO.sub.4,
and 10 g 100% Foamblast were mixed together and autoclaved. 5.6 mL,
Macro Salt Solution, 0.8 mL 1000.times. Modified Trace Metal
Solution, and 6.7 mL Vitamin Solution were added after the solution
had cooled to 25.degree. C.
[0227] Fermentation was performed in a 15-L bioreactor with E. coli
BL21 cells expressing the upper mevalonic acid (MVA) pathway (pCL
Upper), the integrated lower MVA pathway (PL.2 mKKDyI), mevalonate
kinase from M. mazei and truncated isoprene synthase from P. alba
(pTrcAlba (MEA) mMVK (pDW34)), and containing a restored
chromosomal pgl gene (t ybgS::Kan) (strain name CMP234).
[0228] This example was carried out to monitor isoprene formation
from glucose at the desired fermentation pH 7.0 and temperature
34.degree. C. in an MBR, using a separate "non-MBR" membrane-free
reactor as a control. A frozen vial of E. coli BL21 strain CMP234
was thawed and inoculated into tryptone-yeast extract medium for
each reactor. After the inoculum grew to optical density 1.0,
measured at 550 nm (OD), 500 mL was used to inoculate a 15-L
reactor and bring the initial tank volume to 5 L.
[0229] FIG. 21 shows a membrane bioreactor including a tangential
flow filter set up with a 15-L bioreactor growing E. coli strain
CMP234. FIG. 22 shows the operational parameters of an MBR during a
15-L scale fermentation run.
[0230] The feed solution was added at an exponential rate until a
top feed rate of 6.4 g/minute was reached. Glucose was then fed to
meet metabolic demands at rates less than or equal to 6.4 g/minute.
The total amount of glucose delivered to the MBR reactor during the
88 h fermentation was 9.2 kg, compared to 8.4 kg of glucose
delivered to the non-MBR control reactor. Induction of protein
expression was achieved by adding
isopropyl-beta-D-1-thiogalactopyranoside (IPTG). The IPTG
concentration was brought to 110 .mu.M when the OD reached 5 and
raised to 200 .mu.M when the OD reached 100.
[0231] Clarified fermentation broth (permeate) was removed using
the MBR (FIG. 21) starting at 30 hours of fermentation in amounts
necessary to maintain reactor weight at 9.7 kg (FIG. 28; 7.8 kg
permeate removed in 88 hours of fermentation). Whole broth
including cells was removed starting at 30 hours of fermentation
from the non-MBR control reactor in amounts necessary to maintain
reactor weight at 9.7 kg (FIG. 28; 6.6 kg whole broth removed in 88
hours of fermentation). OD profiles within the MBR and non-MBR
reactors over time are shown in FIG. 23.
[0232] The isoprene level in reactor off-gas was determined using a
Hiden mass spectrometer. Isoprene titer increased during
fermentation to 100.5 g/L at 88 hours in the MBR and to 84.3 g/L in
the non-MBR control (FIG. 25). Total isoprene produced during the
88 hour fermentation was 843.9 g in the MBR, compared to 721.0 g in
the non-MBR control. The time course of production is shown in FIG.
26. The time course of specific productivity shows very similar
profiles for both reactors: the MBR did not seem to dramatically
alter cell physiology (FIG. 24). The molar yield of isoprene from
glucose carbon during fermentation was 20.1% at 88 hours in the
MBR, compared to 18.8% at 88 hours in the non-MBR control. The
weight-% yield of isoprene from glucose was 9.3% at 88 hours in the
MBR, compared to 8.7% at 88 hours in the non-MBR control.
[0233] Isoprene evolution rate, isoprene titer, total isoprene,
volumetric productivity, and specific productivity were calculated
according to the equations below.
HGER = Airflow OffgasN 2 Supply N 2 OffgasHG ( 60 min / h ) ( 100 %
24.14 ) 1.05` Ferm Wt ##EQU00001## Isoprene Titer = 68.117 .intg. (
HGER ) t ##EQU00001.2## Total Isoprene = .intg. ( Airflow HG .mu.g
/ L 60 min / h 1 g / 1000000 .mu.g ) t ##EQU00001.3## VolProd = t (
Isoprene Titer ) .apprxeq. ( Isoprene Titer ) n + 1 - ( Isoprene
Titer ) n - 1 ( t ) n + 1 - ( t ) n - 1 ##EQU00001.4## SpProd =
VolProd 1000 mg / g 2.7 OD ##EQU00001.5##
where
[0234] HGER=total isoprene evolution rate per vol. broth[=]
mol/L/h
[0235] Airflow=air flow rate into reactor [=] std L/min
[0236] Offgas N2=nitrogen conc. in reactor off-gas [=] mol %
[0237] Supply N2=nitrogen conc. in air entering reactor [=] mol
%
[0238] Offgas HG=isoprene conc. in reactor off-gas [=] mol %
[0239] 24.14=ideal gas conversion at 1 atm, 21.1.degree. C. [=]
L/mol
[0240] 1.05=broth density [=] kg/L
[0241] Ferm Wt=reactor broth wt [=] kg
[0242] Isoprene Titer=isoprene produced on a broth volume basis [=]
g/L
[0243] t=time [=] h
[0244] n=time interval designation [=] unitless
[0245] 68.117=isoprene molecular wt [=] g/mol
[0246] Total Isoprene=total isoprene produced [=] g
[0247] HG .mu.g/L=isoprene conc. in reactor off-gas [=] g/L
[0248] Vol Prod=isoprene volumetric productivity [=] g/L/h
[0249] Sp Prod=isoprene specific productivity [=] mg isopr/g
cell/h
[0250] OD=optical density of broth at 550 nm [=] abs. unit
[0251] 2.7=empirical conversion of OD to cell conc. [=] abs.
unit.circle-w/dot.L/g cell
and where integrals may be estimated by the trapezoidal rule.
Example 5
Recycled Permeate from an MBR Improves Isoprene Specific
Productivity
[0252] Recycling Permeate from MBR.
[0253] Medium from 15-L scale fermentations of the isoprene
producing E. coli strain DW202 (strain DW199 (produced as described
above)+pBBR gi1.5-pgl (produced as described above)), carrying the
MVA pathway (upper MVA pathway from E. faecalis and integrated
lower MVA pathway from S. cerevisiae, plus MVK from M. mazei) and
isoprene synthase (from P. alba), was isolated from the bioreactors
38 hours after inoculation. 15-L scale fermentations were performed
as described above. Cell mass was quickly removed by
centrifugation. The remaining medium (analogous to permeate) was
ultracentrifuged at 50,000 rpm for 30 minutes at 4.degree. C. to
ensure that all solids were removed. The resulting clarified, spent
medium was diluted into fresh TM3 minimal medium at concentrations
ranging from 0 to 30%.
[0254] The E. coli strain MCM597 (E. coli BL21 (DE3) pLysS
expressing a truncated version of P. alba isoprene synthase (the
MEA variant). E. coli DXS and S. cerevisiae IDI (prepared as
described in Example 7 of U.S. patent application Ser. No.
12/335,071, which is hereby incorporated herein by reference in its
entirety) was grown overnight and inoculated in the medium. Protein
expression in strain MCM597 was induced with 200 .mu.M IPTG and the
induced strain was grown at 30.degree. C. in a microfermentor.
Culture growth (i.e., cell mass) was followed by measuring optical
density at 600 nm using a plate reader. Isoprene production was
followed by GC analysis of 100 .mu.L headspace samples taken at 4
hours after inoculation. Specific productivity was calculated as
the isoprene production divided by the optical density.
[0255] A greater than three-fold increase in isoprene specific
productivity was achieved by supplementing the culture medium with
30% (w/w) of spent media (i.e., permeate), despite about 25% less
growth (FIG. 29). A higher specific productivity means that more
isoprene is produced per cell mass per time. The result suggests
that MBR permeate containing spent medium can be used to enhance
specific productivity of isoprene-producing cells, thereby reducing
production costs.
[0256] The headings provided herein are not limitations of the
various aspects or aspects of the invention which can be had by
reference to the specification as a whole.
[0257] Although the foregoing invention has been described in some
detail by way of illustration and example for purposes of clarity
of understanding, it will be readily apparent to those of ordinary
skill in the art in light of the teachings of this invention that
certain changes and modifications may be made thereto without
departing from the spirit or scope of the appended claims.
Sequence CWU 1 SEQUENCE LISTING <160> NUMBER OF SEQ ID
NOS: 47 <210> SEQ ID NO 1 <211> LENGTH: 6957
<212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 1 tggcgaatgg gacgcgccct gtagcggcgc
attaagcgcg gcgggtgtgg tggttacgcg 60 cagcgtgacc gctacacttg
ccagcgccct agcgcccgct cctttcgctt tcttcccttc 120 ctttctcgcc
acgttcgccg gctttccccg tcaagctcta aatcgggggc tccctttagg 180
gttccgattt agtgctttac ggcacctcga ccccaaaaaa cttgattagg gtgatggttc
240 acgtagtggg ccatcgccct gatagacggt ttttcgccct ttgacgttgg
agtccacgtt 300 ctttaatagt ggactcttgt tccaaactgg aacaacactc
aaccctatct cggtctattc 360 ttttgattta taagggattt tgccgatttc
ggcctattgg ttaaaaaatg agctgattta 420 acaaaaattt aacgcgaatt
ttaacaaaat attaacgttt acaatttcag gtggcacttt 480 tcggggaaat
gtgcgcggaa cccctatttg tttatttttc taaatacatt caaatatgta 540
tccgctcatg aattaattct tagaaaaact catcgagcat caaatgaaac tgcaatttat
600 tcatatcagg attatcaata ccatattttt gaaaaagccg tttctgtaat
gaaggagaaa 660 actcaccgag gcagttccat aggatggcaa gatcctggta
tcggtctgcg attccgactc 720 gtccaacatc aatacaacct attaatttcc
cctcgtcaaa aataaggtta tcaagtgaga 780 aatcaccatg agtgacgact
gaatccggtg agaatggcaa aagtttatgc atttctttcc 840 agacttgttc
aacaggccag ccattacgct cgtcatcaaa atcactcgca tcaaccaaac 900
cgttattcat tcgtgattgc gcctgagcga gacgaaatac gcgatcgctg ttaaaaggac
960 aattacaaac aggaatcgaa tgcaaccggc gcaggaacac tgccagcgca
tcaacaatat 1020 tttcacctga atcaggatat tcttctaata cctggaatgc
tgttttcccg gggatcgcag 1080 tggtgagtaa ccatgcatca tcaggagtac
ggataaaatg cttgatggtc ggaagaggca 1140 taaattccgt cagccagttt
agtctgacca tctcatctgt aacatcattg gcaacgctac 1200 ctttgccatg
tttcagaaac aactctggcg catcgggctt cccatacaat cgatagattg 1260
tcgcacctga ttgcccgaca ttatcgcgag cccatttata cccatataaa tcagcatcca
1320 tgttggaatt taatcgcggc ctagagcaag acgtttcccg ttgaatatgg
ctcataacac 1380 cccttgtatt actgtttatg taagcagaca gttttattgt
tcatgaccaa aatcccttaa 1440 cgtgagtttt cgttccactg agcgtcagac
cccgtagaaa agatcaaagg atcttcttga 1500 gatccttttt ttctgcgcgt
aatctgctgc ttgcaaacaa aaaaaccacc gctaccagcg 1560 gtggtttgtt
tgccggatca agagctacca actctttttc cgaaggtaac tggcttcagc 1620
agagcgcaga taccaaatac tgtccttcta gtgtagccgt agttaggcca ccacttcaag
1680 aactctgtag caccgcctac atacctcgct ctgctaatcc tgttaccagt
ggctgctgcc 1740 agtggcgata agtcgtgtct taccgggttg gactcaagac
gatagttacc ggataaggcg 1800 cagcggtcgg gctgaacggg gggttcgtgc
acacagccca gcttggagcg aacgacctac 1860 accgaactga gatacctaca
gcgtgagcta tgagaaagcg ccacgcttcc cgaagggaga 1920 aaggcggaca
ggtatccggt aagcggcagg gtcggaacag gagagcgcac gagggagctt 1980
ccagggggaa acgcctggta tctttatagt cctgtcgggt ttcgccacct ctgacttgag
2040 cgtcgatttt tgtgatgctc gtcagggggg cggagcctat ggaaaaacgc
cagcaacgcg 2100 gcctttttac ggttcctggc cttttgctgg ccttttgctc
acatgttctt tcctgcgtta 2160 tcccctgatt ctgtggataa ccgtattacc
gcctttgagt gagctgatac cgctcgccgc 2220 agccgaacga ccgagcgcag
cgagtcagtg agcgaggaag cggaagagcg cctgatgcgg 2280 tattttctcc
ttacgcatct gtgcggtatt tcacaccgca tatatggtgc actctcagta 2340
caatctgctc tgatgccgca tagttaagcc agtatacact ccgctatcgc tacgtgactg
2400 ggtcatggct gcgccccgac acccgccaac acccgctgac gcgccctgac
gggcttgtct 2460 gctcccggca tccgcttaca gacaagctgt gaccgtctcc
gggagctgca tgtgtcagag 2520 gttttcaccg tcatcaccga aacgcgcgag
gcagctgcgg taaagctcat cagcgtggtc 2580 gtgaagcgat tcacagatgt
ctgcctgttc atccgcgtcc agctcgttga gtttctccag 2640 aagcgttaat
gtctggcttc tgataaagcg ggccatgtta agggcggttt tttcctgttt 2700
ggtcactgat gcctccgtgt aagggggatt tctgttcatg ggggtaatga taccgatgaa
2760 acgagagagg atgctcacga tacgggttac tgatgatgaa catgcccggt
tactggaacg 2820 ttgtgagggt aaacaactgg cggtatggat gcggcgggac
cagagaaaaa tcactcaggg 2880 tcaatgccag cgcttcgtta atacagatgt
aggtgttcca cagggtagcc agcagcatcc 2940 tgcgatgcag atccggaaca
taatggtgca gggcgctgac ttccgcgttt ccagacttta 3000 cgaaacacgg
aaaccgaaga ccattcatgt tgttgctcag gtcgcagacg ttttgcagca 3060
gcagtcgctt cacgttcgct cgcgtatcgg tgattcattc tgctaaccag taaggcaacc
3120 ccgccagcct agccgggtcc tcaacgacag gagcacgatc atgcgcaccc
gtggggccgc 3180 catgccggcg ataatggcct gcttctcgcc gaaacgtttg
gtggcgggac cagtgacgaa 3240 ggcttgagcg agggcgtgca agattccgaa
taccgcaagc gacaggccga tcatcgtcgc 3300 gctccagcga aagcggtcct
cgccgaaaat gacccagagc gctgccggca cctgtcctac 3360 gagttgcatg
ataaagaaga cagtcataag tgcggcgacg atagtcatgc cccgcgccca 3420
ccggaaggag ctgactgggt tgaaggctct caagggcatc ggtcgagatc ccggtgccta
3480 atgagtgagc taacttacat taattgcgtt gcgctcactg cccgctttcc
agtcgggaaa 3540 cctgtcgtgc cagctgcatt aatgaatcgg ccaacgcgcg
gggagaggcg gtttgcgtat 3600 tgggcgccag ggtggttttt cttttcacca
gtgagacggg caacagctga ttgcccttca 3660 ccgcctggcc ctgagagagt
tgcagcaagc ggtccacgct ggtttgcccc agcaggcgaa 3720 aatcctgttt
gatggtggtt aacggcggga tataacatga gctgtcttcg gtatcgtcgt 3780
atcccactac cgagatatcc gcaccaacgc gcagcccgga ctcggtaatg gcgcgcattg
3840 cgcccagcgc catctgatcg ttggcaacca gcatcgcagt gggaacgatg
ccctcattca 3900 gcatttgcat ggtttgttga aaaccggaca tggcactcca
gtcgccttcc cgttccgcta 3960 tcggctgaat ttgattgcga gtgagatatt
tatgccagcc agccagacgc agacgcgccg 4020 agacagaact taatgggccc
gctaacagcg cgatttgctg gtgacccaat gcgaccagat 4080 gctccacgcc
cagtcgcgta ccgtcttcat gggagaaaat aatactgttg atgggtgtct 4140
ggtcagagac atcaagaaat aacgccggaa cattagtgca ggcagcttcc acagcaatgg
4200 catcctggtc atccagcgga tagttaatga tcagcccact gacgcgttgc
gcgagaagat 4260 tgtgcaccgc cgctttacag gcttcgacgc cgcttcgttc
taccatcgac accaccacgc 4320 tggcacccag ttgatcggcg cgagatttaa
tcgccgcgac aatttgcgac ggcgcgtgca 4380 gggccagact ggaggtggca
acgccaatca gcaacgactg tttgcccgcc agttgttgtg 4440 ccacgcggtt
gggaatgtaa ttcagctccg ccatcgccgc ttccactttt tcccgcgttt 4500
tcgcagaaac gtggctggcc tggttcacca cgcgggaaac ggtctgataa gagacaccgg
4560 catactctgc gacatcgtat aacgttactg gtttcacatt caccaccctg
aattgactct 4620 cttccgggcg ctatcatgcc ataccgcgaa aggttttgcg
ccattcgatg gtgtccggga 4680 tctcgacgct ctcccttatg cgactcctgc
attaggaagc agcccagtag taggttgagg 4740 ccgttgagca ccgccgccgc
aaggaatggt gcatgcaagg agatggcgcc caacagtccc 4800 ccggccacgg
ggcctgccac catacccacg ccgaaacaag cgctcatgag cccgaagtgg 4860
cgagcccgat cttccccatc ggtgatgtcg gcgatatagg cgccagcaac cgcacctgtg
4920 gcgccggtga tgccggccac gatgcgtccg gcgtagagga tcgagatctc
gatcccgcga 4980 aattaatacg actcactata ggggaattgt gagcggataa
caattcccct ctagaaataa 5040 ttttgtttaa ctttaagaag gagatataca
tatgcgttgt agcgtgtcca ccgaaaatgt 5100 gtctttcacc gaaactgaaa
ccgaagctcg tcgttctgcg aactacgaac ctaacagctg 5160 ggactatgat
tacctgctgt cctccgacac ggacgagtcc atcgaagtat acaaagacaa 5220
agcgaaaaag ctggaagccg aagttcgtcg cgagattaat aacgaaaaag cagaatttct
5280 gaccctgctg gaactgattg acaacgtcca gcgcctgggc ctgggttacc
gtttcgagtc 5340 tgatatccgt ggtgcgctgg atcgcttcgt ttcctccggc
ggcttcgatg cggtaaccaa 5400 gacttccctg cacggtacgg cactgtcttt
ccgtctgctg cgtcaacacg gttttgaggt 5460 ttctcaggaa gcgttcagcg
gcttcaaaga ccaaaacggc aacttcctgg agaacctgaa 5520 ggaagatatc
aaagctatcc tgagcctgta cgaggccagc ttcctggctc tggaaggcga 5580
aaacatcctg gacgaggcga aggttttcgc aatctctcat ctgaaagaac tgtctgaaga
5640 aaagatcggt aaagagctgg cagaacaggt gaaccatgca ctggaactgc
cactgcatcg 5700 ccgtactcag cgtctggaag cagtatggtc tatcgaggcc
taccgtaaaa aggaggacgc 5760 gaatcaggtt ctgctggagc tggcaattct
ggattacaac atgatccagt ctgtatacca 5820 gcgtgatctg cgtgaaacgt
cccgttggtg gcgtcgtgtg ggtctggcga ccaaactgca 5880 ctttgctcgt
gaccgcctga ttgagagctt ctactgggcc gtgggtgtag cattcgaacc 5940
gcaatactcc gactgccgta actccgtcgc aaaaatgttt tctttcgtaa ccattatcga
6000 cgatatctac gatgtatacg gcaccctgga cgaactggag ctgtttactg
atgcagttga 6060 gcgttgggac gtaaacgcca tcaacgacct gccggattac
atgaaactgt gctttctggc 6120 tctgtataac actattaacg aaatcgccta
cgacaacctg aaagataaag gtgagaacat 6180 cctgccgtat ctgaccaaag
cctgggctga cctgtgcaac gctttcctgc aagaagccaa 6240 gtggctgtac
aacaaatcta ctccgacctt tgacgactac ttcggcaacg catggaaatc 6300
ctcttctggc ccgctgcaac tggtgttcgc ttacttcgct gtcgtgcaga acattaaaaa
6360 ggaagagatc gaaaacctgc aaaaatacca tgacaccatc tctcgtcctt
cccatatctt 6420 ccgtctgtgc aatgacctgg ctagcgcgtc tgcggaaatt
gcgcgtggtg aaaccgcaaa 6480 tagcgtttct tgttacatgc gcactaaagg
tatctccgaa gaactggcta ccgaaagcgt 6540 gatgaatctg atcgatgaaa
cctggaaaaa gatgaacaag gaaaaactgg gtggtagcct 6600 gttcgcgaaa
ccgttcgtgg aaaccgcgat caacctggca cgtcaatctc actgcactta 6660
tcataacggc gacgcgcata cctctccgga tgagctgacc cgcaaacgcg ttctgtctgt
6720 aatcactgaa ccgattctgc cgtttgaacg ctaaggatcc gaattcgagc
tccgtcgaca 6780 agcttgcggc cgcactcgag caccaccacc accaccactg
agatccggct gctaacaaag 6840 cccgaaagga agctgagttg gctgctgcca
ccgctgagca ataactagca taaccccttg 6900 gggcctctaa acgggtcttg
aggggttttt tgctgaaagg aggaactata tccggat 6957 <210> SEQ ID NO
2 <211> LENGTH: 6068 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 2
gtttgacagc ttatcatcga ctgcacggtg caccaatgct tctggcgtca ggcagccatc
60 ggaagctgtg gtatggctgt gcaggtcgta aatcactgca taattcgtgt
cgctcaaggc 120 gcactcccgt tctggataat gttttttgcg ccgacatcat
aacggttctg gcaaatattc 180 tgaaatgagc tgttgacaat taatcatccg
gctcgtataa tgtgtggaat tgtgagcgga 240 taacaatttc acacaggaaa
cagcgccgct gagaaaaagc gaagcggcac tgctctttaa 300 caatttatca
gacaatctgt gtgggcactc gaccggaatt atcgattaac tttattatta 360
aaaattaaag aggtatatat taatgtatcg attaaataag gaggaataaa ccatgagatg
420 tagcgtgtcc accgaaaatg tgtctttcac cgaaactgaa accgaagctc
gtcgttctgc 480 gaactacgaa cctaacagct gggactatga ttacctgctg
tcctccgaca cggacgagtc 540 catcgaagta tacaaagaca aagcgaaaaa
gctggaagcc gaagttcgtc gcgagattaa 600 taacgaaaaa gcagaatttc
tgaccctgct ggaactgatt gacaacgtcc agcgcctggg 660 cctgggttac
cgtttcgagt ctgatatccg tggtgcgctg gatcgcttcg tttcctccgg 720
cggcttcgat gcggtaacca agacttccct gcacggtacg gcactgtctt tccgtctgct
780 gcgtcaacac ggttttgagg tttctcagga agcgttcagc ggcttcaaag
accaaaacgg 840 caacttcctg gagaacctga aggaagatat caaagctatc
ctgagcctgt acgaggccag 900 cttcctggct ctggaaggcg aaaacatcct
ggacgaggcg aaggttttcg caatctctca 960 tctgaaagaa ctgtctgaag
aaaagatcgg taaagagctg gcagaacagg tgaaccatgc 1020 actggaactg
ccactgcatc gccgtactca gcgtctggaa gcagtatggt ctatcgaggc 1080
ctaccgtaaa aaggaggacg cgaatcaggt tctgctggag ctggcaattc tggattacaa
1140 catgatccag tctgtatacc agcgtgatct gcgtgaaacg tcccgttggt
ggcgtcgtgt 1200 gggtctggcg accaaactgc actttgctcg tgaccgcctg
attgagagct tctactgggc 1260 cgtgggtgta gcattcgaac cgcaatactc
cgactgccgt aactccgtcg caaaaatgtt 1320 ttctttcgta accattatcg
acgatatcta cgatgtatac ggcaccctgg acgaactgga 1380 gctgtttact
gatgcagttg agcgttggga cgtaaacgcc atcaacgacc tgccggatta 1440
catgaaactg tgctttctgg ctctgtataa cactattaac gaaatcgcct acgacaacct
1500 gaaagataaa ggtgagaaca tcctgccgta tctgaccaaa gcctgggctg
acctgtgcaa 1560 cgctttcctg caagaagcca agtggctgta caacaaatct
actccgacct ttgacgacta 1620 cttcggcaac gcatggaaat cctcttctgg
cccgctgcaa ctggtgttcg cttacttcgc 1680 tgtcgtgcag aacattaaaa
aggaagagat cgaaaacctg caaaaatacc atgacaccat 1740 ctctcgtcct
tcccatatct tccgtctgtg caatgacctg gctagcgcgt ctgcggaaat 1800
tgcgcgtggt gaaaccgcaa atagcgtttc ttgttacatg cgcactaaag gtatctccga
1860 agaactggct accgaaagcg tgatgaatct gatcgatgaa acctggaaaa
agatgaacaa 1920 ggaaaaactg ggtggtagcc tgttcgcgaa accgttcgtg
gaaaccgcga tcaacctggc 1980 acgtcaatct cactgcactt atcataacgg
cgacgcgcat acctctccgg atgagctgac 2040 ccgcaaacgc gttctgtctg
taatcactga accgattctg ccgtttgaac gctaactgca 2100 gctggtacca
tatgggaatt cgaagctttc tagaacaaaa actcatctca gaagaggatc 2160
tgaatagcgc cgtcgaccat catcatcatc atcattgagt ttaaacggtc tccagcttgg
2220 ctgttttggc ggatgagaga agattttcag cctgatacag attaaatcag
aacgcagaag 2280 cggtctgata aaacagaatt tgcctggcgg cagtagcgcg
gtggtcccac ctgaccccat 2340 gccgaactca gaagtgaaac gccgtagcgc
cgatggtagt gtggggtctc cccatgcgag 2400 agtagggaac tgccaggcat
caaataaaac gaaaggctca gtcgaaagac tgggcctttc 2460 gttttatctg
ttgtttgtcg gtgaacgctc tcctgagtag gacaaatccg ccgggagcgg 2520
atttgaacgt tgcgaagcaa cggcccggag ggtggcgggc aggacgcccg ccataaactg
2580 ccaggcatca aattaagcag aaggccatcc tgacggatgg cctttttgcg
tttctacaaa 2640 ctctttttgt ttatttttct aaatacattc aaatatgtat
ccgctcatga gacaataacc 2700 ctgataaatg cttcaataat attgaaaaag
gaagagtatg agtattcaac atttccgtgt 2760 cgcccttatt cccttttttg
cggcattttg ccttcctgtt tttgctcacc cagaaacgct 2820 ggtgaaagta
aaagatgctg aagatcagtt gggtgcacga gtgggttaca tcgaactgga 2880
tctcaacagc ggtaagatcc ttgagagttt tcgccccgaa gaacgttttc caatgatgag
2940 cacttttaaa gttctgctat gtggcgcggt attatcccgt gttgacgccg
ggcaagagca 3000 actcggtcgc cgcatacact attctcagaa tgacttggtt
gagtactcac cagtcacaga 3060 aaagcatctt acggatggca tgacagtaag
agaattatgc agtgctgcca taaccatgag 3120 tgataacact gcggccaact
tacttctgac aacgatcgga ggaccgaagg agctaaccgc 3180 ttttttgcac
aacatggggg atcatgtaac tcgccttgat cgttgggaac cggagctgaa 3240
tgaagccata ccaaacgacg agcgtgacac cacgatgcct gtagcaatgg caacaacgtt
3300 gcgcaaacta ttaactggcg aactacttac tctagcttcc cggcaacaat
taatagactg 3360 gatggaggcg gataaagttg caggaccact tctgcgctcg
gcccttccgg ctggctggtt 3420 tattgctgat aaatctggag ccggtgagcg
tgggtctcgc ggtatcattg cagcactggg 3480 gccagatggt aagccctccc
gtatcgtagt tatctacacg acggggagtc aggcaactat 3540 ggatgaacga
aatagacaga tcgctgagat aggtgcctca ctgattaagc attggtaact 3600
gtcagaccaa gtttactcat atatacttta gattgattta aaacttcatt tttaatttaa
3660 aaggatctag gtgaagatcc tttttgataa tctcatgacc aaaatccctt
aacgtgagtt 3720 ttcgttccac tgagcgtcag accccgtaga aaagatcaaa
ggatcttctt gagatccttt 3780 ttttctgcgc gtaatctgct gcttgcaaac
aaaaaaacca ccgctaccag cggtggtttg 3840 tttgccggat caagagctac
caactctttt tccgaaggta actggcttca gcagagcgca 3900 gataccaaat
actgtccttc tagtgtagcc gtagttaggc caccacttca agaactctgt 3960
agcaccgcct acatacctcg ctctgctaat cctgttacca gtggctgctg ccagtggcga
4020 taagtcgtgt cttaccgggt tggactcaag acgatagtta ccggataagg
cgcagcggtc 4080 gggctgaacg gggggttcgt gcacacagcc cagcttggag
cgaacgacct acaccgaact 4140 gagataccta cagcgtgagc tatgagaaag
cgccacgctt cccgaaggga gaaaggcgga 4200 caggtatccg gtaagcggca
gggtcggaac aggagagcgc acgagggagc ttccaggggg 4260 aaacgcctgg
tatctttata gtcctgtcgg gtttcgccac ctctgacttg agcgtcgatt 4320
tttgtgatgc tcgtcagggg ggcggagcct atggaaaaac gccagcaacg cggccttttt
4380 acggttcctg gccttttgct ggccttttgc tcacatgttc tttcctgcgt
tatcccctga 4440 ttctgtggat aaccgtatta ccgcctttga gtgagctgat
accgctcgcc gcagccgaac 4500 gaccgagcgc agcgagtcag tgagcgagga
agcggaagag cgcctgatgc ggtattttct 4560 ccttacgcat ctgtgcggta
tttcacaccg catatggtgc actctcagta caatctgctc 4620 tgatgccgca
tagttaagcc agtatacact ccgctatcgc tacgtgactg ggtcatggct 4680
gcgccccgac acccgccaac acccgctgac gcgccctgac gggcttgtct gctcccggca
4740 tccgcttaca gacaagctgt gaccgtctcc gggagctgca tgtgtcagag
gttttcaccg 4800 tcatcaccga aacgcgcgag gcagcagatc aattcgcgcg
cgaaggcgaa gcggcatgca 4860 tttacgttga caccatcgaa tggtgcaaaa
cctttcgcgg tatggcatga tagcgcccgg 4920 aagagagtca attcagggtg
gtgaatgtga aaccagtaac gttatacgat gtcgcagagt 4980 atgccggtgt
ctcttatcag accgtttccc gcgtggtgaa ccaggccagc cacgtttctg 5040
cgaaaacgcg ggaaaaagtg gaagcggcga tggcggagct gaattacatt cccaaccgcg
5100 tggcacaaca actggcgggc aaacagtcgt tgctgattgg cgttgccacc
tccagtctgg 5160 ccctgcacgc gccgtcgcaa attgtcgcgg cgattaaatc
tcgcgccgat caactgggtg 5220 ccagcgtggt ggtgtcgatg gtagaacgaa
gcggcgtcga agcctgtaaa gcggcggtgc 5280 acaatcttct cgcgcaacgc
gtcagtgggc tgatcattaa ctatccgctg gatgaccagg 5340 atgccattgc
tgtggaagct gcctgcacta atgttccggc gttatttctt gatgtctctg 5400
accagacacc catcaacagt attattttct cccatgaaga cggtacgcga ctgggcgtgg
5460 agcatctggt cgcattgggt caccagcaaa tcgcgctgtt agcgggccca
ttaagttctg 5520 tctcggcgcg tctgcgtctg gctggctggc ataaatatct
cactcgcaat caaattcagc 5580 cgatagcgga acgggaaggc gactggagtg
ccatgtccgg ttttcaacaa accatgcaaa 5640 tgctgaatga gggcatcgtt
cccactgcga tgctggttgc caacgatcag atggcgctgg 5700 gcgcaatgcg
cgccattacc gagtccgggc tgcgcgttgg tgcggatatc tcggtagtgg 5760
gatacgacga taccgaagac agctcatgtt atatcccgcc gtcaaccacc atcaaacagg
5820 attttcgcct gctggggcaa accagcgtgg accgcttgct gcaactctct
cagggccagg 5880 cggtgaaggg caatcagctg ttgcccgtct cactggtgaa
aagaaaaacc accctggcgc 5940 ccaatacgca aaccgcctct ccccgcgcgt
tggccgattc attaatgcag ctggcacgac 6000 aggtttcccg actggaaagc
gggcagtgag cgcaacgcaa ttaatgtgag ttagcgcgaa 6060 ttgatctg 6068
<210> SEQ ID NO 3 <211> LENGTH: 6906 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 3 gtttgacagc ttatcatcga ctgcacggtg caccaatgct tctggcgtca
ggcagccatc 60 ggaagctgtg gtatggctgt gcaggtcgta aatcactgca
taattcgtgt cgctcaaggc 120 gcactcccgt tctggataat gttttttgcg
ccgacatcat aacggttctg gcaaatattc 180 tgaaatgagc tgttgacaat
taatcatccg gctcgtataa tgtgtggaat tgtgagcgga 240 taacaatttc
acacaggaaa cagcgccgct gagaaaaagc gaagcggcac tgctctttaa 300
caatttatca gacaatctgt gtgggcactc gaccggaatt atcgattaac tttattatta
360 aaaattaaag aggtatatat taatgtatcg attaaataag gaggaataaa
ccatgagatg 420 tagcgtgtcc accgaaaatg tgtctttcac cgaaactgaa
accgaagctc gtcgttctgc 480 gaactacgaa cctaacagct gggactatga
ttacctgctg tcctccgaca cggacgagtc 540 catcgaagta tacaaagaca
aagcgaaaaa gctggaagcc gaagttcgtc gcgagattaa 600 taacgaaaaa
gcagaatttc tgaccctgct ggaactgatt gacaacgtcc agcgcctggg 660
cctgggttac cgtttcgagt ctgatatccg tggtgcgctg gatcgcttcg tttcctccgg
720 cggcttcgat gcggtaacca agacttccct gcacggtacg gcactgtctt
tccgtctgct 780 gcgtcaacac ggttttgagg tttctcagga agcgttcagc
ggcttcaaag accaaaacgg 840 caacttcctg gagaacctga aggaagatat
caaagctatc ctgagcctgt acgaggccag 900 cttcctggct ctggaaggcg
aaaacatcct ggacgaggcg aaggttttcg caatctctca 960 tctgaaagaa
ctgtctgaag aaaagatcgg taaagagctg gcagaacagg tgaaccatgc 1020
actggaactg ccactgcatc gccgtactca gcgtctggaa gcagtatggt ctatcgaggc
1080 ctaccgtaaa aaggaggacg cgaatcaggt tctgctggag ctggcaattc
tggattacaa 1140 catgatccag tctgtatacc agcgtgatct gcgtgaaacg
tcccgttggt ggcgtcgtgt 1200 gggtctggcg accaaactgc actttgctcg
tgaccgcctg attgagagct tctactgggc 1260 cgtgggtgta gcattcgaac
cgcaatactc cgactgccgt aactccgtcg caaaaatgtt 1320 ttctttcgta
accattatcg acgatatcta cgatgtatac ggcaccctgg acgaactgga 1380
gctgtttact gatgcagttg agcgttggga cgtaaacgcc atcaacgacc tgccggatta
1440 catgaaactg tgctttctgg ctctgtataa cactattaac gaaatcgcct
acgacaacct 1500 gaaagataaa ggtgagaaca tcctgccgta tctgaccaaa
gcctgggctg acctgtgcaa 1560 cgctttcctg caagaagcca agtggctgta
caacaaatct actccgacct ttgacgacta 1620 cttcggcaac gcatggaaat
cctcttctgg cccgctgcaa ctggtgttcg cttacttcgc 1680 tgtcgtgcag
aacattaaaa aggaagagat cgaaaacctg caaaaatacc atgacaccat 1740
ctctcgtcct tcccatatct tccgtctgtg caatgacctg gctagcgcgt ctgcggaaat
1800 tgcgcgtggt gaaaccgcaa atagcgtttc ttgttacatg cgcactaaag
gtatctccga 1860 agaactggct accgaaagcg tgatgaatct gatcgatgaa
acctggaaaa agatgaacaa 1920 ggaaaaactg ggtggtagcc tgttcgcgaa
accgttcgtg gaaaccgcga tcaacctggc 1980 acgtcaatct cactgcactt
atcataacgg cgacgcgcat acctctccgg atgagctgac 2040 ccgcaaacgc
gttctgtctg taatcactga accgattctg ccgtttgaac gctaactgca 2100
taaaggaggt aaaaaaacat ggtatcctgt tctgcgccgg gtaagattta cctgttcggt
2160 gaacacgccg tagtttatgg cgaaactgca attgcgtgtg cggtggaact
gcgtacccgt 2220 gttcgcgcgg aactcaatga ctctatcact attcagagcc
agatcggccg caccggtctg 2280 gatttcgaaa agcaccctta tgtgtctgcg
gtaattgaga aaatgcgcaa atctattcct 2340 attaacggtg ttttcttgac
cgtcgattcc gacatcccgg tgggctccgg tctgggtagc 2400 agcgcagccg
ttactatcgc gtctattggt gcgctgaacg agctgttcgg ctttggcctc 2460
agcctgcaag aaatcgctaa actgggccac gaaatcgaaa ttaaagtaca gggtgccgcg
2520 tccccaaccg atacgtatgt ttctaccttc ggcggcgtgg ttaccatccc
ggaacgtcgc 2580 aaactgaaaa ctccggactg cggcattgtg attggcgata
ccggcgtttt ctcctccacc 2640 aaagagttag tagctaacgt acgtcagctg
cgcgaaagct acccggattt gatcgaaccg 2700 ctgatgacct ctattggcaa
aatctctcgt atcggcgaac aactggttct gtctggcgac 2760 tacgcatcca
tcggccgcct gatgaacgtc aaccagggtc tcctggacgc cctgggcgtt 2820
aacatcttag aactgagcca gctgatctat tccgctcgtg cggcaggtgc gtttggcgct
2880 aaaatcacgg gcgctggcgg cggtggctgt atggttgcgc tgaccgctcc
ggaaaaatgc 2940 aaccaagtgg cagaagcggt agcaggcgct ggcggtaaag
tgactatcac taaaccgacc 3000 gagcaaggtc tgaaagtaga ttaaagtcta
gttaaagttt aaacggtctc cagcttggct 3060 gttttggcgg atgagagaag
attttcagcc tgatacagat taaatcagaa cgcagaagcg 3120 gtctgataaa
acagaatttg cctggcggca gtagcgcggt ggtcccacct gaccccatgc 3180
cgaactcaga agtgaaacgc cgtagcgccg atggtagtgt ggggtctccc catgcgagag
3240 tagggaactg ccaggcatca aataaaacga aaggctcagt cgaaagactg
ggcctttcgt 3300 tttatctgtt gtttgtcggt gaacgctctc ctgagtagga
caaatccgcc gggagcggat 3360 ttgaacgttg cgaagcaacg gcccggaggg
tggcgggcag gacgcccgcc ataaactgcc 3420 aggcatcaaa ttaagcagaa
ggccatcctg acggatggcc tttttgcgtt tctacaaact 3480 ctttttgttt
atttttctaa atacattcaa atatgtatcc gctcatgaga caataaccct 3540
gataaatgct tcaataatat tgaaaaagga agagtatgag tattcaacat ttccgtgtcg
3600 cccttattcc cttttttgcg gcattttgcc ttcctgtttt tgctcaccca
gaaacgctgg 3660 tgaaagtaaa agatgctgaa gatcagttgg gtgcacgagt
gggttacatc gaactggatc 3720 tcaacagcgg taagatcctt gagagttttc
gccccgaaga acgttttcca atgatgagca 3780 cttttaaagt tctgctatgt
ggcgcggtat tatcccgtgt tgacgccggg caagagcaac 3840 tcggtcgccg
catacactat tctcagaatg acttggttga gtactcacca gtcacagaaa 3900
agcatcttac ggatggcatg acagtaagag aattatgcag tgctgccata accatgagtg
3960 ataacactgc ggccaactta cttctgacaa cgatcggagg accgaaggag
ctaaccgctt 4020 ttttgcacaa catgggggat catgtaactc gccttgatcg
ttgggaaccg gagctgaatg 4080 aagccatacc aaacgacgag cgtgacacca
cgatgcctgt agcaatggca acaacgttgc 4140 gcaaactatt aactggcgaa
ctacttactc tagcttcccg gcaacaatta atagactgga 4200 tggaggcgga
taaagttgca ggaccacttc tgcgctcggc ccttccggct ggctggttta 4260
ttgctgataa atctggagcc ggtgagcgtg ggtctcgcgg tatcattgca gcactggggc
4320 cagatggtaa gccctcccgt atcgtagtta tctacacgac ggggagtcag
gcaactatgg 4380 atgaacgaaa tagacagatc gctgagatag gtgcctcact
gattaagcat tggtaactgt 4440 cagaccaagt ttactcatat atactttaga
ttgatttaaa acttcatttt taatttaaaa 4500 ggatctaggt gaagatcctt
tttgataatc tcatgaccaa aatcccttaa cgtgagtttt 4560 cgttccactg
agcgtcagac cccgtagaaa agatcaaagg atcttcttga gatccttttt 4620
ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccacc gctaccagcg gtggtttgtt
4680 tgccggatca agagctacca actctttttc cgaaggtaac tggcttcagc
agagcgcaga 4740 taccaaatac tgtccttcta gtgtagccgt agttaggcca
ccacttcaag aactctgtag 4800 caccgcctac atacctcgct ctgctaatcc
tgttaccagt ggctgctgcc agtggcgata 4860 agtcgtgtct taccgggttg
gactcaagac gatagttacc ggataaggcg cagcggtcgg 4920 gctgaacggg
gggttcgtgc acacagccca gcttggagcg aacgacctac accgaactga 4980
gatacctaca gcgtgagcta tgagaaagcg ccacgcttcc cgaagggaga aaggcggaca
5040 ggtatccggt aagcggcagg gtcggaacag gagagcgcac gagggagctt
ccagggggaa 5100 acgcctggta tctttatagt cctgtcgggt ttcgccacct
ctgacttgag cgtcgatttt 5160 tgtgatgctc gtcagggggg cggagcctat
ggaaaaacgc cagcaacgcg gcctttttac 5220 ggttcctggc cttttgctgg
ccttttgctc acatgttctt tcctgcgtta tcccctgatt 5280 ctgtggataa
ccgtattacc gcctttgagt gagctgatac cgctcgccgc agccgaacga 5340
ccgagcgcag cgagtcagtg agcgaggaag cggaagagcg cctgatgcgg tattttctcc
5400 ttacgcatct gtgcggtatt tcacaccgca tatggtgcac tctcagtaca
atctgctctg 5460 atgccgcata gttaagccag tatacactcc gctatcgcta
cgtgactggg tcatggctgc 5520 gccccgacac ccgccaacac ccgctgacgc
gccctgacgg gcttgtctgc tcccggcatc 5580 cgcttacaga caagctgtga
ccgtctccgg gagctgcatg tgtcagaggt tttcaccgtc 5640 atcaccgaaa
cgcgcgaggc agcagatcaa ttcgcgcgcg aaggcgaagc ggcatgcatt 5700
tacgttgaca ccatcgaatg gtgcaaaacc tttcgcggta tggcatgata gcgcccggaa
5760 gagagtcaat tcagggtggt gaatgtgaaa ccagtaacgt tatacgatgt
cgcagagtat 5820 gccggtgtct cttatcagac cgtttcccgc gtggtgaacc
aggccagcca cgtttctgcg 5880 aaaacgcggg aaaaagtgga agcggcgatg
gcggagctga attacattcc caaccgcgtg 5940 gcacaacaac tggcgggcaa
acagtcgttg ctgattggcg ttgccacctc cagtctggcc 6000 ctgcacgcgc
cgtcgcaaat tgtcgcggcg attaaatctc gcgccgatca actgggtgcc 6060
agcgtggtgg tgtcgatggt agaacgaagc ggcgtcgaag cctgtaaagc ggcggtgcac
6120 aatcttctcg cgcaacgcgt cagtgggctg atcattaact atccgctgga
tgaccaggat 6180 gccattgctg tggaagctgc ctgcactaat gttccggcgt
tatttcttga tgtctctgac 6240 cagacaccca tcaacagtat tattttctcc
catgaagacg gtacgcgact gggcgtggag 6300 catctggtcg cattgggtca
ccagcaaatc gcgctgttag cgggcccatt aagttctgtc 6360 tcggcgcgtc
tgcgtctggc tggctggcat aaatatctca ctcgcaatca aattcagccg 6420
atagcggaac gggaaggcga ctggagtgcc atgtccggtt ttcaacaaac catgcaaatg
6480 ctgaatgagg gcatcgttcc cactgcgatg ctggttgcca acgatcagat
ggcgctgggc 6540 gcaatgcgcg ccattaccga gtccgggctg cgcgttggtg
cggatatctc ggtagtggga 6600 tacgacgata ccgaagacag ctcatgttat
atcccgccgt caaccaccat caaacaggat 6660 tttcgcctgc tggggcaaac
cagcgtggac cgcttgctgc aactctctca gggccaggcg 6720 gtgaagggca
atcagctgtt gcccgtctca ctggtgaaaa gaaaaaccac cctggcgccc 6780
aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat taatgcagct ggcacgacag
6840 gtttcccgac tggaaagcgg gcagtgagcg caacgcaatt aatgtgagtt
agcgcgaatt 6900 gatctg 6906 <210> SEQ ID NO 4 <211>
LENGTH: 3913 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 4 gcggccgcgc ccttgacgat
gccacatcct gagcaaataa ttcaaccact aattgtgagc 60 ggataacaca
aggaggaaac agccatggta tcctgttctg cgccgggtaa gatttacctg 120
ttcggtgaac acgccgtagt ttatggcgaa actgcaattg cgtgtgcggt ggaactgcgt
180 acccgtgttc gcgcggaact caatgactct atcactattc agagccagat
cggccgcacc 240 ggtctggatt tcgaaaagca cccttatgtg tctgcggtaa
ttgagaaaat gcgcaaatct 300 attcctatta acggtgtttt cttgaccgtc
gattccgaca tcccggtggg ctccggtctg 360 ggtagcagcg cagccgttac
tatcgcgtct attggtgcgc tgaacgagct gttcggcttt 420 ggcctcagcc
tgcaagaaat cgctaaactg ggccacgaaa tcgaaattaa agtacagggt 480
gccgcgtccc caaccgatac gtatgtttct accttcggcg gcgtggttac catcccggaa
540 cgtcgcaaac tgaaaactcc ggactgcggc attgtgattg gcgataccgg
cgttttctcc 600 tccaccaaag agttagtagc taacgtacgt cagctgcgcg
aaagctaccc ggatttgatc 660 gaaccgctga tgacctctat tggcaaaatc
tctcgtatcg gcgaacaact ggttctgtct 720 ggcgactacg catccatcgg
ccgcctgatg aacgtcaacc agggtctcct ggacgccctg 780 ggcgttaaca
tcttagaact gagccagctg atctattccg ctcgtgcggc aggtgcgttt 840
ggcgctaaaa tcacgggcgc tggcggcggt ggctgtatgg ttgcgctgac cgctccggaa
900 aaatgcaacc aagtggcaga agcggtagca ggcgctggcg gtaaagtgac
tatcactaaa 960 ccgaccgagc aaggtctgaa agtagattaa gccttgactt
aatagctgct tatttcgccc 1020 ttatggtacc tagtaggagg aaaaaaacat
ggaaatgcgt caaccggctg tcgcaggtca 1080 attctaccca ctgcgttgcg
agaacctgga aaacgaactg aaacgctgct tcgaaggcct 1140 ggagatccgc
gaacaagaag tgctgggcgc agtctgtccg cacgccggtt atatgtactc 1200
tggcaaagtt gcggcgcacg tctatgccac tctgccggaa gctgatacct acgtaatctt
1260 cggcccgaac cacaccggct acggtagccc tgtctctgtg agccgtgaaa
cttggaagac 1320 cccgttgggc aatatcgatg ttgacctgga actggcggac
ggcttcctgg gttccatcgt 1380 agatgcggat gaactcggtc acaaatacga
acactctatc gaagttcagc tgccgtttct 1440 gcaataccgt tttgaacgcg
atttcaaaat tctgccaatc tgcatgggta tgcaagacga 1500 agaaaccgcg
gtcgaagtag gtaacctgct ggcggatctg atcagcgagt ccggtaaacg 1560
tgctgtgatc atcgcaagct ctgatttcac ccactatgag acggctgaac gtgccaaaga
1620 aatcgattcc gaagttattg attctatcct gaactttgac atctctggca
tgtacgatcg 1680 cctgtatcgc cgtaacgcct ctgtttgcgg ttacggcccg
atcaccgcta tgctgacggc 1740 aagcaaaaag ctgggcggct ctcgtgcgac
tttgctgaaa tacgcaaaca gcggtgacgt 1800 gtccggtgat aaagacgctg
tggtgggcta cgccgccatc atcgttgagt aagctgatta 1860 aaggttgaac
agataggatt tcgtcatgga tcctacaagg aggaaaaaaa catgaatgct 1920
tctaatgaac cggtgattct gaaactgggt ggctctgcta ttaccgacaa aggtgcctac
1980 gaaggcgtag ttaaggaagc tgatttgctg cgcatcgcac aggaagttag
cggtttccgt 2040 ggcaagatga tcgtggttca tggtgctggt agcttcggcc
atacgtacgc gaagaaatac 2100 ggcctggacc gtaccttcga cccagagggc
gcaattgtta ctcatgaatc tgttaaaaag 2160 ctcgcctcca aagttgtagg
tgctctgaat agcttcggcg tgcgtgctat cgcggtgcat 2220 cctatggact
gcgcagtatg ccgtaacggt cgtatcgaaa cgatgtatct ggactccatc 2280
aagttaatgc tggaaaaagg tctggtgccg gttctgcacg gcgacgtcgc aatggatatt
2340 gaactgggca cttgtatcct gtccggtgat caaatcgttc cttacctggc
caaagaactg 2400 ggtatctccc gcctcggcct gggcagcgca gaggatggtg
tgctggatat ggagggcaaa 2460 cctgtaccgg aaatcacccc agaaactttc
gaagagttcc gccactgcat cggtggttct 2520 ggttctactg atgtaaccgg
tggcatgctg ggcaaagtgc tggaacttct ggaattgagc 2580 aaaaattctt
ccattactag ctacattttc aacgctggta aagcagacaa catctaccgc 2640
tttctgaatg gtgagtccat cggcactcgc atcagcccgg acaagcgtgt ttaagctagt
2700 tattaaccta aatgctctaa accagttatg agctctacaa ggaggaaaaa
aacatgatta 2760 acactaccag ccgccgcaaa attgaacacc tgaaactctg
cgcagaatcc ccggttgaag 2820 cgcgtcaggt atctgccggc tttgaagacg
ttactctgat ccaccgcgct ttaccggagc 2880 tgaacatgga tgaactggac
ctcagcgttg atttcctggg taaacgcatc aaagcgccgt 2940 tcctgattgc
gtctatcacg ggtggtcacc cagataccat cccggttaac gctgcgctgg 3000
cagctgctgc tgaggagctg ggtgttggca tcggcgttgg ctctcagcgc gcggccattg
3060 atgatccgag ccaggaagac agcttccgtg tagtgcgtga tgaagcccca
gatgcgtttg 3120 tttatggcaa cgtcggcgca gcacagatcc gtcagtatgg
tgttgaaggt gttgaaaaac 3180 tgatcgaaat gattgacgca gatgccttgg
caatccacct gaactttctg caagaagcgg 3240 tccaaccgga aggtgaccgc
gacgcgaccg gttgcctgga catgattacc gaaatttgct 3300 ctcagattaa
aactccggta atcgtgaaag aaaccggtgc aggcattagc cgtgaagatg 3360
cgattctgtt ccagaaagct ggcgtgagcg caatcgacgt tggcggcgcg ggcggcacct
3420 cctgggctgg cgtcgaggtc taccgtgcta aagaaagccg tgactctgtt
agcgagcgtt 3480 taggtgagct gttttgggat ttcggcattc cgacggtagc
ttctctgatt gaatcccgcg 3540 tttccttgcc gctgatcgca accggcggta
tccgtaacgg tctggacatt gctaaaagca 3600 ttgctctcgg cgcaagcgct
gccagcgccg ctctgccgtt cgttggtccg tccctggagg 3660 gcaaagaatc
cgttgtacgt gtgctgagct gcatgctgga agaatttaaa gcagcaatgt 3720
ttttgtgcgg ttgcggcaac atcaaagacc tgcacaactc tccagtagtg gtaactggtt
3780 ggacccgcga atacctggag cagcgcggtt ttaacgttaa ggacctctcc
ctgccgggca 3840 acgctctgta agcttcaacg cgtctacaaa taaaaaaggc
acgtcagatg acgtgccttt 3900 tttcttgtct aga 3913 <210> SEQ ID
NO 5 <211> LENGTH: 6647 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 5
aagggcgagc tcaacgatcc ggctgctaac aaagcccgaa aggaagctga gttggctgct
60 gccaccgctg agcaataact agcataaccc cttggggcct ctaaacgggt
cttgaggagt 120 tttttgctga aaggaggaac tatatccgga tatcccgcaa
gaggcccggc agtaccggca 180 taaccaagcc tatgcctaca gcatccaggg
tgacggtgcc gaggatgacg atgagcgcat 240 tgttagattt catacacggt
gcctgactgc gttagcaatt taactgtgat aaactaccgc 300 attaaagctt
atcgatgata agctgtcaaa catgagaatt aattcttgaa gacgaaaggg 360
cctcgtgata cgcctatttt tataggttaa tgtcatgata ataatggttt cttagacgtc
420 aggtggcact tttcggggaa atgtgcgcgg aacccctatt tgtttatttt
tctaaataca 480 ttcaaatatg tatccgctca tgagacaata accctgataa
atgcttcaat aatattgaaa 540 aaggaagagt atgattgaac aagatggatt
gcacgcaggt tctccggccg cttgggtgga 600 gaggctattc ggctatgact
gggcacaact gacaatcggc tgctctgatg ccgccgtgtt 660 ccggctgtca
gcgcaggggc gcccggttct ttttgtcaag accgacctgt ccggtgccct 720
gaatgaactg caggacgagg cagcgcggct atcgtggctg gccacgacgg gcgttccttg
780 cgcagctgtg ctcgacgttg tcactgaagc gggaagggac tggctgctat
tgggcgaagt 840 gccggggcag gatctcctgt catctcacct tgctcctgcc
gagaaagtat ccatcatggc 900 tgatgcaatg cggcggctgc atacgcttga
tccggctacc tgcccattcg accaccaagc 960 gaaacatcgc atcgagcggg
cacgtactcg gatggaagcc ggtcttgtcg atcaggatga 1020 tctggacgaa
gagcatcagg ggctcgcgcc agccgaactg ttcgccaggc tcaaggcgcg 1080
catgcccgac ggcgaggatc tcgtcgtgac acatggcgat gcctgcttgc cgaatatcat
1140 ggtggaaaat ggccgctttt ctggattcat cgactgtggc cggctgggtg
tggcggaccg 1200 ctatcaggac atagcgttgg ctacccgtga tattgctgaa
gagcttggcg gcgaatgggc 1260 tgaccgcttc ctcgtgcttt acggtatcgc
cgctcccgat tcgcagcgca tcgccttcta 1320 tcgccttctt gacgagttct
tctgagcggg actctggggt tcgaaatgac cgaccaagcg 1380 acgcctaact
gtcagaccaa gtttactcat atatacttta gattgattta aaacttcatt 1440
tttaatttaa aaggatctag gtgaagatcc tttttgataa tctcatgacc aaaatccctt
1500 aacgtgagtt ttcgttccac tgagcgtcag accccgtaga aaagatcaaa
ggatcttctt 1560 gagatccttt ttttctgcgc gtaatctgct gcttgcaaac
aaaaaaacca ccgctaccag 1620 cggtggtttg tttgccggat caagagctac
caactctttt tccgaaggta actggcttca 1680 gcagagcgca gataccaaat
actgtccttc tagtgtagcc gtagttaggc caccacttca 1740 agaactctgt
agcaccgcct acatacctcg ctctgctaat cctgttacca gtggctgctg 1800
ccagtggcga taagtcgtgt cttaccgggt tggactcaag acgatagtta ccggataagg
1860 cgcagcggtc gggctgaacg gggggttcgt gcacacagcc cagcttggag
cgaacgacct 1920 acaccgaact gagataccta cagcgtgagc tatgagaaag
cgccacgctt cccgaaggga 1980 gaaaggcgga caggtatccg gtaagcggca
gggtcggaac aggagagcgc acgagggagc 2040 ttccaggggg aaacgcctgg
tatctttata gtcctgtcgg gtttcgccac ctctgacttg 2100 agcgtcgatt
tttgtgatgc tcgtcagggg ggcggagcct atggaaaaac gccagcaacg 2160
cggccttttt acggttcctg gccttttgct ggccttttgc tcacatgttc tttcctgcgt
2220 tatcccctga ttctgtggat aaccgtatta ccgcctttga gtgagctgat
accgctcgcc 2280 gcagccgaac gaccgagcgc agcgagtcag tgagcgagga
agcggaagag cgcctgatgc 2340 ggtattttct ccttacgcat ctgtgcggta
tttcacaccg caatggtgca ctctcagtac 2400 aatctgctct gatgccgcat
agttaagcca gtatacactc cgctatcgct acgtgactgg 2460 gtcatggctg
cgccccgaca cccgccaaca cccgctgacg cgccctgacg ggcttgtctg 2520
ctcccggcat ccgcttacag acaagctgtg accgtctccg ggagctgcat gtgtcagagg
2580 ttttcaccgt catcaccgaa acgcgcgagg cagctgcggt aaagctcatc
agcgtggtcg 2640 tgaagcgatt cacagatgtc tgcctgttca tccgcgtcca
gctcgttgag tttctccaga 2700 agcgttaatg tctggcttct gataaagcgg
gccatgttaa gggcggtttt ttcctgtttg 2760 gtcactgatg cctccgtgta
agggggattt ctgttcatgg gggtaatgat accgatgaaa 2820 cgagagagga
tgctcacgat acgggttact gatgatgaac atgcccggtt actggaacgt 2880
tgtgagggta aacaactggc ggtatggatg cggcgggacc agagaaaaat cactcagggt
2940 caatgccagc gcttcgttaa tacagatgta ggtgttccac agggtagcca
gcagcatcct 3000 gcgatgcaga tccggaacat aatggtgcag ggcgctgact
tccgcgtttc cagactttac 3060 gaaacacgga aaccgaagac cattcatgtt
gttgctcagg tcgcagacgt tttgcagcag 3120 cagtcgcttc acgttcgctc
gcgtatcggt gattcattct gctaaccagt aaggcaaccc 3180 cgccagccta
gccgggtcct caacgacagg agcacgatca tgcgcacccg tggccaggac 3240
ccaacgctgc ccgagatgcg ccgcgtgcgg ctgctggaga tggcggacgc gatggatatg
3300 ttctgccaag ggttggtttg cgcattcaca gttctccgca agaattgatt
ggctccaatt 3360 cttggagtgg tgaatccgtt agcgaggtgc cgccggcttc
cattcaggtc gaggtggccc 3420 ggctccatgc accgcgacgc aacgcgggga
ggcagacaag gtatagggcg gcgcctacaa 3480 tccatgccaa cccgttccat
gtgctcgccg aggcggcata aatcgccgtg acgatcagcg 3540 gtccaatgat
cgaagttagg ctggtaagag ccgcgagcga tccttgaagc tgtccctgat 3600
ggtcgtcatc tacctgcctg gacagcatgg cctgcaacgc gggcatcccg atgccgccgg
3660 aagcgagaag aatcataatg gggaaggcca tccagcctcg cgtcgcgaac
gccagcaaga 3720 cgtagcccag cgcgtcggcc gccatgccgg cgataatggc
ctgcttctcg ccgaaacgtt 3780 tggtggcggg accagtgacg aaggcttgag
cgagggcgtg caagattccg aataccgcaa 3840 gcgacaggcc gatcatcgtc
gcgctccagc gaaagcggtc ctcgccgaaa atgacccaga 3900 gcgctgccgg
cacctgtcct acgagttgca tgataaagaa gacagtcata agtgcggcga 3960
cgatagtcat gccccgcgcc caccggaagg agctgactgg gttgaaggct ctcaagggca
4020 tcggtcgaga tcccggtgcc taatgagtga gctaacttac attaattgcg
ttgcgctcac 4080 tgcccgcttt ccagtcggga aacctgtcgt gccagctgca
ttaatgaatc ggccaacgcg 4140 cggggagagg cggtttgcgt attgggcgcc
agggtggttt ttcttttcac cagtgagacg 4200 ggcaacagct gattgccctt
caccgcctgg ccctgagaga gttgcagcaa gcggtccacg 4260 ctggtttgcc
ccagcaggcg aaaatcctgt ttgatggtgg ttaacggcgg gatataacat 4320
gagctgtctt cggtatcgtc gtatcccact accgagatat ccgcaccaac gcgcagcccg
4380 gactcggtaa tggcgcgcat tgcgcccagc gccatctgat cgttggcaac
cagcatcgca 4440 gtgggaacga tgccctcatt cagcatttgc atggtttgtt
gaaaaccgga catggcactc 4500 cagtcgcctt cccgttccgc tatcggctga
atttgattgc gagtgagata tttatgccag 4560 ccagccagac gcagacgcgc
cgagacagaa cttaatgggc ccgctaacag cgcgatttgc 4620 tggtgaccca
atgcgaccag atgctccacg cccagtcgcg taccgtcttc atgggagaaa 4680
ataatactgt tgatgggtgt ctggtcagag acatcaagaa ataacgccgg aacattagtg
4740 caggcagctt ccacagcaat ggcatcctgg tcatccagcg gatagttaat
gatcagccca 4800 ctgacgcgtt gcgcgagaag attgtgcacc gccgctttac
aggcttcgac gccgcttcgt 4860 tctaccatcg acaccaccac gctggcaccc
agttgatcgg cgcgagattt aatcgccgcg 4920 acaatttgcg acggcgcgtg
cagggccaga ctggaggtgg caacgccaat cagcaacgac 4980 tgtttgcccg
ccagttgttg tgccacgcgg ttgggaatgt aattcagctc cgccatcgcc 5040
gcttccactt tttcccgcgt tttcgcagaa acgtggctgg cctggttcac cacgcgggaa
5100 acggtctgat aagagacacc ggcatactct gcgacatcgt ataacgttac
tggtttcaca 5160 ttcaccaccc tgaattgact ctcttccggg cgctatcatg
ccataccgcg aaaggttttg 5220 cgccattcga tggtgtccgg gatctcgacg
ctctccctta tgcgactcct gcattaggaa 5280 gcagcccagt agtaggttga
ggccgttgag caccgccgcc gcaaggaatg gtgcatgcaa 5340 ggagatggcg
cccaacagtc ccccggccac ggggcctgcc accataccca cgccgaaaca 5400
agcgctcatg agcccgaagt ggcgagcccg atcttcccca tcggtgatgt cggcgatata
5460 ggcgccagca accgcacctg tggcgccggt gatgccggcc acgatgcgtc
cggcgtagag 5520 gatcgagatc tcgatcccgc gaaattaata cgactcacta
taggggaatt gtgagcggat 5580 aacaattccc ctctagaaat aattttgttt
aactttaaga aggagatata catatgcggg 5640 gttctcatca tcatcatcat
catggtatgg ctagcatgac tggtggacag caaatgggtc 5700 gggatctgta
cgacgatgac gataaggatc atcccttcac catggtatcc tgttctgcgc 5760
cgggtaagat ttacctgttc ggtgaacacg ccgtagttta tggcgaaact gcaattgcgt
5820 gtgcggtgga actgcgtacc cgtgttcgcg cggaactcaa tgactctatc
actattcaga 5880 gccagatcgg ccgcaccggt ctggatttcg aaaagcaccc
ttatgtgtct gcggtaattg 5940 agaaaatgcg caaatctatt cctattaacg
gtgttttctt gaccgtcgat tccgacatcc 6000 cggtgggctc cggtctgggt
agcagcgcag ccgttactat cgcgtctatt ggtgcgctga 6060 acgagctgtt
cggctttggc ctcagcctgc aagaaatcgc taaactgggc cacgaaatcg 6120
aaattaaagt acagggtgcc gcgtccccaa ccgatacgta tgtttctacc ttcggcggcg
6180 tggttaccat cccggaacgt cgcaaactga aaactccgga ctgcggcatt
gtgattggcg 6240 ataccggcgt tttctcctcc accaaagagt tagtagctaa
cgtacgtcag ctgcgcgaaa 6300 gctacccgga tttgatcgaa ccgctgatga
cctctattgg caaaatctct cgtatcggcg 6360 aacaactggt tctgtctggc
gactacgcat ccatcggccg cctgatgaac gtcaaccagg 6420 gtctcctgga
cgccctgggc gttaacatct tagaactgag ccagctgatc tattccgctc 6480
gtgcggcagg tgcgtttggc gctaaaatca cgggcgctgg cggcggtggc tgtatggttg
6540 cgctgaccgc tccggaaaaa tgcaaccaag tggcagaagc ggtagcaggc
gctggcggta 6600 aagtgactat cactaaaccg accgagcaag gtctgaaagt agattaa
6647 <210> SEQ ID NO 6 <211> LENGTH: 7519 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 6 ctcgggccgt ctcttgggct tgatcggcct tcttgcgcat
ctcacgcgct cctgcggcgg 60 cctgtagggc aggctcatac ccctgccgaa
ccgcttttgt cagccggtcg gccacggctt 120 ccggcgtctc aacgcgcttt
gagattccca gcttttcggc caatccctgc ggtgcatagg 180 cgcgtggctc
gaccgcttgc gggctgatgg tgacgtggcc cactggtggc cgctccaggg 240
cctcgtagaa cgcctgaatg cgcgtgtgac gtgccttgct gccctcgatg ccccgttgca
300 gccctagatc ggccacagcg gccgcaaacg tggtctggtc gcgggtcatc
tgcgctttgt 360 tgccgatgaa ctccttggcc gacagcctgc cgtcctgcgt
cagcggcacc acgaacgcgg 420 tcatgtgcgg gctggtttcg tcacggtgga
tgctggccgt cacgatgcga tccgccccgt 480 acttgtccgc cagccacttg
tgcgccttct cgaagaacgc cgcctgctgt tcttggctgg 540 ccgacttcca
ccattccggg ctggccgtca tgacgtactc gaccgccaac acagcgtcct 600
tgcgccgctt ctctggcagc aactcgcgca gtcggcccat cgcttcatcg gtgctgctgg
660 ccgcccagtg ctcgttctct ggcgtcctgc tggcgtcagc gttgggcgtc
tcgcgctcgc 720 ggtaggcgtg cttgagactg gccgccacgt tgcccatttt
cgccagcttc ttgcatcgca 780 tgatcgcgta tgccgccatg cctgcccctc
ccttttggtg tccaaccggc tcgacggggg 840 cagcgcaagg cggtgcctcc
ggcgggccac tcaatgcttg agtatactca ctagactttg 900 cttcgcaaag
tcgtgaccgc ctacggcggc tgcggcgccc tacgggcttg ctctccgggc 960
ttcgccctgc gcggtcgctg cgctcccttg ccagcccgtg gatatgtgga cgatggccgc
1020 gagcggccac cggctggctc gcttcgctcg gcccgtggac aaccctgctg
gacaagctga 1080 tggacaggct gcgcctgccc acgagcttga ccacagggat
tgcccaccgg ctacccagcc 1140 ttcgaccaca tacccaccgg ctccaactgc
gcggcctgcg gccttgcccc atcaattttt 1200 ttaattttct ctggggaaaa
gcctccggcc tgcggcctgc gcgcttcgct tgccggttgg 1260 acaccaagtg
gaaggcgggt caaggctcgc gcagcgaccg cgcagcggct tggccttgac 1320
gcgcctggaa cgacccaagc ctatgcgagt gggggcagtc gaaggcgaag cccgcccgcc
1380 tgccccccga gcctcacggc ggcgagtgcg ggggttccaa gggggcagcg
ccaccttggg 1440 caaggccgaa ggccgcgcag tcgatcaaca agccccggag
gggccacttt ttgccggagg 1500 gggagccgcg ccgaaggcgt gggggaaccc
cgcaggggtg cccttctttg ggcaccaaag 1560 aactagatat agggcgaaat
gcgaaagact taaaaatcaa caacttaaaa aaggggggta 1620 cgcaacagct
cattgcggca ccccccgcaa tagctcattg cgtaggttaa agaaaatctg 1680
taattgactg ccacttttac gcaacgcata attgttgtcg cgctgccgaa aagttgcagc
1740 tgattgcgca tggtgccgca accgtgcggc accctaccgc atggagataa
gcatggccac 1800 gcagtccaga gaaatcggca ttcaagccaa gaacaagccc
ggtcactggg tgcaaacgga 1860 acgcaaagcg catgaggcgt gggccgggct
tattgcgagg aaacccacgg cggcaatgct 1920 gctgcatcac ctcgtggcgc
agatgggcca ccagaacgcc gtggtggtca gccagaagac 1980 actttccaag
ctcatcggac gttctttgcg gacggtccaa tacgcagtca aggacttggt 2040
ggccgagcgc tggatctccg tcgtgaagct caacggcccc ggcaccgtgt cggcctacgt
2100 ggtcaatgac cgcgtggcgt ggggccagcc ccgcgaccag ttgcgcctgt
cggtgttcag 2160 tgccgccgtg gtggttgatc acgacgacca ggacgaatcg
ctgttggggc atggcgacct 2220 gcgccgcatc ccgaccctgt atccgggcga
gcagcaacta ccgaccggcc ccggcgagga 2280 gccgcccagc cagcccggca
ttccgggcat ggaaccagac ctgccagcct tgaccgaaac 2340 ggaggaatgg
gaacggcgcg ggcagcagcg cctgccgatg cccgatgagc cgtgttttct 2400
ggacgatggc gagccgttgg agccgccgac acgggtcacg ctgccgcgcc ggtagcactt
2460 gggttgcgca gcaacccgta agtgcgctgt tccagactat cggctgtagc
cgcctcgccg 2520 ccctatacct tgtctgcctc cccgcgttgc gtcgcggtgc
atggagccgg gccacctcga 2580 cctgaatgga agccggcggc acctcgctaa
cggattcacc gtttttatca ggctctggga 2640 ggcagaataa atgatcatat
cgtcaattat tacctccacg gggagagcct gagcaaactg 2700 gcctcaggca
tttgagaagc acacggtcac actgcttccg gtagtcaata aaccggtaaa 2760
ccagcaatag acataagcgg ctatttaacg accctgccct gaaccgacga ccgggtcgaa
2820 tttgctttcg aatttctgcc attcatccgc ttattatcac ttattcaggc
gtagcaccag 2880 gcgtttaagg gcaccaataa ctgccttaaa aaaattacgc
cccgccctgc cactcatcgc 2940 agtcggccta ttggttaaaa aatgagctga
tttaacaaaa atttaacgcg aattttaaca 3000 aaatattaac gcttacaatt
tccattcgcc attcaggctg cgcaactgtt gggaagggcg 3060 atcggtgcgg
gcctcttcgc tattacgcca gctggcgaaa gggggatgtg ctgcaaggcg 3120
attaagttgg gtaacgccag ggttttccca gtcacgacgt tgtaaaacga cggccagtga
3180 gcgcgcgtaa tacgactcac tatagggcga attggagctc caccgcggtg
gcggccgctc 3240 tagaactagt ggatcccccg ggctgcatgc tcgagcggcc
gccagtgtga tggatatctg 3300 cagaattcgc ccttcttgat atcttagtgt
gcgttaacca ccacccacat tggtccctgc 3360 ccgaccgcat agcggccttt
ttcatgcagt agcccctgct cgccaacaat ttcgtatacc 3420 gagatgtggt
gagatttttg cccggcggca atcagatact tgccgctgtg atcaacattg 3480
aagccgcgcg gctgggtttc cgttggctgg aagccttctt tactcaacac gctgccatct
3540 tccgaaacgc tgaaaacggt aatcaggctg gcggtacggt cgcaggcgta
taaatggcga 3600 ccatccgggg tgatatgaat atcagccgcc caacgggtgt
cggagaagtt ttccggcatc 3660 atatccagcg tctggacaca ttcgatatta
ccgtgcggat ctttcagttc ccagacatcc 3720 actgagctgt ttaactcatt
gacgcaatac gcatattgtt cgtttggatg gaataccata 3780 tgacgcgggc
cggccccttc aacggtggtc acttccgcag ggtcctgcgc cacgagatga 3840
ccatcatcgc tgaccgtaaa caggcaaatg cgatcctgct ttaatgccgg aacccacagc
3900 gtacggttgt ccggtgagat attggcggaa tggcaaccgt ccagcccctc
gaccacatcg 3960 acgacgccca ctggcaggcc atcttccaga cgcgttacgc
tcacgttacc cgcattgtaa 4020 gaacctacaa agacaaactg cccctggtga
tcggtggaaa tatgcgtcgg actacccggc 4080 agcgcagact ctgcggcaaa
ggtcagtgcg ccatcgtccg gggcgatacg atacgccagg 4140 acgcgaaact
cagggcgaac accaacatag agataacgtt tgtccgggct gaccaccatc 4200
ggctgcacct gccccggcac atcgacaacc tgtgtcagcg tcagtgcgcc ttcatgattc
4260 agattccaga cgtgaatttg ctggctctca gggctggcga tataaactgt
ttgcttcatg 4320 aatgctcctt tgggttacct ccgggaaacg cggttgattt
gtttagtggt tgaattattt 4380 gctcaggatg tggcatagtc aagggcgtga
cggctcgcta atacaactca ctatagggct 4440 cgaggaagtt cctatacttt
ctagagaata ggaacttccg cgccgcacac aaaaaccaac 4500 acacagatca
tgaaaataaa gctcttttat tggtaccgaa ttcgccaggg agctctcaga 4560
cgtcgcttgg tcggtcttta ttcgaacccc agagtcccgc ttacgccccg ccctgccact
4620 catcgcagta ctgttgtaat tcattaagca ttctgccgac atggaagcca
tcacaaacgg 4680 catgatgaac ctgaatcgcc agcggcatca gcaccttgtc
gccttgcgta taatatttgc 4740 ccatggtgaa aacgggggcg aagaagttgt
ccatattggc cacgtttaaa tcaaaactgg 4800 tgaaactcac ccagggattg
gctgagacga aaaacatatt ctcaataaac cctttaggga 4860 aataggccag
gttttcaccg taacacgcca catcttgcga atatatgtgt agaaactgcc 4920
ggaaatcgtc gtggtattca ctccagagcg atgaaaacgt ttcagtttgc tcatggaaaa
4980 cggtgtaaca agggtgaaca ctatcccata tcaccagctc accgtctttc
attgccatac 5040 ggaattccgg atgagcattc atcaggcggg caagaatgtg
aataaaggcc ggataaaact 5100 tgtgcttatt tttctttacg gtctttaaaa
aggccgtaat atccagctga acggtctggt 5160 tataggtaca ttgagcaact
gactgaaatg cctcaaaatg ttctttacga tgccattggg 5220 atatatcaac
ggtggtatat ccagtgattt ttttctccat ggtttagttc ctcaccttgt 5280
cgtattatac tatgccgata tactatgccg atgattaatt gtcaacacgt gctgctgcag
5340 gtcgaaaggc ccggagatga ggaagaggag aacagcgcgg cagacgtgcg
cttttgaagc 5400 gtgcagaatg ccgggcctcc ggaggacctt cgggcgcccg
ccccgcccct gagcccgccc 5460 ctgagcccgc ccccggaccc accccttccc
agcctctgag cccagaaagc gaaggagcaa 5520 agctgctatt ggccgctgcc
ccaaaggcct acccgcttcc attgctcagc ggtgctgtcc 5580 atctgcacga
gactagtgag acgtgctact tccatttgtc acgtcctgca cgacgcgagc 5640
tgcggggcgg gggggaactt cctgactagg ggaggagtgg aaggtggcgc gaaggggcca
5700 ccaaagaacg gagccggttg gcgcctaccg gtggatgtgg aatgtgtgcg
aggccagagg 5760 ccacttgtgt agcgccaagt gcccagcggg gctgctaaag
cgcatgctcc agactgcctt 5820 gggaaaagcg cctcccctac ccggtagaat
gaagttccta tactttctag agaataggaa 5880 cttcgcggcc gccctttagt
gagggttaat tcaactgact gtaacagcta aaattagtcg 5940 cttttggcgg
taagggcgaa ttccagcaca ctggcggccg ttactagtgg atccgagctc 6000
ggtaccaagc ttgatgcagg aattcgatat caagcttatc gataccgtcg acctcgaggg
6060 ggggcccggt acccagcttt tgttcccttt agtgagggtt aattgcgcgc
ttggcgtaat 6120 catggtcata gctgtttcct gtgtgaaatt gttatccgct
cacaattcca cacaacatac 6180 gagccggaag cataaagtgt aaagcctggg
gtgcctaatg agtgagctaa ctcacattaa 6240 ttgcgttgcg ctcactgccc
gctttccagt cgggaaacct gtcgtgccag ctgcattaat 6300 gaatcggcca
acgcgcgggg agaggcggtt tgcgtattgg gcgcatgcat aaaaactgtt 6360
gtaattcatt aagcattctg ccgacatgga agccatcaca aacggcatga tgaacctgaa
6420 tcgccagcgg catcagcacc ttgtcgcctt gcgtataata tttgcccatg
gacgcacacc 6480 gtggaaacgg atgaaggcac gaacccagtt gacataagcc
tgttcggttc gtaaactgta 6540 atgcaagtag cgtatgcgct cacgcaactg
gtccagaacc ttgaccgaac gcagcggtgg 6600 taacggcgca gtggcggttt
tcatggcttg ttatgactgt ttttttgtac agtctatgcc 6660 tcgggcatcc
aagcagcaag cgcgttacgc cgtgggtcga tgtttgatgt tatggagcag 6720
caacgatgtt acgcagcagc aacgatgtta cgcagcaggg cagtcgccct aaaacaaagt
6780 taggtggctc aagtatgggc atcattcgca catgtaggct cggccctgac
caagtcaaat 6840 ccatgcgggc tgctcttgat cttttcggtc gtgagttcgg
agacgtagcc acctactccc 6900 aacatcagcc ggactccgat tacctcggga
acttgctccg tagtaagaca ttcatcgcgc 6960 ttgctgcctt cgaccaagaa
gcggttgttg gcgctctcgc ggcttacgtt ctgcccaggt 7020 ttgagcagcc
gcgtagtgag atctatatct atgatctcgc agtctccggc gagcaccgga 7080
ggcagggcat tgccaccgcg ctcatcaatc tcctcaagca tgaggccaac gcgcttggtg
7140 cttatgtgat ctacgtgcaa gcagattacg gtgacgatcc cgcagtggct
ctctatacaa 7200 agttgggcat acgggaagaa gtgatgcact ttgatatcga
cccaagtacc gccacctaac 7260 aattcgttca agccgagatc ggcttcccgg
ccgcggagtt gttcggtaaa ttgtcacaac 7320 gccgccaggt ggcacttttc
ggggaaatgt gcgcgcccgc gttcctgctg gcgctgggcc 7380 tgtttctggc
gctggacttc ccgctgttcc gtcagcagct tttcgcccac ggccttgatg 7440
atcgcggcgg ccttggcctg catatcccga ttcaacggcc ccagggcgtc cagaacgggc
7500 ttcaggcgct cccgaaggt 7519 <210> SEQ ID NO 7 <211>
LENGTH: 6858 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 7 gtttgacagc ttatcatcga
ctgcacggtg caccaatgct tctggcgtca ggcagccatc 60 ggaagctgtg
gtatggctgt gcaggtcgta aatcactgca taattcgtgt cgctcaaggc 120
gcactcccgt tctggataat gttttttgcg ccgacatcat aacggttctg gcaaatattc
180 tgaaatgagc tgttgacaat taatcatccg gctcgtataa tgtgtggaat
tgtgagcgga 240 taacaatttc acacaggaaa cagcgccgct gagaaaaagc
gaagcggcac tgctctttaa 300 caatttatca gacaatctgt gtgggcactc
gaccggaatt atcgattaac tttattatta 360 aaaattaaag aggtatatat
taatgtatcg attaaataag gaggaataaa ccatggaagc 420 tcgtcgttct
gcgaactacg aacctaacag ctgggactat gattacctgc tgtcctccga 480
cacggacgag tccatcgaag tatacaaaga caaagcgaaa aagctggaag ccgaagttcg
540 tcgcgagatt aataacgaaa aagcagaatt tctgaccctg ctggaactga
ttgacaacgt 600 ccagcgcctg ggcctgggtt accgtttcga gtctgatatc
cgtggtgcgc tggatcgctt 660 cgtttcctcc ggcggcttcg atgcggtaac
caagacttcc ctgcacggta cggcactgtc 720 tttccgtctg ctgcgtcaac
acggttttga ggtttctcag gaagcgttca gcggcttcaa 780 agaccaaaac
ggcaacttcc tggagaacct gaaggaagat atcaaagcta tcctgagcct 840
gtacgaggcc agcttcctgg ctctggaagg cgaaaacatc ctggacgagg cgaaggtttt
900 cgcaatctct catctgaaag aactgtctga agaaaagatc ggtaaagagc
tggcagaaca 960 ggtgaaccat gcactggaac tgccactgca tcgccgtact
cagcgtctgg aagcagtatg 1020 gtctatcgag gcctaccgta aaaaggagga
cgcgaatcag gttctgctgg agctggcaat 1080 tctggattac aacatgatcc
agtctgtata ccagcgtgat ctgcgtgaaa cgtcccgttg 1140 gtggcgtcgt
gtgggtctgg cgaccaaact gcactttgct cgtgaccgcc tgattgagag 1200
cttctactgg gccgtgggtg tagcattcga accgcaatac tccgactgcc gtaactccgt
1260 cgcaaaaatg ttttctttcg taaccattat cgacgatatc tacgatgtat
acggcaccct 1320 ggacgaactg gagctgttta ctgatgcagt tgagcgttgg
gacgtaaacg ccatcaacga 1380 cctgccggat tacatgaaac tgtgctttct
ggctctgtat aacactatta acgaaatcgc 1440 ctacgacaac ctgaaagata
aaggtgagaa catcctgccg tatctgacca aagcctgggc 1500 tgacctgtgc
aacgctttcc tgcaagaagc caagtggctg tacaacaaat ctactccgac 1560
ctttgacgac tacttcggca acgcatggaa atcctcttct ggcccgctgc aactggtgtt
1620 cgcttacttc gctgtcgtgc agaacattaa aaaggaagag atcgaaaacc
tgcaaaaata 1680 ccatgacacc atctctcgtc cttcccatat cttccgtctg
tgcaatgacc tggctagcgc 1740 gtctgcggaa attgcgcgtg gtgaaaccgc
aaatagcgtt tcttgttaca tgcgcactaa 1800 aggtatctcc gaagaactgg
ctaccgaaag cgtgatgaat ctgatcgatg aaacctggaa 1860 aaagatgaac
aaggaaaaac tgggtggtag cctgttcgcg aaaccgttcg tggaaaccgc 1920
gatcaacctg gcacgtcaat ctcactgcac ttatcataac ggcgacgcgc atacctctcc
1980 ggatgagctg acccgcaaac gcgttctgtc tgtaatcact gaaccgattc
tgccgtttga 2040 acgctaactg cataaaggag gtaaaaaaac atggtatcct
gttctgcgcc gggtaagatt 2100 tacctgttcg gtgaacacgc cgtagtttat
ggcgaaactg caattgcgtg tgcggtggaa 2160 ctgcgtaccc gtgttcgcgc
ggaactcaat gactctatca ctattcagag ccagatcggc 2220 cgcaccggtc
tggatttcga aaagcaccct tatgtgtctg cggtaattga gaaaatgcgc 2280
aaatctattc ctattaacgg tgttttcttg accgtcgatt ccgacatccc ggtgggctcc
2340 ggtctgggta gcagcgcagc cgttactatc gcgtctattg gtgcgctgaa
cgagctgttc 2400 ggctttggcc tcagcctgca agaaatcgct aaactgggcc
acgaaatcga aattaaagta 2460 cagggtgccg cgtccccaac cgatacgtat
gtttctacct tcggcggcgt ggttaccatc 2520 ccggaacgtc gcaaactgaa
aactccggac tgcggcattg tgattggcga taccggcgtt 2580 ttctcctcca
ccaaagagtt agtagctaac gtacgtcagc tgcgcgaaag ctacccggat 2640
ttgatcgaac cgctgatgac ctctattggc aaaatctctc gtatcggcga acaactggtt
2700 ctgtctggcg actacgcatc catcggccgc ctgatgaacg tcaaccaggg
tctcctggac 2760 gccctgggcg ttaacatctt agaactgagc cagctgatct
attccgctcg tgcggcaggt 2820 gcgtttggcg ctaaaatcac gggcgctggc
ggcggtggct gtatggttgc gctgaccgct 2880 ccggaaaaat gcaaccaagt
ggcagaagcg gtagcaggcg ctggcggtaa agtgactatc 2940 actaaaccga
ccgagcaagg tctgaaagta gattaaagtc tagttaaagt ttaaacggtc 3000
tccagcttgg ctgttttggc ggatgagaga agattttcag cctgatacag attaaatcag
3060 aacgcagaag cggtctgata aaacagaatt tgcctggcgg cagtagcgcg
gtggtcccac 3120 ctgaccccat gccgaactca gaagtgaaac gccgtagcgc
cgatggtagt gtggggtctc 3180 cccatgcgag agtagggaac tgccaggcat
caaataaaac gaaaggctca gtcgaaagac 3240 tgggcctttc gttttatctg
ttgtttgtcg gtgaacgctc tcctgagtag gacaaatccg 3300 ccgggagcgg
atttgaacgt tgcgaagcaa cggcccggag ggtggcgggc aggacgcccg 3360
ccataaactg ccaggcatca aattaagcag aaggccatcc tgacggatgg cctttttgcg
3420 tttctacaaa ctctttttgt ttatttttct aaatacattc aaatatgtat
ccgctcatga 3480 gacaataacc ctgataaatg cttcaataat attgaaaaag
gaagagtatg agtattcaac 3540 atttccgtgt cgcccttatt cccttttttg
cggcattttg ccttcctgtt tttgctcacc 3600 cagaaacgct ggtgaaagta
aaagatgctg aagatcagtt gggtgcacga gtgggttaca 3660 tcgaactgga
tctcaacagc ggtaagatcc ttgagagttt tcgccccgaa gaacgttttc 3720
caatgatgag cacttttaaa gttctgctat gtggcgcggt attatcccgt gttgacgccg
3780 ggcaagagca actcggtcgc cgcatacact attctcagaa tgacttggtt
gagtactcac 3840 cagtcacaga aaagcatctt acggatggca tgacagtaag
agaattatgc agtgctgcca 3900 taaccatgag tgataacact gcggccaact
tacttctgac aacgatcgga ggaccgaagg 3960 agctaaccgc ttttttgcac
aacatggggg atcatgtaac tcgccttgat cgttgggaac 4020 cggagctgaa
tgaagccata ccaaacgacg agcgtgacac cacgatgcct gtagcaatgg 4080
caacaacgtt gcgcaaacta ttaactggcg aactacttac tctagcttcc cggcaacaat
4140 taatagactg gatggaggcg gataaagttg caggaccact tctgcgctcg
gcccttccgg 4200 ctggctggtt tattgctgat aaatctggag ccggtgagcg
tgggtctcgc ggtatcattg 4260 cagcactggg gccagatggt aagccctccc
gtatcgtagt tatctacacg acggggagtc 4320 aggcaactat ggatgaacga
aatagacaga tcgctgagat aggtgcctca ctgattaagc 4380 attggtaact
gtcagaccaa gtttactcat atatacttta gattgattta aaacttcatt 4440
tttaatttaa aaggatctag gtgaagatcc tttttgataa tctcatgacc aaaatccctt
4500 aacgtgagtt ttcgttccac tgagcgtcag accccgtaga aaagatcaaa
ggatcttctt 4560 gagatccttt ttttctgcgc gtaatctgct gcttgcaaac
aaaaaaacca ccgctaccag 4620 cggtggtttg tttgccggat caagagctac
caactctttt tccgaaggta actggcttca 4680 gcagagcgca gataccaaat
actgtccttc tagtgtagcc gtagttaggc caccacttca 4740 agaactctgt
agcaccgcct acatacctcg ctctgctaat cctgttacca gtggctgctg 4800
ccagtggcga taagtcgtgt cttaccgggt tggactcaag acgatagtta ccggataagg
4860 cgcagcggtc gggctgaacg gggggttcgt gcacacagcc cagcttggag
cgaacgacct 4920 acaccgaact gagataccta cagcgtgagc tatgagaaag
cgccacgctt cccgaaggga 4980 gaaaggcgga caggtatccg gtaagcggca
gggtcggaac aggagagcgc acgagggagc 5040 ttccaggggg aaacgcctgg
tatctttata gtcctgtcgg gtttcgccac ctctgacttg 5100 agcgtcgatt
tttgtgatgc tcgtcagggg ggcggagcct atggaaaaac gccagcaacg 5160
cggccttttt acggttcctg gccttttgct ggccttttgc tcacatgttc tttcctgcgt
5220 tatcccctga ttctgtggat aaccgtatta ccgcctttga gtgagctgat
accgctcgcc 5280 gcagccgaac gaccgagcgc agcgagtcag tgagcgagga
agcggaagag cgcctgatgc 5340 ggtattttct ccttacgcat ctgtgcggta
tttcacaccg catatggtgc actctcagta 5400 caatctgctc tgatgccgca
tagttaagcc agtatacact ccgctatcgc tacgtgactg 5460 ggtcatggct
gcgccccgac acccgccaac acccgctgac gcgccctgac gggcttgtct 5520
gctcccggca tccgcttaca gacaagctgt gaccgtctcc gggagctgca tgtgtcagag
5580 gttttcaccg tcatcaccga aacgcgcgag gcagcagatc aattcgcgcg
cgaaggcgaa 5640 gcggcatgca tttacgttga caccatcgaa tggtgcaaaa
cctttcgcgg tatggcatga 5700 tagcgcccgg aagagagtca attcagggtg
gtgaatgtga aaccagtaac gttatacgat 5760 gtcgcagagt atgccggtgt
ctcttatcag accgtttccc gcgtggtgaa ccaggccagc 5820 cacgtttctg
cgaaaacgcg ggaaaaagtg gaagcggcga tggcggagct gaattacatt 5880
cccaaccgcg tggcacaaca actggcgggc aaacagtcgt tgctgattgg cgttgccacc
5940 tccagtctgg ccctgcacgc gccgtcgcaa attgtcgcgg cgattaaatc
tcgcgccgat 6000 caactgggtg ccagcgtggt ggtgtcgatg gtagaacgaa
gcggcgtcga agcctgtaaa 6060 gcggcggtgc acaatcttct cgcgcaacgc
gtcagtgggc tgatcattaa ctatccgctg 6120 gatgaccagg atgccattgc
tgtggaagct gcctgcacta atgttccggc gttatttctt 6180 gatgtctctg
accagacacc catcaacagt attattttct cccatgaaga cggtacgcga 6240
ctgggcgtgg agcatctggt cgcattgggt caccagcaaa tcgcgctgtt agcgggccca
6300 ttaagttctg tctcggcgcg tctgcgtctg gctggctggc ataaatatct
cactcgcaat 6360 caaattcagc cgatagcgga acgggaaggc gactggagtg
ccatgtccgg ttttcaacaa 6420 accatgcaaa tgctgaatga gggcatcgtt
cccactgcga tgctggttgc caacgatcag 6480 atggcgctgg gcgcaatgcg
cgccattacc gagtccgggc tgcgcgttgg tgcggatatc 6540 tcggtagtgg
gatacgacga taccgaagac agctcatgtt atatcccgcc gtcaaccacc 6600
atcaaacagg attttcgcct gctggggcaa accagcgtgg accgcttgct gcaactctct
6660 cagggccagg cggtgaaggg caatcagctg ttgcccgtct cactggtgaa
aagaaaaacc 6720 accctggcgc ccaatacgca aaccgcctct ccccgcgcgt
tggccgattc attaatgcag 6780 ctggcacgac aggtttcccg actggaaagc
gggcagtgag cgcaacgcaa ttaatgtgag 6840 ttagcgcgaa ttgatctg 6858
<210> SEQ ID NO 8 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 8 gacgctttcg ccaagtcagg 20 <210> SEQ ID NO 9
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 9 gtcaggctgg
aatactcttc g 21 <210> SEQ ID NO 10 <211> LENGTH: 19
<212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 10 accaattgca cccggcaga 19
<210> SEQ ID NO 11 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 11 gctaaagcgc atgctccaga c 21 <210> SEQ ID NO 12
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 12
gactggcctc agatgaaagc 20 <210> SEQ ID NO 13 <211>
LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 13 caaacatgtg gcatggaaag
20 <210> SEQ ID NO 14 <211> LENGTH: 52 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 14 gggcccgttt aaactttaac tagactctgc
agttagcgtt caaacggcag aa 52 <210> SEQ ID NO 15 <211>
LENGTH: 38 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 15 cgcatgcatg tcatgagatg
tagcgtgtcc accgaaaa 38 <210> SEQ ID NO 16 <211> LENGTH:
22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 16 acaatttcac acaggaaaca gc 22
<210> SEQ ID NO 17 <211> LENGTH: 23 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 17 ccaggcaaat tctgttttat cag 23 <210> SEQ ID NO 18
<211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 18
gcactgtctt tccgtctgct gc 22 <210> SEQ ID NO 19 <211>
LENGTH: 66 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 19 gcgaacgatg cataaaggag
gtaaaaaaac atggtatcct gttctgcgcc gggtaagatt 60 tacctg 66
<210> SEQ ID NO 20 <211> LENGTH: 48 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 20 gggcccgttt aaactttaac tagactttaa tctactttca gaccttgc
48 <210> SEQ ID NO 21 <211> LENGTH: 24 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 21 gatagtaacg gctgcgctgc tacc 24 <210>
SEQ ID NO 22 <211> LENGTH: 23 <212> TYPE: DNA
<213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 22 gacagcttat catcgactgc acg 23 <210> SEQ ID NO 23
<211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 23
caccatggta tcctgttctg cg 22 <210> SEQ ID NO 24 <211>
LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 24 ttaatctact ttcagacctt
gc 22 <210> SEQ ID NO 25 <211> LENGTH: 67 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 25 accgccaaaa gcgactaatt ttagctgtta
cagtcagttg aattaaccct cactaaaggg 60 cggccgc 67 <210> SEQ ID
NO 26 <211> LENGTH: 152 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 26
gctggcgata taaactgttt gcttcatgaa tgctcctttg ggttacctcc gggaaacgcg
60 gttgatttgt ttagtggttg aattatttgc tcaggatgtg gcatagtcaa
gggcgtgacg 120 gctcgctaat acgactcact atagggctcg ag 152 <210>
SEQ ID NO 27 <211> LENGTH: 26 <212> TYPE: DNA
<213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 27 accgccaaaa gcgactaatt ttagct 26 <210> SEQ ID NO
28 <211> LENGTH: 30 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 28
cttgatatct tagtgtgcgt taaccaccac 30 <210> SEQ ID NO 29
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 29
cgtgaatttg ctggctctca g 21 <210> SEQ ID NO 30 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 30 ggtttagttc ctcaccttgt
c 21 <210> SEQ ID NO 31 <211> LENGTH: 21 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 31 actgaaacgt tttcatcgct c 21 <210> SEQ
ID NO 32 <211> LENGTH: 81 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 32
aaagtagccg aagatgacgg tttgtcacat ggagttggca ggatgtttga ttaaaagcaa
60 ttaaccctca ctaaagggcg g 81 <210> SEQ ID NO 33 <211>
LENGTH: 199 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <220> FEATURE: <221> NAME/KEY:
misc_feature <222> LOCATION: 112 <223> OTHER
INFORMATION: n = A,T,C or G <400> SEQUENCE: 33 taaatcttac
ccggcgcaga acaggatacc atgttttttt acctcctttg caccttcatg 60
gtggtcagtg cgtcctgctg atgtgctcag tatcaccgcc agtggtattt angtcaacac
120 cgccagagat aatttatcac cgcagatggt tatctgtatg ttttttatat
gaatttaata 180 cgactcacta tagggctcg 199 <210> SEQ ID NO 34
<211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 34
aaagaccgac caagcgacgt ctga 24 <210> SEQ ID NO 35 <211>
LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 35 gctctgaata gtgatagagt
ca 22 <210> SEQ ID NO 36 <211> LENGTH: 445 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 36 aaagaccgac caagcgacgt ctgagagctc
cctggcgaat tcggtaccaa taaaagagct 60 ttattttcat gatctgtgtg
ttggtttttg tgtgcggcgc ggaagttcct attctctaga 120 aagtatagga
acttcctcga gccctatagt gagtcgtatt aaattcatat aaaaaacata 180
cagataacca tctgcggtga taaattatct ctggcggtgt tgacataaat accactggcg
240 gtgatactga gcacatcagc aggacgcact gaccaccatg aaggtgcaaa
ggaggtaaaa 300 aaacatggta tcctgttctg cgccgggtaa gatttacctg
ttcggtgaac acgccgtagt 360 ttatggcgaa actgcaattg cgtgtgcggt
ggaactgcgt acccgtgttc gcgcggaact 420 caatgactct atcactattc agagc
445 <210> SEQ ID NO 37 <211> LENGTH: 445 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 37 aaagaccgac caagcgacgt ctgagagctc
cctggcgaat tcggtaccaa taaaagagct 60 ttattttcat gatctgtgtg
ttggtttttg tgtgcggcgc ggaagttcct attctctaga 120 aagtatagga
acttcctcga gccctatagt gagtcgtatt aaattcatat aaaaaacata 180
cagataacca tctgcggtga taaattatct ctggcggtgt tgacctaaat accactggcg
240 gtgatactga gcacatcagc aggacgcact gaccaccatg aaggtgcaaa
ggaggtaaaa 300 aaacatggta tcctgttctg cgccgggtaa gatttacctg
ttcggtgaac acgccgtagt 360 ttatggcgaa actgcaattg cgtgtgcggt
ggaactgcgt acccgtgttc gcgcggaact 420 caatgactct atcactattc agagc
445 <210> SEQ ID NO 38 <211> LENGTH: 442 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 38 aaagaccgac caagcgacgt ctgagagctc
cctggcgaat tcggtaccaa taaaagagct 60 ttattttcat gatctgtgtg
ttggtttttg tgtgcggcgc ggaagttcct attctctaga 120 aagtatagga
acttcctcga gccctatagt gagtcgtatt aaattcatat aaaaaacata 180
cagataacca tctgcggtga taaattatct ctggcggtgt tgacctaaat accactggcg
240 gtgatactga gcacatcagc aggacgcact gaccaccatg aaggtgcaaa
ggtaaaaaaa 300 catggtatcc tgttctgcgc cgggtaagat ttacctgttc
ggtgaacacg ccgtagttta 360 tggcgaaact gcaattgcgt gtgcggtgga
actgcgtacc cgtgttcgcg cggaactcaa 420 tgactctatc actattcaga gc 442
<210> SEQ ID NO 39 <211> LENGTH: 445 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 39 aaagaccgac caagcgacgt ctgagagctc cctggcgaat tcggtaccaa
taaaagagct 60 ttattttcat gatctgtgtg ttggtttttg tgtgcggcgc
ggaagttcct attctctaga 120 aagtatagga acttcctcga gccctatagt
gagtcgtatt aaattcatat aaaaaacata 180 cagataacca tctgcggtga
taaattatct ctggcggtgt tgacgtaaat accactggcg 240 gtgatactga
gcacatcagc aggacgcact gaccaccatg aaggtgcaaa ggaggtaaaa 300
aaacatggta tcctgttctg cgccgggtaa gatttacctg ttcggtgaac acgccgtagt
360 ttatggcgaa actgcaattg cgtgtgcggt ggaactgcgt acccgtgttc
gcgcggaact 420 caatgactct atcactattc agagc 445 <210> SEQ ID
NO 40 <211> LENGTH: 30 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 40
gaggaataaa ccatggaagc tcgtcgttct 30 <210> SEQ ID NO 41
<211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 41
agaacgacga gcttccatgg tttattcctc 30 <210> SEQ ID NO 42
<400> SEQUENCE: 42 000 <210> SEQ ID NO 43 <400>
SEQUENCE: 43 000 <210> SEQ ID NO 44 <211> LENGTH: 20
<212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 44 ctcgtacagg ctcaggatag 20
<210> SEQ ID NO 45 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 45 ttacgtccca acgctcaact 20 <210> SEQ ID NO 46
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 46
cttcggcaac gcatggaaat 20 <210> SEQ ID NO 47 <400>
SEQUENCE: 47 000
1 SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 47 <210>
SEQ ID NO 1 <211> LENGTH: 6957 <212> TYPE: DNA
<213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 1 tggcgaatgg gacgcgccct gtagcggcgc attaagcgcg gcgggtgtgg
tggttacgcg 60 cagcgtgacc gctacacttg ccagcgccct agcgcccgct
cctttcgctt tcttcccttc 120 ctttctcgcc acgttcgccg gctttccccg
tcaagctcta aatcgggggc tccctttagg 180 gttccgattt agtgctttac
ggcacctcga ccccaaaaaa cttgattagg gtgatggttc 240 acgtagtggg
ccatcgccct gatagacggt ttttcgccct ttgacgttgg agtccacgtt 300
ctttaatagt ggactcttgt tccaaactgg aacaacactc aaccctatct cggtctattc
360 ttttgattta taagggattt tgccgatttc ggcctattgg ttaaaaaatg
agctgattta 420 acaaaaattt aacgcgaatt ttaacaaaat attaacgttt
acaatttcag gtggcacttt 480 tcggggaaat gtgcgcggaa cccctatttg
tttatttttc taaatacatt caaatatgta 540 tccgctcatg aattaattct
tagaaaaact catcgagcat caaatgaaac tgcaatttat 600 tcatatcagg
attatcaata ccatattttt gaaaaagccg tttctgtaat gaaggagaaa 660
actcaccgag gcagttccat aggatggcaa gatcctggta tcggtctgcg attccgactc
720 gtccaacatc aatacaacct attaatttcc cctcgtcaaa aataaggtta
tcaagtgaga 780 aatcaccatg agtgacgact gaatccggtg agaatggcaa
aagtttatgc atttctttcc 840 agacttgttc aacaggccag ccattacgct
cgtcatcaaa atcactcgca tcaaccaaac 900 cgttattcat tcgtgattgc
gcctgagcga gacgaaatac gcgatcgctg ttaaaaggac 960 aattacaaac
aggaatcgaa tgcaaccggc gcaggaacac tgccagcgca tcaacaatat 1020
tttcacctga atcaggatat tcttctaata cctggaatgc tgttttcccg gggatcgcag
1080 tggtgagtaa ccatgcatca tcaggagtac ggataaaatg cttgatggtc
ggaagaggca 1140 taaattccgt cagccagttt agtctgacca tctcatctgt
aacatcattg gcaacgctac 1200 ctttgccatg tttcagaaac aactctggcg
catcgggctt cccatacaat cgatagattg 1260 tcgcacctga ttgcccgaca
ttatcgcgag cccatttata cccatataaa tcagcatcca 1320 tgttggaatt
taatcgcggc ctagagcaag acgtttcccg ttgaatatgg ctcataacac 1380
cccttgtatt actgtttatg taagcagaca gttttattgt tcatgaccaa aatcccttaa
1440 cgtgagtttt cgttccactg agcgtcagac cccgtagaaa agatcaaagg
atcttcttga 1500 gatccttttt ttctgcgcgt aatctgctgc ttgcaaacaa
aaaaaccacc gctaccagcg 1560 gtggtttgtt tgccggatca agagctacca
actctttttc cgaaggtaac tggcttcagc 1620 agagcgcaga taccaaatac
tgtccttcta gtgtagccgt agttaggcca ccacttcaag 1680 aactctgtag
caccgcctac atacctcgct ctgctaatcc tgttaccagt ggctgctgcc 1740
agtggcgata agtcgtgtct taccgggttg gactcaagac gatagttacc ggataaggcg
1800 cagcggtcgg gctgaacggg gggttcgtgc acacagccca gcttggagcg
aacgacctac 1860 accgaactga gatacctaca gcgtgagcta tgagaaagcg
ccacgcttcc cgaagggaga 1920 aaggcggaca ggtatccggt aagcggcagg
gtcggaacag gagagcgcac gagggagctt 1980 ccagggggaa acgcctggta
tctttatagt cctgtcgggt ttcgccacct ctgacttgag 2040 cgtcgatttt
tgtgatgctc gtcagggggg cggagcctat ggaaaaacgc cagcaacgcg 2100
gcctttttac ggttcctggc cttttgctgg ccttttgctc acatgttctt tcctgcgtta
2160 tcccctgatt ctgtggataa ccgtattacc gcctttgagt gagctgatac
cgctcgccgc 2220 agccgaacga ccgagcgcag cgagtcagtg agcgaggaag
cggaagagcg cctgatgcgg 2280 tattttctcc ttacgcatct gtgcggtatt
tcacaccgca tatatggtgc actctcagta 2340 caatctgctc tgatgccgca
tagttaagcc agtatacact ccgctatcgc tacgtgactg 2400 ggtcatggct
gcgccccgac acccgccaac acccgctgac gcgccctgac gggcttgtct 2460
gctcccggca tccgcttaca gacaagctgt gaccgtctcc gggagctgca tgtgtcagag
2520 gttttcaccg tcatcaccga aacgcgcgag gcagctgcgg taaagctcat
cagcgtggtc 2580 gtgaagcgat tcacagatgt ctgcctgttc atccgcgtcc
agctcgttga gtttctccag 2640 aagcgttaat gtctggcttc tgataaagcg
ggccatgtta agggcggttt tttcctgttt 2700 ggtcactgat gcctccgtgt
aagggggatt tctgttcatg ggggtaatga taccgatgaa 2760 acgagagagg
atgctcacga tacgggttac tgatgatgaa catgcccggt tactggaacg 2820
ttgtgagggt aaacaactgg cggtatggat gcggcgggac cagagaaaaa tcactcaggg
2880 tcaatgccag cgcttcgtta atacagatgt aggtgttcca cagggtagcc
agcagcatcc 2940 tgcgatgcag atccggaaca taatggtgca gggcgctgac
ttccgcgttt ccagacttta 3000 cgaaacacgg aaaccgaaga ccattcatgt
tgttgctcag gtcgcagacg ttttgcagca 3060 gcagtcgctt cacgttcgct
cgcgtatcgg tgattcattc tgctaaccag taaggcaacc 3120 ccgccagcct
agccgggtcc tcaacgacag gagcacgatc atgcgcaccc gtggggccgc 3180
catgccggcg ataatggcct gcttctcgcc gaaacgtttg gtggcgggac cagtgacgaa
3240 ggcttgagcg agggcgtgca agattccgaa taccgcaagc gacaggccga
tcatcgtcgc 3300 gctccagcga aagcggtcct cgccgaaaat gacccagagc
gctgccggca cctgtcctac 3360 gagttgcatg ataaagaaga cagtcataag
tgcggcgacg atagtcatgc cccgcgccca 3420 ccggaaggag ctgactgggt
tgaaggctct caagggcatc ggtcgagatc ccggtgccta 3480 atgagtgagc
taacttacat taattgcgtt gcgctcactg cccgctttcc agtcgggaaa 3540
cctgtcgtgc cagctgcatt aatgaatcgg ccaacgcgcg gggagaggcg gtttgcgtat
3600 tgggcgccag ggtggttttt cttttcacca gtgagacggg caacagctga
ttgcccttca 3660 ccgcctggcc ctgagagagt tgcagcaagc ggtccacgct
ggtttgcccc agcaggcgaa 3720 aatcctgttt gatggtggtt aacggcggga
tataacatga gctgtcttcg gtatcgtcgt 3780 atcccactac cgagatatcc
gcaccaacgc gcagcccgga ctcggtaatg gcgcgcattg 3840 cgcccagcgc
catctgatcg ttggcaacca gcatcgcagt gggaacgatg ccctcattca 3900
gcatttgcat ggtttgttga aaaccggaca tggcactcca gtcgccttcc cgttccgcta
3960 tcggctgaat ttgattgcga gtgagatatt tatgccagcc agccagacgc
agacgcgccg 4020 agacagaact taatgggccc gctaacagcg cgatttgctg
gtgacccaat gcgaccagat 4080 gctccacgcc cagtcgcgta ccgtcttcat
gggagaaaat aatactgttg atgggtgtct 4140 ggtcagagac atcaagaaat
aacgccggaa cattagtgca ggcagcttcc acagcaatgg 4200 catcctggtc
atccagcgga tagttaatga tcagcccact gacgcgttgc gcgagaagat 4260
tgtgcaccgc cgctttacag gcttcgacgc cgcttcgttc taccatcgac accaccacgc
4320 tggcacccag ttgatcggcg cgagatttaa tcgccgcgac aatttgcgac
ggcgcgtgca 4380 gggccagact ggaggtggca acgccaatca gcaacgactg
tttgcccgcc agttgttgtg 4440 ccacgcggtt gggaatgtaa ttcagctccg
ccatcgccgc ttccactttt tcccgcgttt 4500 tcgcagaaac gtggctggcc
tggttcacca cgcgggaaac ggtctgataa gagacaccgg 4560 catactctgc
gacatcgtat aacgttactg gtttcacatt caccaccctg aattgactct 4620
cttccgggcg ctatcatgcc ataccgcgaa aggttttgcg ccattcgatg gtgtccggga
4680 tctcgacgct ctcccttatg cgactcctgc attaggaagc agcccagtag
taggttgagg 4740 ccgttgagca ccgccgccgc aaggaatggt gcatgcaagg
agatggcgcc caacagtccc 4800 ccggccacgg ggcctgccac catacccacg
ccgaaacaag cgctcatgag cccgaagtgg 4860 cgagcccgat cttccccatc
ggtgatgtcg gcgatatagg cgccagcaac cgcacctgtg 4920 gcgccggtga
tgccggccac gatgcgtccg gcgtagagga tcgagatctc gatcccgcga 4980
aattaatacg actcactata ggggaattgt gagcggataa caattcccct ctagaaataa
5040 ttttgtttaa ctttaagaag gagatataca tatgcgttgt agcgtgtcca
ccgaaaatgt 5100 gtctttcacc gaaactgaaa ccgaagctcg tcgttctgcg
aactacgaac ctaacagctg 5160 ggactatgat tacctgctgt cctccgacac
ggacgagtcc atcgaagtat acaaagacaa 5220 agcgaaaaag ctggaagccg
aagttcgtcg cgagattaat aacgaaaaag cagaatttct 5280 gaccctgctg
gaactgattg acaacgtcca gcgcctgggc ctgggttacc gtttcgagtc 5340
tgatatccgt ggtgcgctgg atcgcttcgt ttcctccggc ggcttcgatg cggtaaccaa
5400 gacttccctg cacggtacgg cactgtcttt ccgtctgctg cgtcaacacg
gttttgaggt 5460 ttctcaggaa gcgttcagcg gcttcaaaga ccaaaacggc
aacttcctgg agaacctgaa 5520 ggaagatatc aaagctatcc tgagcctgta
cgaggccagc ttcctggctc tggaaggcga 5580 aaacatcctg gacgaggcga
aggttttcgc aatctctcat ctgaaagaac tgtctgaaga 5640 aaagatcggt
aaagagctgg cagaacaggt gaaccatgca ctggaactgc cactgcatcg 5700
ccgtactcag cgtctggaag cagtatggtc tatcgaggcc taccgtaaaa aggaggacgc
5760 gaatcaggtt ctgctggagc tggcaattct ggattacaac atgatccagt
ctgtatacca 5820 gcgtgatctg cgtgaaacgt cccgttggtg gcgtcgtgtg
ggtctggcga ccaaactgca 5880 ctttgctcgt gaccgcctga ttgagagctt
ctactgggcc gtgggtgtag cattcgaacc 5940 gcaatactcc gactgccgta
actccgtcgc aaaaatgttt tctttcgtaa ccattatcga 6000 cgatatctac
gatgtatacg gcaccctgga cgaactggag ctgtttactg atgcagttga 6060
gcgttgggac gtaaacgcca tcaacgacct gccggattac atgaaactgt gctttctggc
6120 tctgtataac actattaacg aaatcgccta cgacaacctg aaagataaag
gtgagaacat 6180 cctgccgtat ctgaccaaag cctgggctga cctgtgcaac
gctttcctgc aagaagccaa 6240 gtggctgtac aacaaatcta ctccgacctt
tgacgactac ttcggcaacg catggaaatc 6300 ctcttctggc ccgctgcaac
tggtgttcgc ttacttcgct gtcgtgcaga acattaaaaa 6360 ggaagagatc
gaaaacctgc aaaaatacca tgacaccatc tctcgtcctt cccatatctt 6420
ccgtctgtgc aatgacctgg ctagcgcgtc tgcggaaatt gcgcgtggtg aaaccgcaaa
6480 tagcgtttct tgttacatgc gcactaaagg tatctccgaa gaactggcta
ccgaaagcgt 6540 gatgaatctg atcgatgaaa cctggaaaaa gatgaacaag
gaaaaactgg gtggtagcct 6600 gttcgcgaaa ccgttcgtgg aaaccgcgat
caacctggca cgtcaatctc actgcactta 6660 tcataacggc gacgcgcata
cctctccgga tgagctgacc cgcaaacgcg ttctgtctgt 6720 aatcactgaa
ccgattctgc cgtttgaacg ctaaggatcc gaattcgagc tccgtcgaca 6780
agcttgcggc cgcactcgag caccaccacc accaccactg agatccggct gctaacaaag
6840 cccgaaagga agctgagttg gctgctgcca ccgctgagca ataactagca
taaccccttg 6900 gggcctctaa acgggtcttg aggggttttt tgctgaaagg
aggaactata tccggat 6957 <210> SEQ ID NO 2 <211> LENGTH:
6068
<212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 2 gtttgacagc ttatcatcga ctgcacggtg
caccaatgct tctggcgtca ggcagccatc 60 ggaagctgtg gtatggctgt
gcaggtcgta aatcactgca taattcgtgt cgctcaaggc 120 gcactcccgt
tctggataat gttttttgcg ccgacatcat aacggttctg gcaaatattc 180
tgaaatgagc tgttgacaat taatcatccg gctcgtataa tgtgtggaat tgtgagcgga
240 taacaatttc acacaggaaa cagcgccgct gagaaaaagc gaagcggcac
tgctctttaa 300 caatttatca gacaatctgt gtgggcactc gaccggaatt
atcgattaac tttattatta 360 aaaattaaag aggtatatat taatgtatcg
attaaataag gaggaataaa ccatgagatg 420 tagcgtgtcc accgaaaatg
tgtctttcac cgaaactgaa accgaagctc gtcgttctgc 480 gaactacgaa
cctaacagct gggactatga ttacctgctg tcctccgaca cggacgagtc 540
catcgaagta tacaaagaca aagcgaaaaa gctggaagcc gaagttcgtc gcgagattaa
600 taacgaaaaa gcagaatttc tgaccctgct ggaactgatt gacaacgtcc
agcgcctggg 660 cctgggttac cgtttcgagt ctgatatccg tggtgcgctg
gatcgcttcg tttcctccgg 720 cggcttcgat gcggtaacca agacttccct
gcacggtacg gcactgtctt tccgtctgct 780 gcgtcaacac ggttttgagg
tttctcagga agcgttcagc ggcttcaaag accaaaacgg 840 caacttcctg
gagaacctga aggaagatat caaagctatc ctgagcctgt acgaggccag 900
cttcctggct ctggaaggcg aaaacatcct ggacgaggcg aaggttttcg caatctctca
960 tctgaaagaa ctgtctgaag aaaagatcgg taaagagctg gcagaacagg
tgaaccatgc 1020 actggaactg ccactgcatc gccgtactca gcgtctggaa
gcagtatggt ctatcgaggc 1080 ctaccgtaaa aaggaggacg cgaatcaggt
tctgctggag ctggcaattc tggattacaa 1140 catgatccag tctgtatacc
agcgtgatct gcgtgaaacg tcccgttggt ggcgtcgtgt 1200 gggtctggcg
accaaactgc actttgctcg tgaccgcctg attgagagct tctactgggc 1260
cgtgggtgta gcattcgaac cgcaatactc cgactgccgt aactccgtcg caaaaatgtt
1320 ttctttcgta accattatcg acgatatcta cgatgtatac ggcaccctgg
acgaactgga 1380 gctgtttact gatgcagttg agcgttggga cgtaaacgcc
atcaacgacc tgccggatta 1440 catgaaactg tgctttctgg ctctgtataa
cactattaac gaaatcgcct acgacaacct 1500 gaaagataaa ggtgagaaca
tcctgccgta tctgaccaaa gcctgggctg acctgtgcaa 1560 cgctttcctg
caagaagcca agtggctgta caacaaatct actccgacct ttgacgacta 1620
cttcggcaac gcatggaaat cctcttctgg cccgctgcaa ctggtgttcg cttacttcgc
1680 tgtcgtgcag aacattaaaa aggaagagat cgaaaacctg caaaaatacc
atgacaccat 1740 ctctcgtcct tcccatatct tccgtctgtg caatgacctg
gctagcgcgt ctgcggaaat 1800 tgcgcgtggt gaaaccgcaa atagcgtttc
ttgttacatg cgcactaaag gtatctccga 1860 agaactggct accgaaagcg
tgatgaatct gatcgatgaa acctggaaaa agatgaacaa 1920 ggaaaaactg
ggtggtagcc tgttcgcgaa accgttcgtg gaaaccgcga tcaacctggc 1980
acgtcaatct cactgcactt atcataacgg cgacgcgcat acctctccgg atgagctgac
2040 ccgcaaacgc gttctgtctg taatcactga accgattctg ccgtttgaac
gctaactgca 2100 gctggtacca tatgggaatt cgaagctttc tagaacaaaa
actcatctca gaagaggatc 2160 tgaatagcgc cgtcgaccat catcatcatc
atcattgagt ttaaacggtc tccagcttgg 2220 ctgttttggc ggatgagaga
agattttcag cctgatacag attaaatcag aacgcagaag 2280 cggtctgata
aaacagaatt tgcctggcgg cagtagcgcg gtggtcccac ctgaccccat 2340
gccgaactca gaagtgaaac gccgtagcgc cgatggtagt gtggggtctc cccatgcgag
2400 agtagggaac tgccaggcat caaataaaac gaaaggctca gtcgaaagac
tgggcctttc 2460 gttttatctg ttgtttgtcg gtgaacgctc tcctgagtag
gacaaatccg ccgggagcgg 2520 atttgaacgt tgcgaagcaa cggcccggag
ggtggcgggc aggacgcccg ccataaactg 2580 ccaggcatca aattaagcag
aaggccatcc tgacggatgg cctttttgcg tttctacaaa 2640 ctctttttgt
ttatttttct aaatacattc aaatatgtat ccgctcatga gacaataacc 2700
ctgataaatg cttcaataat attgaaaaag gaagagtatg agtattcaac atttccgtgt
2760 cgcccttatt cccttttttg cggcattttg ccttcctgtt tttgctcacc
cagaaacgct 2820 ggtgaaagta aaagatgctg aagatcagtt gggtgcacga
gtgggttaca tcgaactgga 2880 tctcaacagc ggtaagatcc ttgagagttt
tcgccccgaa gaacgttttc caatgatgag 2940 cacttttaaa gttctgctat
gtggcgcggt attatcccgt gttgacgccg ggcaagagca 3000 actcggtcgc
cgcatacact attctcagaa tgacttggtt gagtactcac cagtcacaga 3060
aaagcatctt acggatggca tgacagtaag agaattatgc agtgctgcca taaccatgag
3120 tgataacact gcggccaact tacttctgac aacgatcgga ggaccgaagg
agctaaccgc 3180 ttttttgcac aacatggggg atcatgtaac tcgccttgat
cgttgggaac cggagctgaa 3240 tgaagccata ccaaacgacg agcgtgacac
cacgatgcct gtagcaatgg caacaacgtt 3300 gcgcaaacta ttaactggcg
aactacttac tctagcttcc cggcaacaat taatagactg 3360 gatggaggcg
gataaagttg caggaccact tctgcgctcg gcccttccgg ctggctggtt 3420
tattgctgat aaatctggag ccggtgagcg tgggtctcgc ggtatcattg cagcactggg
3480 gccagatggt aagccctccc gtatcgtagt tatctacacg acggggagtc
aggcaactat 3540 ggatgaacga aatagacaga tcgctgagat aggtgcctca
ctgattaagc attggtaact 3600 gtcagaccaa gtttactcat atatacttta
gattgattta aaacttcatt tttaatttaa 3660 aaggatctag gtgaagatcc
tttttgataa tctcatgacc aaaatccctt aacgtgagtt 3720 ttcgttccac
tgagcgtcag accccgtaga aaagatcaaa ggatcttctt gagatccttt 3780
ttttctgcgc gtaatctgct gcttgcaaac aaaaaaacca ccgctaccag cggtggtttg
3840 tttgccggat caagagctac caactctttt tccgaaggta actggcttca
gcagagcgca 3900 gataccaaat actgtccttc tagtgtagcc gtagttaggc
caccacttca agaactctgt 3960 agcaccgcct acatacctcg ctctgctaat
cctgttacca gtggctgctg ccagtggcga 4020 taagtcgtgt cttaccgggt
tggactcaag acgatagtta ccggataagg cgcagcggtc 4080 gggctgaacg
gggggttcgt gcacacagcc cagcttggag cgaacgacct acaccgaact 4140
gagataccta cagcgtgagc tatgagaaag cgccacgctt cccgaaggga gaaaggcgga
4200 caggtatccg gtaagcggca gggtcggaac aggagagcgc acgagggagc
ttccaggggg 4260 aaacgcctgg tatctttata gtcctgtcgg gtttcgccac
ctctgacttg agcgtcgatt 4320 tttgtgatgc tcgtcagggg ggcggagcct
atggaaaaac gccagcaacg cggccttttt 4380 acggttcctg gccttttgct
ggccttttgc tcacatgttc tttcctgcgt tatcccctga 4440 ttctgtggat
aaccgtatta ccgcctttga gtgagctgat accgctcgcc gcagccgaac 4500
gaccgagcgc agcgagtcag tgagcgagga agcggaagag cgcctgatgc ggtattttct
4560 ccttacgcat ctgtgcggta tttcacaccg catatggtgc actctcagta
caatctgctc 4620 tgatgccgca tagttaagcc agtatacact ccgctatcgc
tacgtgactg ggtcatggct 4680 gcgccccgac acccgccaac acccgctgac
gcgccctgac gggcttgtct gctcccggca 4740 tccgcttaca gacaagctgt
gaccgtctcc gggagctgca tgtgtcagag gttttcaccg 4800 tcatcaccga
aacgcgcgag gcagcagatc aattcgcgcg cgaaggcgaa gcggcatgca 4860
tttacgttga caccatcgaa tggtgcaaaa cctttcgcgg tatggcatga tagcgcccgg
4920 aagagagtca attcagggtg gtgaatgtga aaccagtaac gttatacgat
gtcgcagagt 4980 atgccggtgt ctcttatcag accgtttccc gcgtggtgaa
ccaggccagc cacgtttctg 5040 cgaaaacgcg ggaaaaagtg gaagcggcga
tggcggagct gaattacatt cccaaccgcg 5100 tggcacaaca actggcgggc
aaacagtcgt tgctgattgg cgttgccacc tccagtctgg 5160 ccctgcacgc
gccgtcgcaa attgtcgcgg cgattaaatc tcgcgccgat caactgggtg 5220
ccagcgtggt ggtgtcgatg gtagaacgaa gcggcgtcga agcctgtaaa gcggcggtgc
5280 acaatcttct cgcgcaacgc gtcagtgggc tgatcattaa ctatccgctg
gatgaccagg 5340 atgccattgc tgtggaagct gcctgcacta atgttccggc
gttatttctt gatgtctctg 5400 accagacacc catcaacagt attattttct
cccatgaaga cggtacgcga ctgggcgtgg 5460 agcatctggt cgcattgggt
caccagcaaa tcgcgctgtt agcgggccca ttaagttctg 5520 tctcggcgcg
tctgcgtctg gctggctggc ataaatatct cactcgcaat caaattcagc 5580
cgatagcgga acgggaaggc gactggagtg ccatgtccgg ttttcaacaa accatgcaaa
5640 tgctgaatga gggcatcgtt cccactgcga tgctggttgc caacgatcag
atggcgctgg 5700 gcgcaatgcg cgccattacc gagtccgggc tgcgcgttgg
tgcggatatc tcggtagtgg 5760 gatacgacga taccgaagac agctcatgtt
atatcccgcc gtcaaccacc atcaaacagg 5820 attttcgcct gctggggcaa
accagcgtgg accgcttgct gcaactctct cagggccagg 5880 cggtgaaggg
caatcagctg ttgcccgtct cactggtgaa aagaaaaacc accctggcgc 5940
ccaatacgca aaccgcctct ccccgcgcgt tggccgattc attaatgcag ctggcacgac
6000 aggtttcccg actggaaagc gggcagtgag cgcaacgcaa ttaatgtgag
ttagcgcgaa 6060 ttgatctg 6068 <210> SEQ ID NO 3 <211>
LENGTH: 6906 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 3 gtttgacagc ttatcatcga
ctgcacggtg caccaatgct tctggcgtca ggcagccatc 60 ggaagctgtg
gtatggctgt gcaggtcgta aatcactgca taattcgtgt cgctcaaggc 120
gcactcccgt tctggataat gttttttgcg ccgacatcat aacggttctg gcaaatattc
180 tgaaatgagc tgttgacaat taatcatccg gctcgtataa tgtgtggaat
tgtgagcgga 240 taacaatttc acacaggaaa cagcgccgct gagaaaaagc
gaagcggcac tgctctttaa 300 caatttatca gacaatctgt gtgggcactc
gaccggaatt atcgattaac tttattatta 360 aaaattaaag aggtatatat
taatgtatcg attaaataag gaggaataaa ccatgagatg 420 tagcgtgtcc
accgaaaatg tgtctttcac cgaaactgaa accgaagctc gtcgttctgc 480
gaactacgaa cctaacagct gggactatga ttacctgctg tcctccgaca cggacgagtc
540 catcgaagta tacaaagaca aagcgaaaaa gctggaagcc gaagttcgtc
gcgagattaa 600 taacgaaaaa gcagaatttc tgaccctgct ggaactgatt
gacaacgtcc agcgcctggg 660 cctgggttac cgtttcgagt ctgatatccg
tggtgcgctg gatcgcttcg tttcctccgg 720 cggcttcgat gcggtaacca
agacttccct gcacggtacg gcactgtctt tccgtctgct 780 gcgtcaacac
ggttttgagg tttctcagga agcgttcagc ggcttcaaag accaaaacgg 840
caacttcctg gagaacctga aggaagatat caaagctatc ctgagcctgt acgaggccag
900
cttcctggct ctggaaggcg aaaacatcct ggacgaggcg aaggttttcg caatctctca
960 tctgaaagaa ctgtctgaag aaaagatcgg taaagagctg gcagaacagg
tgaaccatgc 1020 actggaactg ccactgcatc gccgtactca gcgtctggaa
gcagtatggt ctatcgaggc 1080 ctaccgtaaa aaggaggacg cgaatcaggt
tctgctggag ctggcaattc tggattacaa 1140 catgatccag tctgtatacc
agcgtgatct gcgtgaaacg tcccgttggt ggcgtcgtgt 1200 gggtctggcg
accaaactgc actttgctcg tgaccgcctg attgagagct tctactgggc 1260
cgtgggtgta gcattcgaac cgcaatactc cgactgccgt aactccgtcg caaaaatgtt
1320 ttctttcgta accattatcg acgatatcta cgatgtatac ggcaccctgg
acgaactgga 1380 gctgtttact gatgcagttg agcgttggga cgtaaacgcc
atcaacgacc tgccggatta 1440 catgaaactg tgctttctgg ctctgtataa
cactattaac gaaatcgcct acgacaacct 1500 gaaagataaa ggtgagaaca
tcctgccgta tctgaccaaa gcctgggctg acctgtgcaa 1560 cgctttcctg
caagaagcca agtggctgta caacaaatct actccgacct ttgacgacta 1620
cttcggcaac gcatggaaat cctcttctgg cccgctgcaa ctggtgttcg cttacttcgc
1680 tgtcgtgcag aacattaaaa aggaagagat cgaaaacctg caaaaatacc
atgacaccat 1740 ctctcgtcct tcccatatct tccgtctgtg caatgacctg
gctagcgcgt ctgcggaaat 1800 tgcgcgtggt gaaaccgcaa atagcgtttc
ttgttacatg cgcactaaag gtatctccga 1860 agaactggct accgaaagcg
tgatgaatct gatcgatgaa acctggaaaa agatgaacaa 1920 ggaaaaactg
ggtggtagcc tgttcgcgaa accgttcgtg gaaaccgcga tcaacctggc 1980
acgtcaatct cactgcactt atcataacgg cgacgcgcat acctctccgg atgagctgac
2040 ccgcaaacgc gttctgtctg taatcactga accgattctg ccgtttgaac
gctaactgca 2100 taaaggaggt aaaaaaacat ggtatcctgt tctgcgccgg
gtaagattta cctgttcggt 2160 gaacacgccg tagtttatgg cgaaactgca
attgcgtgtg cggtggaact gcgtacccgt 2220 gttcgcgcgg aactcaatga
ctctatcact attcagagcc agatcggccg caccggtctg 2280 gatttcgaaa
agcaccctta tgtgtctgcg gtaattgaga aaatgcgcaa atctattcct 2340
attaacggtg ttttcttgac cgtcgattcc gacatcccgg tgggctccgg tctgggtagc
2400 agcgcagccg ttactatcgc gtctattggt gcgctgaacg agctgttcgg
ctttggcctc 2460 agcctgcaag aaatcgctaa actgggccac gaaatcgaaa
ttaaagtaca gggtgccgcg 2520 tccccaaccg atacgtatgt ttctaccttc
ggcggcgtgg ttaccatccc ggaacgtcgc 2580 aaactgaaaa ctccggactg
cggcattgtg attggcgata ccggcgtttt ctcctccacc 2640 aaagagttag
tagctaacgt acgtcagctg cgcgaaagct acccggattt gatcgaaccg 2700
ctgatgacct ctattggcaa aatctctcgt atcggcgaac aactggttct gtctggcgac
2760 tacgcatcca tcggccgcct gatgaacgtc aaccagggtc tcctggacgc
cctgggcgtt 2820 aacatcttag aactgagcca gctgatctat tccgctcgtg
cggcaggtgc gtttggcgct 2880 aaaatcacgg gcgctggcgg cggtggctgt
atggttgcgc tgaccgctcc ggaaaaatgc 2940 aaccaagtgg cagaagcggt
agcaggcgct ggcggtaaag tgactatcac taaaccgacc 3000 gagcaaggtc
tgaaagtaga ttaaagtcta gttaaagttt aaacggtctc cagcttggct 3060
gttttggcgg atgagagaag attttcagcc tgatacagat taaatcagaa cgcagaagcg
3120 gtctgataaa acagaatttg cctggcggca gtagcgcggt ggtcccacct
gaccccatgc 3180 cgaactcaga agtgaaacgc cgtagcgccg atggtagtgt
ggggtctccc catgcgagag 3240 tagggaactg ccaggcatca aataaaacga
aaggctcagt cgaaagactg ggcctttcgt 3300 tttatctgtt gtttgtcggt
gaacgctctc ctgagtagga caaatccgcc gggagcggat 3360 ttgaacgttg
cgaagcaacg gcccggaggg tggcgggcag gacgcccgcc ataaactgcc 3420
aggcatcaaa ttaagcagaa ggccatcctg acggatggcc tttttgcgtt tctacaaact
3480 ctttttgttt atttttctaa atacattcaa atatgtatcc gctcatgaga
caataaccct 3540 gataaatgct tcaataatat tgaaaaagga agagtatgag
tattcaacat ttccgtgtcg 3600 cccttattcc cttttttgcg gcattttgcc
ttcctgtttt tgctcaccca gaaacgctgg 3660 tgaaagtaaa agatgctgaa
gatcagttgg gtgcacgagt gggttacatc gaactggatc 3720 tcaacagcgg
taagatcctt gagagttttc gccccgaaga acgttttcca atgatgagca 3780
cttttaaagt tctgctatgt ggcgcggtat tatcccgtgt tgacgccggg caagagcaac
3840 tcggtcgccg catacactat tctcagaatg acttggttga gtactcacca
gtcacagaaa 3900 agcatcttac ggatggcatg acagtaagag aattatgcag
tgctgccata accatgagtg 3960 ataacactgc ggccaactta cttctgacaa
cgatcggagg accgaaggag ctaaccgctt 4020 ttttgcacaa catgggggat
catgtaactc gccttgatcg ttgggaaccg gagctgaatg 4080 aagccatacc
aaacgacgag cgtgacacca cgatgcctgt agcaatggca acaacgttgc 4140
gcaaactatt aactggcgaa ctacttactc tagcttcccg gcaacaatta atagactgga
4200 tggaggcgga taaagttgca ggaccacttc tgcgctcggc ccttccggct
ggctggttta 4260 ttgctgataa atctggagcc ggtgagcgtg ggtctcgcgg
tatcattgca gcactggggc 4320 cagatggtaa gccctcccgt atcgtagtta
tctacacgac ggggagtcag gcaactatgg 4380 atgaacgaaa tagacagatc
gctgagatag gtgcctcact gattaagcat tggtaactgt 4440 cagaccaagt
ttactcatat atactttaga ttgatttaaa acttcatttt taatttaaaa 4500
ggatctaggt gaagatcctt tttgataatc tcatgaccaa aatcccttaa cgtgagtttt
4560 cgttccactg agcgtcagac cccgtagaaa agatcaaagg atcttcttga
gatccttttt 4620 ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccacc
gctaccagcg gtggtttgtt 4680 tgccggatca agagctacca actctttttc
cgaaggtaac tggcttcagc agagcgcaga 4740 taccaaatac tgtccttcta
gtgtagccgt agttaggcca ccacttcaag aactctgtag 4800 caccgcctac
atacctcgct ctgctaatcc tgttaccagt ggctgctgcc agtggcgata 4860
agtcgtgtct taccgggttg gactcaagac gatagttacc ggataaggcg cagcggtcgg
4920 gctgaacggg gggttcgtgc acacagccca gcttggagcg aacgacctac
accgaactga 4980 gatacctaca gcgtgagcta tgagaaagcg ccacgcttcc
cgaagggaga aaggcggaca 5040 ggtatccggt aagcggcagg gtcggaacag
gagagcgcac gagggagctt ccagggggaa 5100 acgcctggta tctttatagt
cctgtcgggt ttcgccacct ctgacttgag cgtcgatttt 5160 tgtgatgctc
gtcagggggg cggagcctat ggaaaaacgc cagcaacgcg gcctttttac 5220
ggttcctggc cttttgctgg ccttttgctc acatgttctt tcctgcgtta tcccctgatt
5280 ctgtggataa ccgtattacc gcctttgagt gagctgatac cgctcgccgc
agccgaacga 5340 ccgagcgcag cgagtcagtg agcgaggaag cggaagagcg
cctgatgcgg tattttctcc 5400 ttacgcatct gtgcggtatt tcacaccgca
tatggtgcac tctcagtaca atctgctctg 5460 atgccgcata gttaagccag
tatacactcc gctatcgcta cgtgactggg tcatggctgc 5520 gccccgacac
ccgccaacac ccgctgacgc gccctgacgg gcttgtctgc tcccggcatc 5580
cgcttacaga caagctgtga ccgtctccgg gagctgcatg tgtcagaggt tttcaccgtc
5640 atcaccgaaa cgcgcgaggc agcagatcaa ttcgcgcgcg aaggcgaagc
ggcatgcatt 5700 tacgttgaca ccatcgaatg gtgcaaaacc tttcgcggta
tggcatgata gcgcccggaa 5760 gagagtcaat tcagggtggt gaatgtgaaa
ccagtaacgt tatacgatgt cgcagagtat 5820 gccggtgtct cttatcagac
cgtttcccgc gtggtgaacc aggccagcca cgtttctgcg 5880 aaaacgcggg
aaaaagtgga agcggcgatg gcggagctga attacattcc caaccgcgtg 5940
gcacaacaac tggcgggcaa acagtcgttg ctgattggcg ttgccacctc cagtctggcc
6000 ctgcacgcgc cgtcgcaaat tgtcgcggcg attaaatctc gcgccgatca
actgggtgcc 6060 agcgtggtgg tgtcgatggt agaacgaagc ggcgtcgaag
cctgtaaagc ggcggtgcac 6120 aatcttctcg cgcaacgcgt cagtgggctg
atcattaact atccgctgga tgaccaggat 6180 gccattgctg tggaagctgc
ctgcactaat gttccggcgt tatttcttga tgtctctgac 6240 cagacaccca
tcaacagtat tattttctcc catgaagacg gtacgcgact gggcgtggag 6300
catctggtcg cattgggtca ccagcaaatc gcgctgttag cgggcccatt aagttctgtc
6360 tcggcgcgtc tgcgtctggc tggctggcat aaatatctca ctcgcaatca
aattcagccg 6420 atagcggaac gggaaggcga ctggagtgcc atgtccggtt
ttcaacaaac catgcaaatg 6480 ctgaatgagg gcatcgttcc cactgcgatg
ctggttgcca acgatcagat ggcgctgggc 6540 gcaatgcgcg ccattaccga
gtccgggctg cgcgttggtg cggatatctc ggtagtggga 6600 tacgacgata
ccgaagacag ctcatgttat atcccgccgt caaccaccat caaacaggat 6660
tttcgcctgc tggggcaaac cagcgtggac cgcttgctgc aactctctca gggccaggcg
6720 gtgaagggca atcagctgtt gcccgtctca ctggtgaaaa gaaaaaccac
cctggcgccc 6780 aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat
taatgcagct ggcacgacag 6840 gtttcccgac tggaaagcgg gcagtgagcg
caacgcaatt aatgtgagtt agcgcgaatt 6900 gatctg 6906 <210> SEQ
ID NO 4 <211> LENGTH: 3913 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 4
gcggccgcgc ccttgacgat gccacatcct gagcaaataa ttcaaccact aattgtgagc
60 ggataacaca aggaggaaac agccatggta tcctgttctg cgccgggtaa
gatttacctg 120 ttcggtgaac acgccgtagt ttatggcgaa actgcaattg
cgtgtgcggt ggaactgcgt 180 acccgtgttc gcgcggaact caatgactct
atcactattc agagccagat cggccgcacc 240 ggtctggatt tcgaaaagca
cccttatgtg tctgcggtaa ttgagaaaat gcgcaaatct 300 attcctatta
acggtgtttt cttgaccgtc gattccgaca tcccggtggg ctccggtctg 360
ggtagcagcg cagccgttac tatcgcgtct attggtgcgc tgaacgagct gttcggcttt
420 ggcctcagcc tgcaagaaat cgctaaactg ggccacgaaa tcgaaattaa
agtacagggt 480 gccgcgtccc caaccgatac gtatgtttct accttcggcg
gcgtggttac catcccggaa 540 cgtcgcaaac tgaaaactcc ggactgcggc
attgtgattg gcgataccgg cgttttctcc 600 tccaccaaag agttagtagc
taacgtacgt cagctgcgcg aaagctaccc ggatttgatc 660 gaaccgctga
tgacctctat tggcaaaatc tctcgtatcg gcgaacaact ggttctgtct 720
ggcgactacg catccatcgg ccgcctgatg aacgtcaacc agggtctcct ggacgccctg
780 ggcgttaaca tcttagaact gagccagctg atctattccg ctcgtgcggc
aggtgcgttt 840 ggcgctaaaa tcacgggcgc tggcggcggt ggctgtatgg
ttgcgctgac cgctccggaa 900 aaatgcaacc aagtggcaga agcggtagca
ggcgctggcg gtaaagtgac tatcactaaa 960 ccgaccgagc aaggtctgaa
agtagattaa gccttgactt aatagctgct tatttcgccc 1020 ttatggtacc
tagtaggagg aaaaaaacat ggaaatgcgt caaccggctg tcgcaggtca 1080
attctaccca ctgcgttgcg agaacctgga aaacgaactg aaacgctgct tcgaaggcct
1140 ggagatccgc gaacaagaag tgctgggcgc agtctgtccg cacgccggtt
atatgtactc 1200
tggcaaagtt gcggcgcacg tctatgccac tctgccggaa gctgatacct acgtaatctt
1260 cggcccgaac cacaccggct acggtagccc tgtctctgtg agccgtgaaa
cttggaagac 1320 cccgttgggc aatatcgatg ttgacctgga actggcggac
ggcttcctgg gttccatcgt 1380 agatgcggat gaactcggtc acaaatacga
acactctatc gaagttcagc tgccgtttct 1440 gcaataccgt tttgaacgcg
atttcaaaat tctgccaatc tgcatgggta tgcaagacga 1500 agaaaccgcg
gtcgaagtag gtaacctgct ggcggatctg atcagcgagt ccggtaaacg 1560
tgctgtgatc atcgcaagct ctgatttcac ccactatgag acggctgaac gtgccaaaga
1620 aatcgattcc gaagttattg attctatcct gaactttgac atctctggca
tgtacgatcg 1680 cctgtatcgc cgtaacgcct ctgtttgcgg ttacggcccg
atcaccgcta tgctgacggc 1740 aagcaaaaag ctgggcggct ctcgtgcgac
tttgctgaaa tacgcaaaca gcggtgacgt 1800 gtccggtgat aaagacgctg
tggtgggcta cgccgccatc atcgttgagt aagctgatta 1860 aaggttgaac
agataggatt tcgtcatgga tcctacaagg aggaaaaaaa catgaatgct 1920
tctaatgaac cggtgattct gaaactgggt ggctctgcta ttaccgacaa aggtgcctac
1980 gaaggcgtag ttaaggaagc tgatttgctg cgcatcgcac aggaagttag
cggtttccgt 2040 ggcaagatga tcgtggttca tggtgctggt agcttcggcc
atacgtacgc gaagaaatac 2100 ggcctggacc gtaccttcga cccagagggc
gcaattgtta ctcatgaatc tgttaaaaag 2160 ctcgcctcca aagttgtagg
tgctctgaat agcttcggcg tgcgtgctat cgcggtgcat 2220 cctatggact
gcgcagtatg ccgtaacggt cgtatcgaaa cgatgtatct ggactccatc 2280
aagttaatgc tggaaaaagg tctggtgccg gttctgcacg gcgacgtcgc aatggatatt
2340 gaactgggca cttgtatcct gtccggtgat caaatcgttc cttacctggc
caaagaactg 2400 ggtatctccc gcctcggcct gggcagcgca gaggatggtg
tgctggatat ggagggcaaa 2460 cctgtaccgg aaatcacccc agaaactttc
gaagagttcc gccactgcat cggtggttct 2520 ggttctactg atgtaaccgg
tggcatgctg ggcaaagtgc tggaacttct ggaattgagc 2580 aaaaattctt
ccattactag ctacattttc aacgctggta aagcagacaa catctaccgc 2640
tttctgaatg gtgagtccat cggcactcgc atcagcccgg acaagcgtgt ttaagctagt
2700 tattaaccta aatgctctaa accagttatg agctctacaa ggaggaaaaa
aacatgatta 2760 acactaccag ccgccgcaaa attgaacacc tgaaactctg
cgcagaatcc ccggttgaag 2820 cgcgtcaggt atctgccggc tttgaagacg
ttactctgat ccaccgcgct ttaccggagc 2880 tgaacatgga tgaactggac
ctcagcgttg atttcctggg taaacgcatc aaagcgccgt 2940 tcctgattgc
gtctatcacg ggtggtcacc cagataccat cccggttaac gctgcgctgg 3000
cagctgctgc tgaggagctg ggtgttggca tcggcgttgg ctctcagcgc gcggccattg
3060 atgatccgag ccaggaagac agcttccgtg tagtgcgtga tgaagcccca
gatgcgtttg 3120 tttatggcaa cgtcggcgca gcacagatcc gtcagtatgg
tgttgaaggt gttgaaaaac 3180 tgatcgaaat gattgacgca gatgccttgg
caatccacct gaactttctg caagaagcgg 3240 tccaaccgga aggtgaccgc
gacgcgaccg gttgcctgga catgattacc gaaatttgct 3300 ctcagattaa
aactccggta atcgtgaaag aaaccggtgc aggcattagc cgtgaagatg 3360
cgattctgtt ccagaaagct ggcgtgagcg caatcgacgt tggcggcgcg ggcggcacct
3420 cctgggctgg cgtcgaggtc taccgtgcta aagaaagccg tgactctgtt
agcgagcgtt 3480 taggtgagct gttttgggat ttcggcattc cgacggtagc
ttctctgatt gaatcccgcg 3540 tttccttgcc gctgatcgca accggcggta
tccgtaacgg tctggacatt gctaaaagca 3600 ttgctctcgg cgcaagcgct
gccagcgccg ctctgccgtt cgttggtccg tccctggagg 3660 gcaaagaatc
cgttgtacgt gtgctgagct gcatgctgga agaatttaaa gcagcaatgt 3720
ttttgtgcgg ttgcggcaac atcaaagacc tgcacaactc tccagtagtg gtaactggtt
3780 ggacccgcga atacctggag cagcgcggtt ttaacgttaa ggacctctcc
ctgccgggca 3840 acgctctgta agcttcaacg cgtctacaaa taaaaaaggc
acgtcagatg acgtgccttt 3900 tttcttgtct aga 3913 <210> SEQ ID
NO 5 <211> LENGTH: 6647 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 5
aagggcgagc tcaacgatcc ggctgctaac aaagcccgaa aggaagctga gttggctgct
60 gccaccgctg agcaataact agcataaccc cttggggcct ctaaacgggt
cttgaggagt 120 tttttgctga aaggaggaac tatatccgga tatcccgcaa
gaggcccggc agtaccggca 180 taaccaagcc tatgcctaca gcatccaggg
tgacggtgcc gaggatgacg atgagcgcat 240 tgttagattt catacacggt
gcctgactgc gttagcaatt taactgtgat aaactaccgc 300 attaaagctt
atcgatgata agctgtcaaa catgagaatt aattcttgaa gacgaaaggg 360
cctcgtgata cgcctatttt tataggttaa tgtcatgata ataatggttt cttagacgtc
420 aggtggcact tttcggggaa atgtgcgcgg aacccctatt tgtttatttt
tctaaataca 480 ttcaaatatg tatccgctca tgagacaata accctgataa
atgcttcaat aatattgaaa 540 aaggaagagt atgattgaac aagatggatt
gcacgcaggt tctccggccg cttgggtgga 600 gaggctattc ggctatgact
gggcacaact gacaatcggc tgctctgatg ccgccgtgtt 660 ccggctgtca
gcgcaggggc gcccggttct ttttgtcaag accgacctgt ccggtgccct 720
gaatgaactg caggacgagg cagcgcggct atcgtggctg gccacgacgg gcgttccttg
780 cgcagctgtg ctcgacgttg tcactgaagc gggaagggac tggctgctat
tgggcgaagt 840 gccggggcag gatctcctgt catctcacct tgctcctgcc
gagaaagtat ccatcatggc 900 tgatgcaatg cggcggctgc atacgcttga
tccggctacc tgcccattcg accaccaagc 960 gaaacatcgc atcgagcggg
cacgtactcg gatggaagcc ggtcttgtcg atcaggatga 1020 tctggacgaa
gagcatcagg ggctcgcgcc agccgaactg ttcgccaggc tcaaggcgcg 1080
catgcccgac ggcgaggatc tcgtcgtgac acatggcgat gcctgcttgc cgaatatcat
1140 ggtggaaaat ggccgctttt ctggattcat cgactgtggc cggctgggtg
tggcggaccg 1200 ctatcaggac atagcgttgg ctacccgtga tattgctgaa
gagcttggcg gcgaatgggc 1260 tgaccgcttc ctcgtgcttt acggtatcgc
cgctcccgat tcgcagcgca tcgccttcta 1320 tcgccttctt gacgagttct
tctgagcggg actctggggt tcgaaatgac cgaccaagcg 1380 acgcctaact
gtcagaccaa gtttactcat atatacttta gattgattta aaacttcatt 1440
tttaatttaa aaggatctag gtgaagatcc tttttgataa tctcatgacc aaaatccctt
1500 aacgtgagtt ttcgttccac tgagcgtcag accccgtaga aaagatcaaa
ggatcttctt 1560 gagatccttt ttttctgcgc gtaatctgct gcttgcaaac
aaaaaaacca ccgctaccag 1620 cggtggtttg tttgccggat caagagctac
caactctttt tccgaaggta actggcttca 1680 gcagagcgca gataccaaat
actgtccttc tagtgtagcc gtagttaggc caccacttca 1740 agaactctgt
agcaccgcct acatacctcg ctctgctaat cctgttacca gtggctgctg 1800
ccagtggcga taagtcgtgt cttaccgggt tggactcaag acgatagtta ccggataagg
1860 cgcagcggtc gggctgaacg gggggttcgt gcacacagcc cagcttggag
cgaacgacct 1920 acaccgaact gagataccta cagcgtgagc tatgagaaag
cgccacgctt cccgaaggga 1980 gaaaggcgga caggtatccg gtaagcggca
gggtcggaac aggagagcgc acgagggagc 2040 ttccaggggg aaacgcctgg
tatctttata gtcctgtcgg gtttcgccac ctctgacttg 2100 agcgtcgatt
tttgtgatgc tcgtcagggg ggcggagcct atggaaaaac gccagcaacg 2160
cggccttttt acggttcctg gccttttgct ggccttttgc tcacatgttc tttcctgcgt
2220 tatcccctga ttctgtggat aaccgtatta ccgcctttga gtgagctgat
accgctcgcc 2280 gcagccgaac gaccgagcgc agcgagtcag tgagcgagga
agcggaagag cgcctgatgc 2340 ggtattttct ccttacgcat ctgtgcggta
tttcacaccg caatggtgca ctctcagtac 2400 aatctgctct gatgccgcat
agttaagcca gtatacactc cgctatcgct acgtgactgg 2460 gtcatggctg
cgccccgaca cccgccaaca cccgctgacg cgccctgacg ggcttgtctg 2520
ctcccggcat ccgcttacag acaagctgtg accgtctccg ggagctgcat gtgtcagagg
2580 ttttcaccgt catcaccgaa acgcgcgagg cagctgcggt aaagctcatc
agcgtggtcg 2640 tgaagcgatt cacagatgtc tgcctgttca tccgcgtcca
gctcgttgag tttctccaga 2700 agcgttaatg tctggcttct gataaagcgg
gccatgttaa gggcggtttt ttcctgtttg 2760 gtcactgatg cctccgtgta
agggggattt ctgttcatgg gggtaatgat accgatgaaa 2820 cgagagagga
tgctcacgat acgggttact gatgatgaac atgcccggtt actggaacgt 2880
tgtgagggta aacaactggc ggtatggatg cggcgggacc agagaaaaat cactcagggt
2940 caatgccagc gcttcgttaa tacagatgta ggtgttccac agggtagcca
gcagcatcct 3000 gcgatgcaga tccggaacat aatggtgcag ggcgctgact
tccgcgtttc cagactttac 3060 gaaacacgga aaccgaagac cattcatgtt
gttgctcagg tcgcagacgt tttgcagcag 3120 cagtcgcttc acgttcgctc
gcgtatcggt gattcattct gctaaccagt aaggcaaccc 3180 cgccagccta
gccgggtcct caacgacagg agcacgatca tgcgcacccg tggccaggac 3240
ccaacgctgc ccgagatgcg ccgcgtgcgg ctgctggaga tggcggacgc gatggatatg
3300 ttctgccaag ggttggtttg cgcattcaca gttctccgca agaattgatt
ggctccaatt 3360 cttggagtgg tgaatccgtt agcgaggtgc cgccggcttc
cattcaggtc gaggtggccc 3420 ggctccatgc accgcgacgc aacgcgggga
ggcagacaag gtatagggcg gcgcctacaa 3480 tccatgccaa cccgttccat
gtgctcgccg aggcggcata aatcgccgtg acgatcagcg 3540 gtccaatgat
cgaagttagg ctggtaagag ccgcgagcga tccttgaagc tgtccctgat 3600
ggtcgtcatc tacctgcctg gacagcatgg cctgcaacgc gggcatcccg atgccgccgg
3660 aagcgagaag aatcataatg gggaaggcca tccagcctcg cgtcgcgaac
gccagcaaga 3720 cgtagcccag cgcgtcggcc gccatgccgg cgataatggc
ctgcttctcg ccgaaacgtt 3780 tggtggcggg accagtgacg aaggcttgag
cgagggcgtg caagattccg aataccgcaa 3840 gcgacaggcc gatcatcgtc
gcgctccagc gaaagcggtc ctcgccgaaa atgacccaga 3900 gcgctgccgg
cacctgtcct acgagttgca tgataaagaa gacagtcata agtgcggcga 3960
cgatagtcat gccccgcgcc caccggaagg agctgactgg gttgaaggct ctcaagggca
4020 tcggtcgaga tcccggtgcc taatgagtga gctaacttac attaattgcg
ttgcgctcac 4080 tgcccgcttt ccagtcggga aacctgtcgt gccagctgca
ttaatgaatc ggccaacgcg 4140 cggggagagg cggtttgcgt attgggcgcc
agggtggttt ttcttttcac cagtgagacg 4200 ggcaacagct gattgccctt
caccgcctgg ccctgagaga gttgcagcaa gcggtccacg 4260 ctggtttgcc
ccagcaggcg aaaatcctgt ttgatggtgg ttaacggcgg gatataacat 4320
gagctgtctt cggtatcgtc gtatcccact accgagatat ccgcaccaac gcgcagcccg
4380 gactcggtaa tggcgcgcat tgcgcccagc gccatctgat cgttggcaac
cagcatcgca 4440
gtgggaacga tgccctcatt cagcatttgc atggtttgtt gaaaaccgga catggcactc
4500 cagtcgcctt cccgttccgc tatcggctga atttgattgc gagtgagata
tttatgccag 4560 ccagccagac gcagacgcgc cgagacagaa cttaatgggc
ccgctaacag cgcgatttgc 4620 tggtgaccca atgcgaccag atgctccacg
cccagtcgcg taccgtcttc atgggagaaa 4680 ataatactgt tgatgggtgt
ctggtcagag acatcaagaa ataacgccgg aacattagtg 4740 caggcagctt
ccacagcaat ggcatcctgg tcatccagcg gatagttaat gatcagccca 4800
ctgacgcgtt gcgcgagaag attgtgcacc gccgctttac aggcttcgac gccgcttcgt
4860 tctaccatcg acaccaccac gctggcaccc agttgatcgg cgcgagattt
aatcgccgcg 4920 acaatttgcg acggcgcgtg cagggccaga ctggaggtgg
caacgccaat cagcaacgac 4980 tgtttgcccg ccagttgttg tgccacgcgg
ttgggaatgt aattcagctc cgccatcgcc 5040 gcttccactt tttcccgcgt
tttcgcagaa acgtggctgg cctggttcac cacgcgggaa 5100 acggtctgat
aagagacacc ggcatactct gcgacatcgt ataacgttac tggtttcaca 5160
ttcaccaccc tgaattgact ctcttccggg cgctatcatg ccataccgcg aaaggttttg
5220 cgccattcga tggtgtccgg gatctcgacg ctctccctta tgcgactcct
gcattaggaa 5280 gcagcccagt agtaggttga ggccgttgag caccgccgcc
gcaaggaatg gtgcatgcaa 5340 ggagatggcg cccaacagtc ccccggccac
ggggcctgcc accataccca cgccgaaaca 5400 agcgctcatg agcccgaagt
ggcgagcccg atcttcccca tcggtgatgt cggcgatata 5460 ggcgccagca
accgcacctg tggcgccggt gatgccggcc acgatgcgtc cggcgtagag 5520
gatcgagatc tcgatcccgc gaaattaata cgactcacta taggggaatt gtgagcggat
5580 aacaattccc ctctagaaat aattttgttt aactttaaga aggagatata
catatgcggg 5640 gttctcatca tcatcatcat catggtatgg ctagcatgac
tggtggacag caaatgggtc 5700 gggatctgta cgacgatgac gataaggatc
atcccttcac catggtatcc tgttctgcgc 5760 cgggtaagat ttacctgttc
ggtgaacacg ccgtagttta tggcgaaact gcaattgcgt 5820 gtgcggtgga
actgcgtacc cgtgttcgcg cggaactcaa tgactctatc actattcaga 5880
gccagatcgg ccgcaccggt ctggatttcg aaaagcaccc ttatgtgtct gcggtaattg
5940 agaaaatgcg caaatctatt cctattaacg gtgttttctt gaccgtcgat
tccgacatcc 6000 cggtgggctc cggtctgggt agcagcgcag ccgttactat
cgcgtctatt ggtgcgctga 6060 acgagctgtt cggctttggc ctcagcctgc
aagaaatcgc taaactgggc cacgaaatcg 6120 aaattaaagt acagggtgcc
gcgtccccaa ccgatacgta tgtttctacc ttcggcggcg 6180 tggttaccat
cccggaacgt cgcaaactga aaactccgga ctgcggcatt gtgattggcg 6240
ataccggcgt tttctcctcc accaaagagt tagtagctaa cgtacgtcag ctgcgcgaaa
6300 gctacccgga tttgatcgaa ccgctgatga cctctattgg caaaatctct
cgtatcggcg 6360 aacaactggt tctgtctggc gactacgcat ccatcggccg
cctgatgaac gtcaaccagg 6420 gtctcctgga cgccctgggc gttaacatct
tagaactgag ccagctgatc tattccgctc 6480 gtgcggcagg tgcgtttggc
gctaaaatca cgggcgctgg cggcggtggc tgtatggttg 6540 cgctgaccgc
tccggaaaaa tgcaaccaag tggcagaagc ggtagcaggc gctggcggta 6600
aagtgactat cactaaaccg accgagcaag gtctgaaagt agattaa 6647
<210> SEQ ID NO 6 <211> LENGTH: 7519 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 6 ctcgggccgt ctcttgggct tgatcggcct tcttgcgcat ctcacgcgct
cctgcggcgg 60 cctgtagggc aggctcatac ccctgccgaa ccgcttttgt
cagccggtcg gccacggctt 120 ccggcgtctc aacgcgcttt gagattccca
gcttttcggc caatccctgc ggtgcatagg 180 cgcgtggctc gaccgcttgc
gggctgatgg tgacgtggcc cactggtggc cgctccaggg 240 cctcgtagaa
cgcctgaatg cgcgtgtgac gtgccttgct gccctcgatg ccccgttgca 300
gccctagatc ggccacagcg gccgcaaacg tggtctggtc gcgggtcatc tgcgctttgt
360 tgccgatgaa ctccttggcc gacagcctgc cgtcctgcgt cagcggcacc
acgaacgcgg 420 tcatgtgcgg gctggtttcg tcacggtgga tgctggccgt
cacgatgcga tccgccccgt 480 acttgtccgc cagccacttg tgcgccttct
cgaagaacgc cgcctgctgt tcttggctgg 540 ccgacttcca ccattccggg
ctggccgtca tgacgtactc gaccgccaac acagcgtcct 600 tgcgccgctt
ctctggcagc aactcgcgca gtcggcccat cgcttcatcg gtgctgctgg 660
ccgcccagtg ctcgttctct ggcgtcctgc tggcgtcagc gttgggcgtc tcgcgctcgc
720 ggtaggcgtg cttgagactg gccgccacgt tgcccatttt cgccagcttc
ttgcatcgca 780 tgatcgcgta tgccgccatg cctgcccctc ccttttggtg
tccaaccggc tcgacggggg 840 cagcgcaagg cggtgcctcc ggcgggccac
tcaatgcttg agtatactca ctagactttg 900 cttcgcaaag tcgtgaccgc
ctacggcggc tgcggcgccc tacgggcttg ctctccgggc 960 ttcgccctgc
gcggtcgctg cgctcccttg ccagcccgtg gatatgtgga cgatggccgc 1020
gagcggccac cggctggctc gcttcgctcg gcccgtggac aaccctgctg gacaagctga
1080 tggacaggct gcgcctgccc acgagcttga ccacagggat tgcccaccgg
ctacccagcc 1140 ttcgaccaca tacccaccgg ctccaactgc gcggcctgcg
gccttgcccc atcaattttt 1200 ttaattttct ctggggaaaa gcctccggcc
tgcggcctgc gcgcttcgct tgccggttgg 1260 acaccaagtg gaaggcgggt
caaggctcgc gcagcgaccg cgcagcggct tggccttgac 1320 gcgcctggaa
cgacccaagc ctatgcgagt gggggcagtc gaaggcgaag cccgcccgcc 1380
tgccccccga gcctcacggc ggcgagtgcg ggggttccaa gggggcagcg ccaccttggg
1440 caaggccgaa ggccgcgcag tcgatcaaca agccccggag gggccacttt
ttgccggagg 1500 gggagccgcg ccgaaggcgt gggggaaccc cgcaggggtg
cccttctttg ggcaccaaag 1560 aactagatat agggcgaaat gcgaaagact
taaaaatcaa caacttaaaa aaggggggta 1620 cgcaacagct cattgcggca
ccccccgcaa tagctcattg cgtaggttaa agaaaatctg 1680 taattgactg
ccacttttac gcaacgcata attgttgtcg cgctgccgaa aagttgcagc 1740
tgattgcgca tggtgccgca accgtgcggc accctaccgc atggagataa gcatggccac
1800 gcagtccaga gaaatcggca ttcaagccaa gaacaagccc ggtcactggg
tgcaaacgga 1860 acgcaaagcg catgaggcgt gggccgggct tattgcgagg
aaacccacgg cggcaatgct 1920 gctgcatcac ctcgtggcgc agatgggcca
ccagaacgcc gtggtggtca gccagaagac 1980 actttccaag ctcatcggac
gttctttgcg gacggtccaa tacgcagtca aggacttggt 2040 ggccgagcgc
tggatctccg tcgtgaagct caacggcccc ggcaccgtgt cggcctacgt 2100
ggtcaatgac cgcgtggcgt ggggccagcc ccgcgaccag ttgcgcctgt cggtgttcag
2160 tgccgccgtg gtggttgatc acgacgacca ggacgaatcg ctgttggggc
atggcgacct 2220 gcgccgcatc ccgaccctgt atccgggcga gcagcaacta
ccgaccggcc ccggcgagga 2280 gccgcccagc cagcccggca ttccgggcat
ggaaccagac ctgccagcct tgaccgaaac 2340 ggaggaatgg gaacggcgcg
ggcagcagcg cctgccgatg cccgatgagc cgtgttttct 2400 ggacgatggc
gagccgttgg agccgccgac acgggtcacg ctgccgcgcc ggtagcactt 2460
gggttgcgca gcaacccgta agtgcgctgt tccagactat cggctgtagc cgcctcgccg
2520 ccctatacct tgtctgcctc cccgcgttgc gtcgcggtgc atggagccgg
gccacctcga 2580 cctgaatgga agccggcggc acctcgctaa cggattcacc
gtttttatca ggctctggga 2640 ggcagaataa atgatcatat cgtcaattat
tacctccacg gggagagcct gagcaaactg 2700 gcctcaggca tttgagaagc
acacggtcac actgcttccg gtagtcaata aaccggtaaa 2760 ccagcaatag
acataagcgg ctatttaacg accctgccct gaaccgacga ccgggtcgaa 2820
tttgctttcg aatttctgcc attcatccgc ttattatcac ttattcaggc gtagcaccag
2880 gcgtttaagg gcaccaataa ctgccttaaa aaaattacgc cccgccctgc
cactcatcgc 2940 agtcggccta ttggttaaaa aatgagctga tttaacaaaa
atttaacgcg aattttaaca 3000 aaatattaac gcttacaatt tccattcgcc
attcaggctg cgcaactgtt gggaagggcg 3060 atcggtgcgg gcctcttcgc
tattacgcca gctggcgaaa gggggatgtg ctgcaaggcg 3120 attaagttgg
gtaacgccag ggttttccca gtcacgacgt tgtaaaacga cggccagtga 3180
gcgcgcgtaa tacgactcac tatagggcga attggagctc caccgcggtg gcggccgctc
3240 tagaactagt ggatcccccg ggctgcatgc tcgagcggcc gccagtgtga
tggatatctg 3300 cagaattcgc ccttcttgat atcttagtgt gcgttaacca
ccacccacat tggtccctgc 3360 ccgaccgcat agcggccttt ttcatgcagt
agcccctgct cgccaacaat ttcgtatacc 3420 gagatgtggt gagatttttg
cccggcggca atcagatact tgccgctgtg atcaacattg 3480 aagccgcgcg
gctgggtttc cgttggctgg aagccttctt tactcaacac gctgccatct 3540
tccgaaacgc tgaaaacggt aatcaggctg gcggtacggt cgcaggcgta taaatggcga
3600 ccatccgggg tgatatgaat atcagccgcc caacgggtgt cggagaagtt
ttccggcatc 3660 atatccagcg tctggacaca ttcgatatta ccgtgcggat
ctttcagttc ccagacatcc 3720 actgagctgt ttaactcatt gacgcaatac
gcatattgtt cgtttggatg gaataccata 3780 tgacgcgggc cggccccttc
aacggtggtc acttccgcag ggtcctgcgc cacgagatga 3840 ccatcatcgc
tgaccgtaaa caggcaaatg cgatcctgct ttaatgccgg aacccacagc 3900
gtacggttgt ccggtgagat attggcggaa tggcaaccgt ccagcccctc gaccacatcg
3960 acgacgccca ctggcaggcc atcttccaga cgcgttacgc tcacgttacc
cgcattgtaa 4020 gaacctacaa agacaaactg cccctggtga tcggtggaaa
tatgcgtcgg actacccggc 4080 agcgcagact ctgcggcaaa ggtcagtgcg
ccatcgtccg gggcgatacg atacgccagg 4140 acgcgaaact cagggcgaac
accaacatag agataacgtt tgtccgggct gaccaccatc 4200 ggctgcacct
gccccggcac atcgacaacc tgtgtcagcg tcagtgcgcc ttcatgattc 4260
agattccaga cgtgaatttg ctggctctca gggctggcga tataaactgt ttgcttcatg
4320 aatgctcctt tgggttacct ccgggaaacg cggttgattt gtttagtggt
tgaattattt 4380 gctcaggatg tggcatagtc aagggcgtga cggctcgcta
atacaactca ctatagggct 4440 cgaggaagtt cctatacttt ctagagaata
ggaacttccg cgccgcacac aaaaaccaac 4500 acacagatca tgaaaataaa
gctcttttat tggtaccgaa ttcgccaggg agctctcaga 4560 cgtcgcttgg
tcggtcttta ttcgaacccc agagtcccgc ttacgccccg ccctgccact 4620
catcgcagta ctgttgtaat tcattaagca ttctgccgac atggaagcca tcacaaacgg
4680 catgatgaac ctgaatcgcc agcggcatca gcaccttgtc gccttgcgta
taatatttgc 4740 ccatggtgaa aacgggggcg aagaagttgt ccatattggc
cacgtttaaa tcaaaactgg 4800 tgaaactcac ccagggattg gctgagacga
aaaacatatt ctcaataaac cctttaggga 4860 aataggccag gttttcaccg
taacacgcca catcttgcga atatatgtgt agaaactgcc 4920 ggaaatcgtc
gtggtattca ctccagagcg atgaaaacgt ttcagtttgc tcatggaaaa 4980
cggtgtaaca agggtgaaca ctatcccata tcaccagctc accgtctttc attgccatac
5040
ggaattccgg atgagcattc atcaggcggg caagaatgtg aataaaggcc ggataaaact
5100 tgtgcttatt tttctttacg gtctttaaaa aggccgtaat atccagctga
acggtctggt 5160 tataggtaca ttgagcaact gactgaaatg cctcaaaatg
ttctttacga tgccattggg 5220 atatatcaac ggtggtatat ccagtgattt
ttttctccat ggtttagttc ctcaccttgt 5280 cgtattatac tatgccgata
tactatgccg atgattaatt gtcaacacgt gctgctgcag 5340 gtcgaaaggc
ccggagatga ggaagaggag aacagcgcgg cagacgtgcg cttttgaagc 5400
gtgcagaatg ccgggcctcc ggaggacctt cgggcgcccg ccccgcccct gagcccgccc
5460 ctgagcccgc ccccggaccc accccttccc agcctctgag cccagaaagc
gaaggagcaa 5520 agctgctatt ggccgctgcc ccaaaggcct acccgcttcc
attgctcagc ggtgctgtcc 5580 atctgcacga gactagtgag acgtgctact
tccatttgtc acgtcctgca cgacgcgagc 5640 tgcggggcgg gggggaactt
cctgactagg ggaggagtgg aaggtggcgc gaaggggcca 5700 ccaaagaacg
gagccggttg gcgcctaccg gtggatgtgg aatgtgtgcg aggccagagg 5760
ccacttgtgt agcgccaagt gcccagcggg gctgctaaag cgcatgctcc agactgcctt
5820 gggaaaagcg cctcccctac ccggtagaat gaagttccta tactttctag
agaataggaa 5880 cttcgcggcc gccctttagt gagggttaat tcaactgact
gtaacagcta aaattagtcg 5940 cttttggcgg taagggcgaa ttccagcaca
ctggcggccg ttactagtgg atccgagctc 6000 ggtaccaagc ttgatgcagg
aattcgatat caagcttatc gataccgtcg acctcgaggg 6060 ggggcccggt
acccagcttt tgttcccttt agtgagggtt aattgcgcgc ttggcgtaat 6120
catggtcata gctgtttcct gtgtgaaatt gttatccgct cacaattcca cacaacatac
6180 gagccggaag cataaagtgt aaagcctggg gtgcctaatg agtgagctaa
ctcacattaa 6240 ttgcgttgcg ctcactgccc gctttccagt cgggaaacct
gtcgtgccag ctgcattaat 6300 gaatcggcca acgcgcgggg agaggcggtt
tgcgtattgg gcgcatgcat aaaaactgtt 6360 gtaattcatt aagcattctg
ccgacatgga agccatcaca aacggcatga tgaacctgaa 6420 tcgccagcgg
catcagcacc ttgtcgcctt gcgtataata tttgcccatg gacgcacacc 6480
gtggaaacgg atgaaggcac gaacccagtt gacataagcc tgttcggttc gtaaactgta
6540 atgcaagtag cgtatgcgct cacgcaactg gtccagaacc ttgaccgaac
gcagcggtgg 6600 taacggcgca gtggcggttt tcatggcttg ttatgactgt
ttttttgtac agtctatgcc 6660 tcgggcatcc aagcagcaag cgcgttacgc
cgtgggtcga tgtttgatgt tatggagcag 6720 caacgatgtt acgcagcagc
aacgatgtta cgcagcaggg cagtcgccct aaaacaaagt 6780 taggtggctc
aagtatgggc atcattcgca catgtaggct cggccctgac caagtcaaat 6840
ccatgcgggc tgctcttgat cttttcggtc gtgagttcgg agacgtagcc acctactccc
6900 aacatcagcc ggactccgat tacctcggga acttgctccg tagtaagaca
ttcatcgcgc 6960 ttgctgcctt cgaccaagaa gcggttgttg gcgctctcgc
ggcttacgtt ctgcccaggt 7020 ttgagcagcc gcgtagtgag atctatatct
atgatctcgc agtctccggc gagcaccgga 7080 ggcagggcat tgccaccgcg
ctcatcaatc tcctcaagca tgaggccaac gcgcttggtg 7140 cttatgtgat
ctacgtgcaa gcagattacg gtgacgatcc cgcagtggct ctctatacaa 7200
agttgggcat acgggaagaa gtgatgcact ttgatatcga cccaagtacc gccacctaac
7260 aattcgttca agccgagatc ggcttcccgg ccgcggagtt gttcggtaaa
ttgtcacaac 7320 gccgccaggt ggcacttttc ggggaaatgt gcgcgcccgc
gttcctgctg gcgctgggcc 7380 tgtttctggc gctggacttc ccgctgttcc
gtcagcagct tttcgcccac ggccttgatg 7440 atcgcggcgg ccttggcctg
catatcccga ttcaacggcc ccagggcgtc cagaacgggc 7500 ttcaggcgct
cccgaaggt 7519 <210> SEQ ID NO 7 <211> LENGTH: 6858
<212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 7 gtttgacagc ttatcatcga ctgcacggtg
caccaatgct tctggcgtca ggcagccatc 60 ggaagctgtg gtatggctgt
gcaggtcgta aatcactgca taattcgtgt cgctcaaggc 120 gcactcccgt
tctggataat gttttttgcg ccgacatcat aacggttctg gcaaatattc 180
tgaaatgagc tgttgacaat taatcatccg gctcgtataa tgtgtggaat tgtgagcgga
240 taacaatttc acacaggaaa cagcgccgct gagaaaaagc gaagcggcac
tgctctttaa 300 caatttatca gacaatctgt gtgggcactc gaccggaatt
atcgattaac tttattatta 360 aaaattaaag aggtatatat taatgtatcg
attaaataag gaggaataaa ccatggaagc 420 tcgtcgttct gcgaactacg
aacctaacag ctgggactat gattacctgc tgtcctccga 480 cacggacgag
tccatcgaag tatacaaaga caaagcgaaa aagctggaag ccgaagttcg 540
tcgcgagatt aataacgaaa aagcagaatt tctgaccctg ctggaactga ttgacaacgt
600 ccagcgcctg ggcctgggtt accgtttcga gtctgatatc cgtggtgcgc
tggatcgctt 660 cgtttcctcc ggcggcttcg atgcggtaac caagacttcc
ctgcacggta cggcactgtc 720 tttccgtctg ctgcgtcaac acggttttga
ggtttctcag gaagcgttca gcggcttcaa 780 agaccaaaac ggcaacttcc
tggagaacct gaaggaagat atcaaagcta tcctgagcct 840 gtacgaggcc
agcttcctgg ctctggaagg cgaaaacatc ctggacgagg cgaaggtttt 900
cgcaatctct catctgaaag aactgtctga agaaaagatc ggtaaagagc tggcagaaca
960 ggtgaaccat gcactggaac tgccactgca tcgccgtact cagcgtctgg
aagcagtatg 1020 gtctatcgag gcctaccgta aaaaggagga cgcgaatcag
gttctgctgg agctggcaat 1080 tctggattac aacatgatcc agtctgtata
ccagcgtgat ctgcgtgaaa cgtcccgttg 1140 gtggcgtcgt gtgggtctgg
cgaccaaact gcactttgct cgtgaccgcc tgattgagag 1200 cttctactgg
gccgtgggtg tagcattcga accgcaatac tccgactgcc gtaactccgt 1260
cgcaaaaatg ttttctttcg taaccattat cgacgatatc tacgatgtat acggcaccct
1320 ggacgaactg gagctgttta ctgatgcagt tgagcgttgg gacgtaaacg
ccatcaacga 1380 cctgccggat tacatgaaac tgtgctttct ggctctgtat
aacactatta acgaaatcgc 1440 ctacgacaac ctgaaagata aaggtgagaa
catcctgccg tatctgacca aagcctgggc 1500 tgacctgtgc aacgctttcc
tgcaagaagc caagtggctg tacaacaaat ctactccgac 1560 ctttgacgac
tacttcggca acgcatggaa atcctcttct ggcccgctgc aactggtgtt 1620
cgcttacttc gctgtcgtgc agaacattaa aaaggaagag atcgaaaacc tgcaaaaata
1680 ccatgacacc atctctcgtc cttcccatat cttccgtctg tgcaatgacc
tggctagcgc 1740 gtctgcggaa attgcgcgtg gtgaaaccgc aaatagcgtt
tcttgttaca tgcgcactaa 1800 aggtatctcc gaagaactgg ctaccgaaag
cgtgatgaat ctgatcgatg aaacctggaa 1860 aaagatgaac aaggaaaaac
tgggtggtag cctgttcgcg aaaccgttcg tggaaaccgc 1920 gatcaacctg
gcacgtcaat ctcactgcac ttatcataac ggcgacgcgc atacctctcc 1980
ggatgagctg acccgcaaac gcgttctgtc tgtaatcact gaaccgattc tgccgtttga
2040 acgctaactg cataaaggag gtaaaaaaac atggtatcct gttctgcgcc
gggtaagatt 2100 tacctgttcg gtgaacacgc cgtagtttat ggcgaaactg
caattgcgtg tgcggtggaa 2160 ctgcgtaccc gtgttcgcgc ggaactcaat
gactctatca ctattcagag ccagatcggc 2220 cgcaccggtc tggatttcga
aaagcaccct tatgtgtctg cggtaattga gaaaatgcgc 2280 aaatctattc
ctattaacgg tgttttcttg accgtcgatt ccgacatccc ggtgggctcc 2340
ggtctgggta gcagcgcagc cgttactatc gcgtctattg gtgcgctgaa cgagctgttc
2400 ggctttggcc tcagcctgca agaaatcgct aaactgggcc acgaaatcga
aattaaagta 2460 cagggtgccg cgtccccaac cgatacgtat gtttctacct
tcggcggcgt ggttaccatc 2520 ccggaacgtc gcaaactgaa aactccggac
tgcggcattg tgattggcga taccggcgtt 2580 ttctcctcca ccaaagagtt
agtagctaac gtacgtcagc tgcgcgaaag ctacccggat 2640 ttgatcgaac
cgctgatgac ctctattggc aaaatctctc gtatcggcga acaactggtt 2700
ctgtctggcg actacgcatc catcggccgc ctgatgaacg tcaaccaggg tctcctggac
2760 gccctgggcg ttaacatctt agaactgagc cagctgatct attccgctcg
tgcggcaggt 2820 gcgtttggcg ctaaaatcac gggcgctggc ggcggtggct
gtatggttgc gctgaccgct 2880 ccggaaaaat gcaaccaagt ggcagaagcg
gtagcaggcg ctggcggtaa agtgactatc 2940 actaaaccga ccgagcaagg
tctgaaagta gattaaagtc tagttaaagt ttaaacggtc 3000 tccagcttgg
ctgttttggc ggatgagaga agattttcag cctgatacag attaaatcag 3060
aacgcagaag cggtctgata aaacagaatt tgcctggcgg cagtagcgcg gtggtcccac
3120 ctgaccccat gccgaactca gaagtgaaac gccgtagcgc cgatggtagt
gtggggtctc 3180 cccatgcgag agtagggaac tgccaggcat caaataaaac
gaaaggctca gtcgaaagac 3240 tgggcctttc gttttatctg ttgtttgtcg
gtgaacgctc tcctgagtag gacaaatccg 3300 ccgggagcgg atttgaacgt
tgcgaagcaa cggcccggag ggtggcgggc aggacgcccg 3360 ccataaactg
ccaggcatca aattaagcag aaggccatcc tgacggatgg cctttttgcg 3420
tttctacaaa ctctttttgt ttatttttct aaatacattc aaatatgtat ccgctcatga
3480 gacaataacc ctgataaatg cttcaataat attgaaaaag gaagagtatg
agtattcaac 3540 atttccgtgt cgcccttatt cccttttttg cggcattttg
ccttcctgtt tttgctcacc 3600 cagaaacgct ggtgaaagta aaagatgctg
aagatcagtt gggtgcacga gtgggttaca 3660 tcgaactgga tctcaacagc
ggtaagatcc ttgagagttt tcgccccgaa gaacgttttc 3720 caatgatgag
cacttttaaa gttctgctat gtggcgcggt attatcccgt gttgacgccg 3780
ggcaagagca actcggtcgc cgcatacact attctcagaa tgacttggtt gagtactcac
3840 cagtcacaga aaagcatctt acggatggca tgacagtaag agaattatgc
agtgctgcca 3900 taaccatgag tgataacact gcggccaact tacttctgac
aacgatcgga ggaccgaagg 3960 agctaaccgc ttttttgcac aacatggggg
atcatgtaac tcgccttgat cgttgggaac 4020 cggagctgaa tgaagccata
ccaaacgacg agcgtgacac cacgatgcct gtagcaatgg 4080 caacaacgtt
gcgcaaacta ttaactggcg aactacttac tctagcttcc cggcaacaat 4140
taatagactg gatggaggcg gataaagttg caggaccact tctgcgctcg gcccttccgg
4200 ctggctggtt tattgctgat aaatctggag ccggtgagcg tgggtctcgc
ggtatcattg 4260 cagcactggg gccagatggt aagccctccc gtatcgtagt
tatctacacg acggggagtc 4320 aggcaactat ggatgaacga aatagacaga
tcgctgagat aggtgcctca ctgattaagc 4380 attggtaact gtcagaccaa
gtttactcat atatacttta gattgattta aaacttcatt 4440 tttaatttaa
aaggatctag gtgaagatcc tttttgataa tctcatgacc aaaatccctt 4500
aacgtgagtt ttcgttccac tgagcgtcag accccgtaga aaagatcaaa ggatcttctt
4560 gagatccttt ttttctgcgc gtaatctgct gcttgcaaac aaaaaaacca
ccgctaccag 4620 cggtggtttg tttgccggat caagagctac caactctttt
tccgaaggta actggcttca 4680
gcagagcgca gataccaaat actgtccttc tagtgtagcc gtagttaggc caccacttca
4740 agaactctgt agcaccgcct acatacctcg ctctgctaat cctgttacca
gtggctgctg 4800 ccagtggcga taagtcgtgt cttaccgggt tggactcaag
acgatagtta ccggataagg 4860 cgcagcggtc gggctgaacg gggggttcgt
gcacacagcc cagcttggag cgaacgacct 4920 acaccgaact gagataccta
cagcgtgagc tatgagaaag cgccacgctt cccgaaggga 4980 gaaaggcgga
caggtatccg gtaagcggca gggtcggaac aggagagcgc acgagggagc 5040
ttccaggggg aaacgcctgg tatctttata gtcctgtcgg gtttcgccac ctctgacttg
5100 agcgtcgatt tttgtgatgc tcgtcagggg ggcggagcct atggaaaaac
gccagcaacg 5160 cggccttttt acggttcctg gccttttgct ggccttttgc
tcacatgttc tttcctgcgt 5220 tatcccctga ttctgtggat aaccgtatta
ccgcctttga gtgagctgat accgctcgcc 5280 gcagccgaac gaccgagcgc
agcgagtcag tgagcgagga agcggaagag cgcctgatgc 5340 ggtattttct
ccttacgcat ctgtgcggta tttcacaccg catatggtgc actctcagta 5400
caatctgctc tgatgccgca tagttaagcc agtatacact ccgctatcgc tacgtgactg
5460 ggtcatggct gcgccccgac acccgccaac acccgctgac gcgccctgac
gggcttgtct 5520 gctcccggca tccgcttaca gacaagctgt gaccgtctcc
gggagctgca tgtgtcagag 5580 gttttcaccg tcatcaccga aacgcgcgag
gcagcagatc aattcgcgcg cgaaggcgaa 5640 gcggcatgca tttacgttga
caccatcgaa tggtgcaaaa cctttcgcgg tatggcatga 5700 tagcgcccgg
aagagagtca attcagggtg gtgaatgtga aaccagtaac gttatacgat 5760
gtcgcagagt atgccggtgt ctcttatcag accgtttccc gcgtggtgaa ccaggccagc
5820 cacgtttctg cgaaaacgcg ggaaaaagtg gaagcggcga tggcggagct
gaattacatt 5880 cccaaccgcg tggcacaaca actggcgggc aaacagtcgt
tgctgattgg cgttgccacc 5940 tccagtctgg ccctgcacgc gccgtcgcaa
attgtcgcgg cgattaaatc tcgcgccgat 6000 caactgggtg ccagcgtggt
ggtgtcgatg gtagaacgaa gcggcgtcga agcctgtaaa 6060 gcggcggtgc
acaatcttct cgcgcaacgc gtcagtgggc tgatcattaa ctatccgctg 6120
gatgaccagg atgccattgc tgtggaagct gcctgcacta atgttccggc gttatttctt
6180 gatgtctctg accagacacc catcaacagt attattttct cccatgaaga
cggtacgcga 6240 ctgggcgtgg agcatctggt cgcattgggt caccagcaaa
tcgcgctgtt agcgggccca 6300 ttaagttctg tctcggcgcg tctgcgtctg
gctggctggc ataaatatct cactcgcaat 6360 caaattcagc cgatagcgga
acgggaaggc gactggagtg ccatgtccgg ttttcaacaa 6420 accatgcaaa
tgctgaatga gggcatcgtt cccactgcga tgctggttgc caacgatcag 6480
atggcgctgg gcgcaatgcg cgccattacc gagtccgggc tgcgcgttgg tgcggatatc
6540 tcggtagtgg gatacgacga taccgaagac agctcatgtt atatcccgcc
gtcaaccacc 6600 atcaaacagg attttcgcct gctggggcaa accagcgtgg
accgcttgct gcaactctct 6660 cagggccagg cggtgaaggg caatcagctg
ttgcccgtct cactggtgaa aagaaaaacc 6720 accctggcgc ccaatacgca
aaccgcctct ccccgcgcgt tggccgattc attaatgcag 6780 ctggcacgac
aggtttcccg actggaaagc gggcagtgag cgcaacgcaa ttaatgtgag 6840
ttagcgcgaa ttgatctg 6858 <210> SEQ ID NO 8 <211>
LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 8 gacgctttcg ccaagtcagg
20 <210> SEQ ID NO 9 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 9 gtcaggctgg aatactcttc g 21 <210> SEQ ID NO 10
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 10
accaattgca cccggcaga 19 <210> SEQ ID NO 11 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 11 gctaaagcgc atgctccaga
c 21 <210> SEQ ID NO 12 <211> LENGTH: 20 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 12 gactggcctc agatgaaagc 20 <210> SEQ
ID NO 13 <211> LENGTH: 20 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 13
caaacatgtg gcatggaaag 20 <210> SEQ ID NO 14 <211>
LENGTH: 52 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 14 gggcccgttt aaactttaac
tagactctgc agttagcgtt caaacggcag aa 52 <210> SEQ ID NO 15
<211> LENGTH: 38 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 15
cgcatgcatg tcatgagatg tagcgtgtcc accgaaaa 38 <210> SEQ ID NO
16 <211> LENGTH: 22 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 16
acaatttcac acaggaaaca gc 22 <210> SEQ ID NO 17 <211>
LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 17 ccaggcaaat tctgttttat
cag 23 <210> SEQ ID NO 18 <211> LENGTH: 22 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 18 gcactgtctt tccgtctgct gc 22 <210>
SEQ ID NO 19 <211> LENGTH: 66 <212> TYPE: DNA
<213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 19 gcgaacgatg cataaaggag gtaaaaaaac atggtatcct gttctgcgcc
gggtaagatt 60 tacctg 66 <210> SEQ ID NO 20 <211>
LENGTH: 48 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 20 gggcccgttt aaactttaac
tagactttaa tctactttca gaccttgc 48 <210> SEQ ID NO 21
<211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 21
gatagtaacg gctgcgctgc tacc 24 <210> SEQ ID NO 22 <211>
LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct
<400> SEQUENCE: 22 gacagcttat catcgactgc acg 23 <210>
SEQ ID NO 23 <211> LENGTH: 22 <212> TYPE: DNA
<213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 23 caccatggta tcctgttctg cg 22 <210> SEQ ID NO 24
<211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 24
ttaatctact ttcagacctt gc 22 <210> SEQ ID NO 25 <211>
LENGTH: 67 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 25 accgccaaaa gcgactaatt
ttagctgtta cagtcagttg aattaaccct cactaaaggg 60 cggccgc 67
<210> SEQ ID NO 26 <211> LENGTH: 152 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 26 gctggcgata taaactgttt gcttcatgaa tgctcctttg ggttacctcc
gggaaacgcg 60 gttgatttgt ttagtggttg aattatttgc tcaggatgtg
gcatagtcaa gggcgtgacg 120 gctcgctaat acgactcact atagggctcg ag 152
<210> SEQ ID NO 27 <211> LENGTH: 26 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 27 accgccaaaa gcgactaatt ttagct 26 <210> SEQ ID NO
28 <211> LENGTH: 30 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 28
cttgatatct tagtgtgcgt taaccaccac 30 <210> SEQ ID NO 29
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 29
cgtgaatttg ctggctctca g 21 <210> SEQ ID NO 30 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 30 ggtttagttc ctcaccttgt
c 21 <210> SEQ ID NO 31 <211> LENGTH: 21 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 31 actgaaacgt tttcatcgct c 21 <210> SEQ
ID NO 32 <211> LENGTH: 81 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 32
aaagtagccg aagatgacgg tttgtcacat ggagttggca ggatgtttga ttaaaagcaa
60 ttaaccctca ctaaagggcg g 81 <210> SEQ ID NO 33 <211>
LENGTH: 199 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <220> FEATURE: <221> NAME/KEY:
misc_feature <222> LOCATION: 112 <223> OTHER
INFORMATION: n = A,T,C or G <400> SEQUENCE: 33 taaatcttac
ccggcgcaga acaggatacc atgttttttt acctcctttg caccttcatg 60
gtggtcagtg cgtcctgctg atgtgctcag tatcaccgcc agtggtattt angtcaacac
120 cgccagagat aatttatcac cgcagatggt tatctgtatg ttttttatat
gaatttaata 180 cgactcacta tagggctcg 199 <210> SEQ ID NO 34
<211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 34
aaagaccgac caagcgacgt ctga 24 <210> SEQ ID NO 35 <211>
LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial
Sequence <220> FEATURE: <223> OTHER INFORMATION:
Synthetic Construct <400> SEQUENCE: 35 gctctgaata gtgatagagt
ca 22 <210> SEQ ID NO 36 <211> LENGTH: 445 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 36 aaagaccgac caagcgacgt ctgagagctc
cctggcgaat tcggtaccaa taaaagagct 60 ttattttcat gatctgtgtg
ttggtttttg tgtgcggcgc ggaagttcct attctctaga 120 aagtatagga
acttcctcga gccctatagt gagtcgtatt aaattcatat aaaaaacata 180
cagataacca tctgcggtga taaattatct ctggcggtgt tgacataaat accactggcg
240 gtgatactga gcacatcagc aggacgcact gaccaccatg aaggtgcaaa
ggaggtaaaa 300 aaacatggta tcctgttctg cgccgggtaa gatttacctg
ttcggtgaac acgccgtagt 360 ttatggcgaa actgcaattg cgtgtgcggt
ggaactgcgt acccgtgttc gcgcggaact 420 caatgactct atcactattc agagc
445 <210> SEQ ID NO 37 <211> LENGTH: 445 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 37 aaagaccgac caagcgacgt ctgagagctc
cctggcgaat tcggtaccaa taaaagagct 60 ttattttcat gatctgtgtg
ttggtttttg tgtgcggcgc ggaagttcct attctctaga 120 aagtatagga
acttcctcga gccctatagt gagtcgtatt aaattcatat aaaaaacata 180
cagataacca tctgcggtga taaattatct ctggcggtgt tgacctaaat accactggcg
240 gtgatactga gcacatcagc aggacgcact gaccaccatg aaggtgcaaa
ggaggtaaaa 300 aaacatggta tcctgttctg cgccgggtaa gatttacctg
ttcggtgaac acgccgtagt 360 ttatggcgaa actgcaattg cgtgtgcggt
ggaactgcgt acccgtgttc gcgcggaact 420 caatgactct atcactattc agagc
445 <210> SEQ ID NO 38 <211> LENGTH: 442 <212>
TYPE: DNA <213> ORGANISM: Artificial Sequence <220>
FEATURE: <223> OTHER INFORMATION: Synthetic Construct
<400> SEQUENCE: 38 aaagaccgac caagcgacgt ctgagagctc
cctggcgaat tcggtaccaa taaaagagct 60 ttattttcat gatctgtgtg
ttggtttttg tgtgcggcgc ggaagttcct attctctaga 120 aagtatagga
acttcctcga gccctatagt gagtcgtatt aaattcatat aaaaaacata 180
cagataacca tctgcggtga taaattatct ctggcggtgt tgacctaaat accactggcg
240 gtgatactga gcacatcagc aggacgcact gaccaccatg aaggtgcaaa
ggtaaaaaaa 300
catggtatcc tgttctgcgc cgggtaagat ttacctgttc ggtgaacacg ccgtagttta
360 tggcgaaact gcaattgcgt gtgcggtgga actgcgtacc cgtgttcgcg
cggaactcaa 420 tgactctatc actattcaga gc 442 <210> SEQ ID NO
39 <211> LENGTH: 445 <212> TYPE: DNA <213>
ORGANISM: Artificial Sequence <220> FEATURE: <223>
OTHER INFORMATION: Synthetic Construct <400> SEQUENCE: 39
aaagaccgac caagcgacgt ctgagagctc cctggcgaat tcggtaccaa taaaagagct
60 ttattttcat gatctgtgtg ttggtttttg tgtgcggcgc ggaagttcct
attctctaga 120 aagtatagga acttcctcga gccctatagt gagtcgtatt
aaattcatat aaaaaacata 180 cagataacca tctgcggtga taaattatct
ctggcggtgt tgacgtaaat accactggcg 240 gtgatactga gcacatcagc
aggacgcact gaccaccatg aaggtgcaaa ggaggtaaaa 300 aaacatggta
tcctgttctg cgccgggtaa gatttacctg ttcggtgaac acgccgtagt 360
ttatggcgaa actgcaattg cgtgtgcggt ggaactgcgt acccgtgttc gcgcggaact
420 caatgactct atcactattc agagc 445 <210> SEQ ID NO 40
<211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 40
gaggaataaa ccatggaagc tcgtcgttct 30 <210> SEQ ID NO 41
<211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 41
agaacgacga gcttccatgg tttattcctc 30 <210> SEQ ID NO 42
<400> SEQUENCE: 42 000 <210> SEQ ID NO 43 <400>
SEQUENCE: 43 000 <210> SEQ ID NO 44 <211> LENGTH: 20
<212> TYPE: DNA <213> ORGANISM: Artificial Sequence
<220> FEATURE: <223> OTHER INFORMATION: Synthetic
Construct <400> SEQUENCE: 44 ctcgtacagg ctcaggatag 20
<210> SEQ ID NO 45 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:
<223> OTHER INFORMATION: Synthetic Construct <400>
SEQUENCE: 45 ttacgtccca acgctcaact 20 <210> SEQ ID NO 46
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial Sequence <220> FEATURE: <223> OTHER
INFORMATION: Synthetic Construct <400> SEQUENCE: 46
cttcggcaac gcatggaaat 20 <210> SEQ ID NO 47 <400>
SEQUENCE: 47 000
* * * * *